ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000440.1|Teicoplanin_1 # 90 # 614 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.682	BGC0000440.1|Teicoplanin_1 	90	614	+	Loose	500	26.9498	STA-1	37.5	3007000	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	STA beta-lactamase	ATGCGATACGTCAAGATCAGCCGAGGGCGCGACGGCAATACGCTGGACGCGACCGGATACCTGGACGCGCTCGGTGCGTTCGCCGAACGACTGCCACCTGGCGCGCGTGCGTTCGCCACCGATCCGCAGCACTACGACCTCTTCGGCGGGCGGTGCGTCAAGGACCTCAAGCCCGTGGCACTGACTCTGGGCGATGGCGATGGCGATGGCGATGGACGAGCATGGGCGGAGCTTCGCCTGCAGCACCACTGCTGGAAACACGAGGAGGACCTGACGATCCGCTACAGCGGCGTACGCAGCGTCGTAGCGGATCCCGACGGTGCCGAGACGGACGTGCGCAGCCTTCGCGACGTGATGCTCGACGAGGTTCTGCCCCACGGGCAGGGGTGCAGCCACGAGATCGCGTTCCTCGCCGGGTCGATGACCATCGTCGCCGACGATCTCGTGGCCACCTGGGACGCGGCTGACTGCGCCGATCGTCAAGCGCTCTCCCGGGCCGCGGGTCCGCCCTCGGCCGCATCCTGA	MRYVKISRGRDGNTLDATGYLDALGAFAERLPPGARAFATDPQHYDLFGGRCVKDLKPVALTLGDGDGDGDGRAWAELRLQHHCWKHEEDLTIRYSGVRSVVADPDGAETDVRSLRDVMLDEVLPHGQGCSHEIAFLAGSMTIVADDLVATWDAADCADRQALSRAAGPPSAAS	MHPPLRPHPLWCSLRPATLALLLGVFGCRTSVPAPRPAAEPFTSITEDLRIQPLAPGVWRLVALSGEEWGHIPANGLVIAEGGGVLLVDPGWTEAQGERLLQWVEDTLKVPVHAGVATHFHADRTGGLRALQARGIPTHALALTAALTSQQDRPAPTHLFPGPAQQLGPVELFFPGPGHAPDNITVWHAASGILFGGCMVKDLKASSLGNLSDADLASWPRSVESLQARYPAARTVIPGHGEPGDTSLLAHTLELLRAGSR	66.67	gnl|BL_ORD_ID|4596|hsp_num:0	5666			579	711	
BGC0000440.1|Teicoplanin_2 # 748 # 1278 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.744	BGC0000440.1|Teicoplanin_2 	748	1278	-	Loose	525	23.8682	EVM-1	48.0	3006886	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	EVM beta-lactamase	ATGCTGGAGCTGATCACTGTGGGGCACGGCACCGCCGGCCGGGACGAGCTGGCGGCGCTGTTCACCGGGGCCGGGCTGGACCGGGTGGTGGACGTGCGCCGCTACCCCGGCAGCCGCCACCATCCACATGTCGGTGTCGAGGCGTTGAGCCGCTGGCTGCCGGAAGCCGGCATCGCCTACCGCGCCGACCAGCGGTTGGGCGGGCGCCGCCGCCTGCCGCCGGAATCACCGGACATCTGGTGGCGGGTCGAGGCGTTCCGCGCCTACGCCGCGCACATGCGCACGGCCGAGTTCCACGAGGCCGTCGACGAGCTGCTCACCGACATCCGGGCGGGCACCACCGCGGTGATGTGCAGCGAGACCCTGTGGTGGCGCTGCCACCGGCGCCTGATCGCCGACTTCGTCAGCGAGATCCACGGGTTCCCGGTCCGCCACCTGGACCACCGCGGTCGGCTCGCCCGCCACCGGGTGGCCGCCGGCGCCCGGTGGCGCTCCCCCGACGAGCTCGTTTACGACGCGGCCCCGCCCTGA	MLELITVGHGTAGRDELAALFTGAGLDRVVDVRRYPGSRHHPHVGVEALSRWLPEAGIAYRADQRLGGRRRLPPESPDIWWRVEAFRAYAAHMRTAEFHEAVDELLTDIRAGTTAVMCSETLWWRCHRRLIADFVSEIHGFPVRHLDHRGRLARHRVAAGARWRSPDELVYDAAPP	MSVKFLVPIAFALSGCAVLPPPIQTPEPLPPAEEVQPEQWAATCEPWDDWDKPAPPYRIFGSTYYVGTCGISAILIAGDDGHILIDSGTEEGAEVVMDNIQKLGFRLNEIASILHSHEHFDHVGGLAKLRAATGAHIVSSAEAAKVLSTGEDHPEDPQFGVHEPMEPVQVDVIVEDGDTVRTETATVTAHATPGHSPGALSWTWVSCSLPGEPPACSRIAYVDSLSAVSSDDYRFTDHPEVVAAFRTSIDKVRSLPCDILLTPHPSSSQLIERLRTGTLGAPGKCATYAAQLGDKLDERLAKENP	57.70	gnl|BL_ORD_ID|3531|hsp_num:0	4600			351	426	
BGC0000440.1|Teicoplanin_4 # 2931 # 4007 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=9bp;gc_cont=0.746	BGC0000440.1|Teicoplanin_4 	2931	4007	-	Loose	1200	25.7942	arnA	38.89	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCCGCACCGCCCGCGCAGGATCGTCACCGCTCTCGTCCTCACCGCCGCGCTCGCCGTGGCCGGAGCCGTCACCGGCCCGGTCGCGCACGCCGGCGACCGACCGGCCACCTCCACCCCGACACCACCGAACCCGTCGCCGTTCCCGCCGACCGCGCCGGCCGGCCTGACCGCCGCCGCGGTGCACGCCACCTCGGTGACGCTGACCTGGACCGCGTCGCGGCCGGGCTGCTGCGTCGTGGACCACTACGAGGTCCAGTACCGCCTGGCGTTCAACGACGTCGTCGCGCTGGTCGACGCCGGCAACGTCACCTCCACCACGATCACCGGCCTGGCGCCCGCCCGGCAGTACTCGTTCCAGGTCACCGCGGTCGACGGCGTCAACCACCGGTCGGCGCCGTCCACCGTGGTCACCGTGGTCACCCCGGTGTCCGACACCGCGCCGGACACCAGCCCGCCGAGCGCGCCCACCGGCCTGGCCGCCACCGAGGTCACCGCGTCCCGCGCGGTACTGACCTGGGCGCCGTCCACCGACGACGTCGGCGTCACCGGCTACGACGTCTACCGGTTCGACGGGTGGTACACCTCCACCCTGCTCACCACCACCACCGCCACGACGTACGCCGTGCCGACCGGCGGCGGCCGGAACGTGTACTACGTACGGGCCCGCGACGCGGCGGGCAACGTGTCGATCGCCTCGGACACGGTCAGCACGGTGATCACCACCCCGTCGCCGAGCACTCCCCCGCCGCCCGAGCCGGTCTGCCGGGTCGGCTACCGCGCCACCTCGACGTGGGCCGGGGGCTTCGTGGCCGAGGTGACCGTCACCAACATCGGGACGGAACCGATCGACGGCTGGACGCTCACCTTCGCCTACGGCGGCGATCAGCGGGTGAGCGCGTCGTGGAACGGCGACGTCACCCAGTCCGGCGCGGACGTCACGGTGACCGGGGCGGCATGGAACCGCCGGCTCGGCGCCGGAGCGAGCGCCACGGTCGGGGTGCTGGGCTCCTGGCGGACCAGCGACGCGCCGCCGGCGGCGTACACGCTCAACGGCCGGTCCTGCGTGACGGCCTGA	MPHRPRRIVTALVLTAALAVAGAVTGPVAHAGDRPATSTPTPPNPSPFPPTAPAGLTAAAVHATSVTLTWTASRPGCCVVDHYEVQYRLAFNDVVALVDAGNVTSTTITGLAPARQYSFQVTAVDGVNHRSAPSTVVTVVTPVSDTAPDTSPPSAPTGLAATEVTASRAVLTWAPSTDDVGVTGYDVYRFDGWYTSTLLTTTTATTYAVPTGGGRNVYYVRARDAAGNVSIASDTVSTVITTPSPSTPPPPEPVCRVGYRATSTWAGGFVAEVTVTNIGTEPIDGWTLTFAYGGDQRVSASWNGDVTQSGADVTVTGAAWNRRLGAGASATVGVLGSWRTSDAPPAAYTLNGRSCVTA	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	54.08	gnl|BL_ORD_ID|1513|hsp_num:0	1643			678	774	polymyxin B
BGC0000440.1|Teicoplanin_5 # 4458 # 5987 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=8bp;gc_cont=0.705	BGC0000440.1|Teicoplanin_5 	4458	5987	+	Loose	500	26.9498	OXA-837	28.85	3005060	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGTTCGAACCCCCCTGGCCGTCGCCCTGGCGGCCGGCACCGTGGCCGCCTCGGCCCTGGTCGCGGTGTCCGGTCCGGCAGCCGCGCAGGCGCCCGCCCCGTCCGTCGACGCGGTCGCGCAGGCCGACGCCGTGGTCGCCGCCCGCCCGGCCGTACTGCAGGCCGGCAAGCACGACGACTTCCACCGGCGGCAGGTCTACAAGTCGCAGGGCCTGACCTACGCGTCCTACGACCGTACCTACAAGGGCTTCCCGGTCAAGGGCGGCGACTTCGTCGTGGTCACCGACAACGCCGGTCAGACCCGGTACACGTCGGTCGCGCAGAGCAGCCCGATCGGTGAGCTCTCGACCGAGCCGACGGTCTCCGAGAGCGCGGCGATCGCCACCGCCAAGAAGCAGCTCAAGAGCGTCACCAGCGTCGAGGCCACCCGGCTGGTGGTCGTCGCGGCCGAGGGCCGCGCGGCGAAGCTGGCGTACGAGACCACGGTCAACGGCACCGGCGCGGAGGGCGTCAGCCGCCTCACCGTCGACGTGGACGCGACCACCGGCGCGGTGCTGGCCACCGAGGAGCACGTCACCGAGGCCACCGGCACGGGCACCGGCTGGATCGTCGGCTCGGTGTCGCTGAACACCACGCAGTCCGGCTCGACGTACTCCCTCAAGGACCCGACGGTCACCAACCTGAGCTGCCAGGACGCCTCCACCCGGACCACGTTCAGCGGCTCGGACAACGTGTGGGGCAACGGCACCGGCACCAGCAAGGAGACCGGCTGCGTCGACGCGCTGTACGCGGCGCAGAAGCAGACCGCGATGCTGTCGGCGTGGCTGGGCCGCAACGGGCAGAACGGCTCCGGCGGCGCGTGGCCGATCCGGGTCGGGCTGAACCAGCAGAACGCGTACTACGACGGCACCCAGATCCAGATCGGCAAGAACACCGCCGGCAAGTGGATCTCGTCGCTCGACGTGGTCGGCCACGAGCTGGGTCACGGCATCGACGACAAGACCCCGGGCGGCATCTCGAAGGGCGGCACCCAGGAGTTCGTCGCCGACACCATCGGCGCGGCCACCGAGGCGTACGCCGCGAACCCCAACGACCCGTTCGACTACCAGGTCGGCGAGGAGGTCAACCTGGTCGGCAGCGGCCCGATCCGGTACATGTACAACCCGTCGCTGGCCGGTGACGACAACTGCTACTCCAGCAGCACCCCGACCGACGAGGTGCACGCCGCCGCCGGCCCCGGCAACCACTGGTTCTACCTGCTGGCCCAGGGCAGCGGCGGCAACGGCCAGCCGGCCAGCTCCACCTGCAACGGCTCCACGGTGACCGGTGTCGGCATCCAGACCGCCATCAAGATCATGTACAACGCGATGCTGCTGAAGACCTCCAGCTCCTCCTACGCCAAGTACCGCGTGTGGACGCTGCAGGCCGCGAAGAACCTGTACCCGGGCAGCTGCACCCAGTTCAACGCGGTCAAGGCCGCGTGGAACGCGGTCAGCCTGCCGGCCCAGTCCGGCGAGCCCACCTGCTGA	MVRTPLAVALAAGTVAASALVAVSGPAAAQAPAPSVDAVAQADAVVAARPAVLQAGKHDDFHRRQVYKSQGLTYASYDRTYKGFPVKGGDFVVVTDNAGQTRYTSVAQSSPIGELSTEPTVSESAAIATAKKQLKSVTSVEATRLVVVAAEGRAAKLAYETTVNGTGAEGVSRLTVDVDATTGAVLATEEHVTEATGTGTGWIVGSVSLNTTQSGSTYSLKDPTVTNLSCQDASTRTTFSGSDNVWGNGTGTSKETGCVDALYAAQKQTAMLSAWLGRNGQNGSGGAWPIRVGLNQQNAYYDGTQIQIGKNTAGKWISSLDVVGHELGHGIDDKTPGGISKGGTQEFVADTIGAATEAYAANPNDPFDYQVGEEVNLVGSGPIRYMYNPSLAGDDNCYSSSTPTDEVHAAAGPGNHWFYLLAQGSGGNGQPASSTCNGSTVTGVGIQTAIKIMYNAMLLKTSSSSYAKYRVWTLQAAKNLYPGSCTQFNAVKAAWNAVSLPAQSGEPTC	MKSRTEAQSLHAHGLYRRRLLQLAGGAALLPAARLALADVAPASAVAAPSEVARGDLMSHFRALDVDGCFALFDVKANRMTLVNASRAKTRMVPASTYKIPNSLIAFETGVVADPDQIQPYGGGKTRFPQWQRDMNLREAIAMSNVPVYQGIARRIGMQRMQTWVDRLDYGNRQLGKVVDQFWLRGPLAISAAEQTRFLARLAQGQLPASRLSQQWVREILRVEANDDHAIYAKTGWAMDAGLNHGWWVGWVERSGGVHAFALNMDLQREELAPKRMAIARAMMAELGVLPVENGQARKMS	169.10	gnl|BL_ORD_ID|2785|hsp_num:0	3800			444	600	cloxacillin; oxacillin; ampicillin; cefalotin
BGC0000440.1|Teicoplanin_6 # 6123 # 6458 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.705	BGC0000440.1|Teicoplanin_6 	6123	6458	-	Loose	1700	24.6386	LpeB	43.48	3004100	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGACGAAGATCACCCCGGCGGCCGAAGCGGCGTCGCTCGACGAGTACTGGTCCCAGCGGGTCCTGACGGCCGCGAACGGCAACCTGTTCAAGGTGGCCAAGGGCCTCGGTTCCACGCGATGGCACGCGCATGACGATCAGGACGAGACGTTCCTGATGCTGGCCGGAACGCTGACCGTGCACCTGCGGGACGGCTCGGTCGAGCTGACCCCGGGTGACCTGCTGGTCATCCCGCGCGGGGTGGAGCACCGCCCGGAGGCGGCCGGCGAGGCCCGTTTCCTGCTCGTCGGACCGGAGGTCACCTCGACCGAGGCGGGCGGGAAGCCGGCCTGA	MLTKITPAAEAASLDEYWSQRVLTAANGNLFKVAKGLGSTRWHAHDDQDETFLMLAGTLTVHLRDGSVELTPGDLLVIPRGVEHRPEAAGEARFLLVGPEVTSTEAGGKPA	MKLTSYFIKHPVITIILNAMIVVLGLLCLYNLSVREYPDINFPTITVSASYPNASPDLVETAITNVLEDRLAGIEGLETITSQSSAGYAQITLMFRSGTSMDRALSTTQDAVGVAKALLPPEVRSPTVERQRKSNGLPFIGISLESTSKDFGELTHYANLNLKNVFRSVQGVASVEVWGQPYTYNITLQPEKLFSFGVNVDEIVNALAKNRISLPAGNYRNKIPSTLNSELKTREDYENLLIKANSKHPILLKSLANVALETDNSQMRVRVNGHAGVVLSINKANEANPIEVSKEIRKVIKGLQQGLPKDLKINTIIDQSDFINASIKNIRSAIGEAIFLVLIIVFLFLRNIKATIIPLITIPISLLGSLLFLKLFGFSINLMTLLAMVLAIGLVVDDAIIVLENIWRHIESGLSPLDAALKGAREIGFAIIAMTFTLSSVYLPIAFIQGMLGQLFVEFAVALAGSVFISGIVALTLSPLMCANLLSASSKNWWPQFDNALEKLTKHYSNILQFILKHQKITLLTALISVVACFGFYNLISHETAPKEDRGLIGIYIPPVAGEDIGMLDNKTGKLEKKLDAIPEANNRLTFIGDWGGSIVLPLKPHAQRHRSANQIVEKLRPSFNHFPSMDPHVWSWDTGLPGVDDAGSGSELTLVISTPDHFRQLFDETEKLKSVLDKSKLFAAVNYDLRLDTMGYNIDLDYNQLAKLGLTANQVAKTIEVFFSGDKSQTFEKDGVVYNISIKGDSSPWTLNELYLTTNEGKSVSLGAITKMQPKAQPATLDHYQQMRSTTLHVQLHKGDSMAKAIEKLWGTTKEVMPQHYKLTWIGAAKAFHESSNSMLFLFFLSLAFIYAILCTQFENFTDPFIILFTVPLACSGALLFTYLFGQSLNIYTQVGLITLIGLISKHGILIVEFANKLHKDGASLPEAIQKSAALRLRPILMTTGAMVFGAIPLVLSHDAGSESRHAIGTVLISGLGLGTLFTLFVLPAVYNIIKSKLIDMQKTGGKKRCSKE	10.95	gnl|BL_ORD_ID|2387|hsp_num:0	2759			2307	2376	erythromycin; spiramycin; azithromycin
BGC0000440.1|Teicoplanin_7 # 6537 # 7502 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.753	BGC0000440.1|Teicoplanin_7 	6537	7502	-	Loose	400	42.3578	mtrA	26.19	3000816	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGTGCCGCGGCGGGTCGCGCTGATAGTCGACGAACATTCCAACCCGTTCGAGGTGGGCTGTGCCTGCGAGATCTTCGGCGGCCGCCGGCGCCCACAGATCGGCTACGAGCTGTACGAACTCACCGTCGTCAGCCCGACCAGATCGGTACCGATGCGGGACCGGCTGTTCCGCGTCAGCGCGCCCGGGCGGCTGAGCGACCTGGACCGGGCCGACATGATCATCGTGCCGAACCGGCCGGATGTCGACGTCCCGTCCCGCGGCGCGGTCCTGGCGGCGATCCGGCGGGCCCACGCGCGGGGCGCCCGCCTGGTCGGCCTCTGCACCGGCGCCTTCACGCTCGCCGAGGCGGGGGTGCTCGACGGCCGCCGCGCGGCGGTGCACTGGCAGCTGGCTCCGGACTTCCACCGGCGCTTCCCGGCCGTACGGCTGGAGCCGGACGTGCTGTTCGTCGATGACGGCGACATCCTGACCTCGGCGGGCAGCGCGGCGGCGCTCGACCTCGGCCTGCACATCGTCCGCCGCGACCACGGCACCGAGGTGGCCAACCGGGTCGGCCGGCAGCTGGTGTTCGCCGCGTTCCGCGACGGCGGCCAGCGGCAGTTCGTCGAACGCCCGCTGCCGGCGCCGGCGACGAGCCCGCTCGCGCCGGTCCTGCAGTGGGCGCAGGAGCGCCTGCACCTGCGGCTGTCGGTCGACGACCTGGCCCGGCACGGCCGGATGAGCACCGCCACGCTGCACCGGCGCTTCCGCAACGAGGTGGGCAGCACCCCGCTGGCGTGGCTGACCGCGCAGCGCGTCGCGCTGGCGTGCCGCCTGATCGAGCAGGGCGCCGCGGGCGTGGACGCCGTGGCCCGGCAGTCCGGTCTGGGCACCGCCGCCAACCTGCGCGCCCTGCTGCGTAAGCACGTGGGCCTGAGCCCGTCGGAGTACCGCCGGCGCTTCGCCGCCGACGGCGCGCGGTGA	MVPRRVALIVDEHSNPFEVGCACEIFGGRRRPQIGYELYELTVVSPTRSVPMRDRLFRVSAPGRLSDLDRADMIIVPNRPDVDVPSRGAVLAAIRRAHARGARLVGLCTGAFTLAEAGVLDGRRAAVHWQLAPDFHRRFPAVRLEPDVLFVDDGDILTSAGSAAALDLGLHIVRRDHGTEVANRVGRQLVFAAFRDGGQRQFVERPLPAPATSPLAPVLQWAQERLHLRLSVDDLARHGRMSTATLHRRFRNEVGSTPLAWLTAQRVALACRLIEQGAAGVDAVARQSGLGTAANLRALLRKHVGLSPSEYRRRFAADGAR	MDILDKLVDLAQLTGSADVQCLLGGQWSVRHETLQCEGLVHIVTAGSGYLCIDGETSPRPVGTGDIVFFPRGLGHVLSHDGKYGESLQPDIRQNGTFMVKQCGNGLDMSLFCARFRYDTHADLMNGLPETVFLNIAHPSLQYVVSMLQLESEKPLTGTVSVVNALPSVLLVLILRAYLEQDKDVELSGVLKGWQDKRLGHLIQKVIDKPEDEWNIDKMVAAANMSRAQLMRRFKSQVGLSPHAFVNHIRLQKGALLLKKTPDSVLEVALSVGFQSETHFGKAFKRQYHVSPGQYRKEGGQK	106.64	gnl|BL_ORD_ID|1431|hsp_num:0	1559			639	891	erythromycin; penicillin; azithromycin
BGC0000440.1|Teicoplanin_8 # 7806 # 8558 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.748	BGC0000440.1|Teicoplanin_8 	7806	8558	-	Loose	400	38.891	tetR	33.33	3003479	protein overexpression model	n/a	n/a	tetracycline antibiotic	antibiotic target alteration; antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGTGCTACGCAGGAGCCCGGCACGTCCTCCCGGCGGCGTGGCGGTGCGGGGCCCGTCGACGACGCCACCGTCCGCGCCGCCCTGATCCAGGCCGCCGAGCGGCAGCTGACCGCCTCCCCGGACGGCGACATCGCCACCCGCGCCGTCAGCGAGGAGGCCGGCGTCACCCAGCCGGTGCTGTACCGGCTGTTCGGTGACAAACGCGGCCTGCTGGACGCCGTCGCCGACGCCGGATTCGACCGCTACGCCCGGCGCAAGAGCGAACTGGAGGTCACCGACAACCCGGTCGGCGACCTGTACGCGGGATGGGACGACCACATGGCGTTCGCCACCGAGAACCCGGCCCTCTACCAGCTGATGTTCGCGCCCCGGCCGCGTTCGGGCGCGACCACCTACCGCCGCATCCTGACACTGCTCGAGGCCACCCTCCTGCGCTGCGCCGCCGCCGGCGCGCTCACCACGACGCCCCGGGCAGCCGCCCAGCTGATCCTGAGCGCCAACATCGGCGTCGCTCTCGGCCGCATCGCCGCGCCGGAGCTCTTCGACGACCCGGCGCTGTCGCACCGCGCCCGCGACGCCGCCTTCGCCACCGTGCTCACCCACCCCGCCACGCCGAGCGGGCCGGACCCGCTCCGCGACGCCGCCCGCCAGCTGCGCTCGCAGCTCTCGCTCAGCGGCACCGACCGGCTGGAACCGGCCGAGACCGTGCTGCTCGACCGGTGGCTGGAGCGCATCGACCAGCCGGAGTGA	MSATQEPGTSSRRRGGAGPVDDATVRAALIQAAERQLTASPDGDIATRAVSEEAGVTQPVLYRLFGDKRGLLDAVADAGFDRYARRKSELEVTDNPVGDLYAGWDDHMAFATENPALYQLMFAPRPRSGATTYRRILTLLEATLLRCAAAGALTTTPRAAAQLILSANIGVALGRIAAPELFDDPALSHRARDAAFATVLTHPATPSGPDPLRDAARQLRSQLSLSGTDRLEPAETVLLDRWLERIDQPE	MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEMLDRHHTHFCPLEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLENALYALSAVGHFTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEKQLKCESGS	120.19	gnl|BL_ORD_ID|442|hsp_num:0	276			18	216	tetracycline
BGC0000440.1|Teicoplanin_9 # 8670 # 9404 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.751	BGC0000440.1|Teicoplanin_9 	8670	9404	+	Loose	500	43.5134	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid	28.3	3003393	protein variant model	V78A, I194T	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant inhA	ATGGGTGATCACCGAGTCGCCGTCGTCACCGGGGCTTCGCGTGGCATCGGCCGTGCCGTCGCCACCGCGCTGGCCGGCGCCGGGCACGCCGTCGTCGTCGGCTACGCCGGCAATGAGGCGGCCGCGAAGGAGGTCGTCGACCGGATCGCCGCCACCGGTGGCCGGGCCGTCGCCGCCCGGGCCGACGTCGCCGACGAGAACGCGGTCGCCGCTCTGTTCGACACCGCCACCGAGGCCTTCGGCGGGGTCGACGTCGTGGTCAACTCGGCCGGCCGGATGGCCCTGTCCCCGATCGCCGACCTCGATCTGGCCGACCTGGACGCCCTGCACCGCACCAACATCCGCGGCACGTTCGTCGTCGCCCGCGAGGCCGCCCGCCGGGTCCGCCCGGGCGGCGCGATCGTGCTGGTGTCCACCTCGATCCTCGGCCTGCAGTTCCCCGGCTACGGCGCGTACGCCGCCAGCAAGGGGGCCGTCGAGGCGATGACGCTGATCCTGGCGCGGGAGATGCGCGGCCGGGACATCACGGTCAACACCGTCGCGCCCGGCCCCACCGCCACCGAGCTGTTCCTGGAGGGCAAGGACGAGGCGACCGTCGAGCACCTGGCCAAGCAGCCGCCGCTGGAGCGGCTCGGCACCCCGGCCGACATCGCCGGGGTCGTCGCCTTCCTCGCCGGGCCGGGCGGGCGCTGGGTCAACGGCCAGGTGCTCCGGGCCAACGGCGGCATCGTCTGA	MGDHRVAVVTGASRGIGRAVATALAGAGHAVVVGYAGNEAAAKEVVDRIAATGGRAVAARADVADENAVAALFDTATEAFGGVDVVVNSAGRMALSPIADLDLADLDALHRTNIRGTFVVAREAARRVRPGGAIVLVSTSILGLQFPGYGAYAASKGAVEAMTLILAREMRGRDITVNTVAPGPTATELFLEGKDEATVEHLAKQPPLERLGTPADIAGVVAFLAGPGGRWVNGQVLRANGGIV	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL	90.71	gnl|BL_ORD_ID|1964|hsp_num:0	1574			141	588	isoniazid
BGC0000440.1|Teicoplanin_10 # 10056 # 11399 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.739	BGC0000440.1|Teicoplanin_10 	10056	11399	+	Loose	500	26.9498	OXA-640	26.42	3005861	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGATCCCGCTCAGCCTCGAGGCGATCGCCGCTGTTGTCGGGGGGACGGTCGAGGGAGACCACACGGTGACGGTCACCGCGCCGGCCGTGCTCGACGGTCGGCAGGCCGAGCCGGGCGGCCTCTTCGTCGCCTTCGCCGGCGAGCACGTCGACGGCCACGACTACGCCGGCCAGGCCGGCCAGGCGGGCGCGGTCGCCGTGCTCGGCTCGCGGCCCACGGCGCTTCCCACCGTCGTCGTCGAAGACGCCCGGACCGCGCTGCAGGCCCTCGCCGCCGACGTCGTGGCGCGGCTGCGTGAACGGTTGACGCTCGTCGGGGTGACCGGCTCCCAGGGCAAGACGAGCACCAAGGACCTGCTGGCCGCCGTGCTGTCGAGCGCCGCGCCGACGATCGCCACCAAGGGCAACCTCAACAACGAGCTCGGCGTGCCCCTCACCATGCTGCGCGCCGGTGCGGCCACCCGGTTCCTCGTCGTCGAGATGGGCGCCCGCCGCATCGGTGACCTCGCCAAGCTCACCGACCTGGTTCCGCTCGACGTCGCCGTCGTCCTCAACGTCGGCGAGGCCCACCTCGGCGTGTTCGGATCGCGTGCGGCCATCGCCGAGGGCAAGGGGGAGCTGGTACGAGGGCTGGTGCCCGGGGGTACCGCGATCCTCAACGCGGACGACCCCAGGGTGGTCGCGATGCGCTCGCTCACCGATGGCCCGGTGTTGACGTTCGGGCACGCGGAAGACGCGGATGTGCGGGTGCGCGACCTGACCCTGGACCGGCTCGGCCGACCGTCCTTCACGCTGCGCACCGCGGACGCCACGGCCCGGGTCAAGTTGCCGATCGTGGGCGCCCACCAGGCACTCAACGCCGCAGCCGCGGTGGCGGCGGCGCTTTCCGCCGGCCTGACGCTCGACGCGGCCGCGGCGCCACTGGCCACCGCCTCACTGACGAGGTGGCGCTTGGAGCTACGTGACATCGCCGGCGGCGTGACACTGCTCAACGACTCCTACAACGCCAGCCCCGGGTCGACGCGAGCCGCGCTGGACGCCCTGGCCGCGATCGAGGGTGGCCGCCGCGTCGCCGTCCTCGGCCAGATGCTGGAGCTGGGGGACGAGAGCGAGGCCGAGCACCGCGCCGTCGGGGAGTACGCCGCCGCCCGGGCCGACGTGGTGGTCACCGTCGGCGAGGCGGTTCGTCCGCTTGCCGTCGGCGCGGGGGAGCGGGCGGTGGCAGTGGCGGACAACGGCGCGGCCGTCGATTGGCTTCGTGGCCACCTCGCCCCCGGCGATGTGGTGCTCGTCAAGGCATCCCGTGGGGCGCGCCTCGATGAAGTCGCCGCCGCGCTGTCCTAG	MIPLSLEAIAAVVGGTVEGDHTVTVTAPAVLDGRQAEPGGLFVAFAGEHVDGHDYAGQAGQAGAVAVLGSRPTALPTVVVEDARTALQALAADVVARLRERLTLVGVTGSQGKTSTKDLLAAVLSSAAPTIATKGNLNNELGVPLTMLRAGAATRFLVVEMGARRIGDLAKLTDLVPLDVAVVLNVGEAHLGVFGSRAAIAEGKGELVRGLVPGGTAILNADDPRVVAMRSLTDGPVLTFGHAEDADVRVRDLTLDRLGRPSFTLRTADATARVKLPIVGAHQALNAAAAVAAALSAGLTLDAAAAPLATASLTRWRLELRDIAGGVTLLNDSYNASPGSTRAALDALAAIEGGRRVAVLGQMLELGDESEAEHRAVGEYAAARADVVVTVGEAVRPLAVGAGERAVAVADNGAAVDWLRGHLAPGDVVLVKASRGARLDEVAAALS	MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGVFITFDGKHYASNDFKRAKQAFSPASTFKIFNALIALDNDVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQEGLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKEIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELLEKYLAIITN	179.52	gnl|BL_ORD_ID|3896|hsp_num:0	4966			75	234	cloxacillin; oxacillin; cefalotin
BGC0000440.1|Teicoplanin_11 # 11421 # 12638 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.608	BGC0000440.1|Teicoplanin_11	11421	12638	+	Strict	200	514.227	vanH gene in vanO cluster	73.11	3002948	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGTGGCGCCGGGGCAGCGCGGACGCCATCCGTCCCGTAACGTGGATTTCCACTACGCGTGGTGCGGGCTTCCTTGACAATCAGTTGACATATCGCGCCGCGGGCCCCTCCGACGTATCGTCGGCATATCCAAAACCGCATACGTGCTCGCAACACCACCTTCCCTTGACTGGGCGCATGGGTTACAGCGAACCAGTACGAGCAGCGGCCCCCCGCACCCGATCGCTGGCCTCGTCGTCCTCCCCGGTCGTTCCGGCAACGGGGATCACGATCTATGGATGCGGCCCGGATGAGGCCGCCCTGTTCCGTGAGCTGGCGCCTCGCTTCGGCGTACTGCCGATCATCACGGAAGCGGCGGTATCCGAGGCCAATGTGAATCTGGCATCCGGAAATCGATGCATCAGCGTCGGGCATAAGACTCAGATCACGAATGGCACGCTTCTCGCGCTGAGCCGATCCGGTGTGAAATACATCTCTACGCGGAGCATAGGCTACAACCACATCGATGTGGCGTATGCGCAGAGCGTGGGTATCTCCGTCGGCAACGTCGCCTACTCGCCGGACAGCGTGGCCGATTACACGCTGATGCTGATGCTGATGGCCGTACGCCATATGAAAGCCATGATCCGCCGCGCGGACGTTCACGATTATCGATTGAACGACGTGCGCGGGAAGGAACTGCGCGATCTGACCGTCGGGGTGGTCGGGACGGGGCGTATCGGTTCGGCCGTCATGGACCGGCTGTGGGGTTTCGGCTGCCGTGTGCTCGCCTACGACAATCGACGTTCGGATTCCGCTCATTATGTTCCGCTCGATGATTTGGTGCGGCAGAGCGACATCGTCACACTTCACACCCCGCTCACCGCGGCCACGCACCATCTTCTCAACCAGGACCGTATCGCGCAGATGAGGAACGGTGCGTTCGTCATCAACACCGGGCGCGGTTCGCTTATCGACACCGAGGCCCTCGTCGCAGCGCTGGAAAGCGACAAACTGGGTGGCGCGGCGCTCGATGTCCTGGAAGGGGAGGAGGGGGTATTCTATGCCGACTGCCGTAACAAGCTCATTGAGAGCAAGGCGCTGTTACGGCTACAGGAAATGCCCAATGTGATCATCAGCCCGCACATGGCCTACTACACGGACCATGCGCTCAGCGACACTGTCGAGAACAGTCTCGTCAACTGCATGAACTTCGAGAGGGAACAACAGCATGGGTAA	MWRRGSADAIRPVTWISTTRGAGFLDNQLTYRAAGPSDVSSAYPKPHTCSQHHLPLTGRMGYSEPVRAAAPRTRSLASSSSPVVPATGITIYGCGPDEAALFRELAPRFGVLPIITEAAVSEANVNLASGNRCISVGHKTQITNGTLLALSRSGVKYISTRSIGYNHIDVAYAQSVGISVGNVAYSPDSVADYTLMLMLMAVRHMKAMIRRADVHDYRLNDVRGKELRDLTVGVVGTGRIGSAVMDRLWGFGCRVLAYDNRRSDSAHYVPLDDLVRQSDIVTLHTPLTAATHHLLNQDRIAQMRNGAFVINTGRGSLIDTEALVAALESDKLGGAALDVLEGEEGVFYADCRNKLIESKALLRLQEMPNVIISPHMAYYTDHALSDTVENSLVNCMNFEREQQHG	MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPSITEEAISETNAELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAASIGISVGNVDYSPDSVGDYTLMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGVIGTGRIGTAVIDRLQGFGCRVLAHDSGPHASADYVPLDELLRQSDIVTLHTPLTADTHHLLDRQRIDQMKHGAYIVNTGRGPLLDTEALLSALESGRLGGAALDVVEGEEGIFYADCRNRLIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVNCLNFESGRTA	115.71	gnl|BL_ORD_ID|761|hsp_num:0	786			42	1035	vancomycin
BGC0000440.1|Teicoplanin_12 # 12631 # 13668 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=10bp;gc_cont=0.683	BGC0000440.1|Teicoplanin_12	12631	13668	+	Strict	350	530.791	vanO	73.18	3002913	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGGGTAAGTTGAAGATCGGCATCATCTTCGGCGGCGTCTCCGAAGAGCACCCCGTCTCGATCAAGTCCGCGCAGGAGGTCGCCAAGAGCCTGGACGCCGAGAAGTACGAGCCGTACTGGATCGGCATCACGAAGGACGGCGCCTGGCGGCTGTGCGACGGCCCGGGCGCGGACTGGGAGATCAGCAGCGCCCGGCCGGCCATGCTGTCGCCGGACCGCAACGTCCACGGGCTGCTGGTCCAGGAGGACGGCCGGTACCGGGAGATCCGCCTGGACGTCGTGCTGCCGGTTCTGCACGGCAAGCTGGGCGAGGACGGCGCGATGCAGGGCCTGTTCGAGCTGTCCGGCATCCCCTACGTCGGCTGTGACGTGCAGAGCTCCGCGGTCTGCATGGACAAGTCGCTGACCTACGCCGTGGTCAGCAGCGCGGGCATCGCGACGCCGCGGTTCTGGGTCGTCACGCCGGACGAGGCGCCGGACCCCGCGCAGCTCACCTACCCGGTCTTCGTGAAGCCGGCCCGCTCGGGCTCCTCCTTCGGCGTCACCAAGGTGTCGACCGAGCAGGAGCTGAAGGCCGCGCTGGAGACCGCGCGGGAGTTCGACTCGAAGGTGCTGATCGAAGAGGCCGTGGTCGGCAGCGAGATCGGTTGCGCCATCATGGGCAACGACCCGGACCTGGTCGCCGGCGAGGTGGACCGGGTCGCCCTGTCCCACGGCTTCTTCCGGATCCACCAGGAGAGCGAGCCGGAGCGCGGTTCCGAGAACTCGACCTTCATCTGTCCCGCCGACATCCCGGCCGAGGCGCGCTCGCTGGTCCAGGAGACGGCGAAGGCCATCTACCGTGCTCTGGGATGCCGCGGGATCGCCCGGGTGGACATGTTCCTCAAGGAGGACGGAACAGTTGTCCTCAACGAGGTCAACACCCTGCCCGGCCTGACCTCGTACAGCCGTTACCCGCGCATGATGGCGGCTGCCGGGATTCCGCTCTCCGCGGTGATCGACCAGATCGTGTCGCTGGCCCTGCCGGGGGACATCTGA	MGKLKIGIIFGGVSEEHPVSIKSAQEVAKSLDAEKYEPYWIGITKDGAWRLCDGPGADWEISSARPAMLSPDRNVHGLLVQEDGRYREIRLDVVLPVLHGKLGEDGAMQGLFELSGIPYVGCDVQSSAVCMDKSLTYAVVSSAGIATPRFWVVTPDEAPDPAQLTYPVFVKPARSGSSFGVTKVSTEQELKAALETAREFDSKVLIEEAVVGSEIGCAIMGNDPDLVAGEVDRVALSHGFFRIHQESEPERGSENSTFICPADIPAEARSLVQETAKAIYRALGCRGIARVDMFLKEDGTVVLNEVNTLPGLTSYSRYPRMMAAAGIPLSAVIDQIVSLALPGDI	MSRLKVGVIFGGASEEHPVSIKSAREVARSLDTEKYEPFWIGITTGGEWKLCDGPDADWENRSARPAVLSPDRSVHGLLVMEQGGYETVRLDLVFPVLHGKLGEDGAIQGLLELAGIPYVGCDIQGSAVCMDKALAYIVAKSAGIATPSFWVVAENEKVDADHLRYPVFVKPARSGSSFGVSKVTREDELPNALSAARQYDSKVLIEEAVAGSEIGCAVMGELFGLITGEVDRVDLSHGFFRIHQEDSPETGSENSTFIVPADISDESRRLVQETAKAIYRTLGCKGLARVDMFLTDDGRVVLNEVNTMPGMTSYSRYPRMMAAAGLPISDMIDRLISMTMHGKKR	99.71	gnl|BL_ORD_ID|1607|hsp_num:0	1754			0	1029	vancomycin
BGC0000440.1|Teicoplanin_13 # 13668 # 14276 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.617	BGC0000440.1|Teicoplanin_13	13668	14276	+	Strict	200	348.206	vanX gene in vanO cluster	80.2	3002954	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	ATGAAAGACGACTTCGCGTTCGTGGACGAGCTCGTGCCAGGCATACGCTGGGATGCCAAGTACGCCACCTGGGACAATTTCACCGGCAAGCCGGTGGACGGTTACGTTGCGAATCGGATCGTCGGAACGAAGGCGTTGTGCGCTGCCCTGGCGCGCGCCCAGGAAGAGGCCGAGACGCTTGGCTTCGGTCTGCTTCTCTGGGATGGGTATCGGCCGCAACGCGCCGTGGACTGCTTCATGCGCTGGGCGGAGCAGCCGGAGGACGGCCGCAAGAAGCTGCGGCACTACCCGAACATCGGCAGGCCCGAGATGTTCGAGAAGGGGTATGTCGCCACCAAGTCCGGTCACAGCCGCGGCAGCACCGTCGACTTGACGCTCTACAACCTTGCCACCGGCGAACTGGCGTCGATGGGCGGCGACCACGACCTGATGGATCCGATCTCCCACCACGGGGCCAGCGGAATCACGCCGATCGAAGCGAAGAACCGTGAATACCTCTGCTCGATCATGGAGGGCTGCGGATTCGCCAGGTACGACTACGAGTGGTGGCACTACACCCTGAAGAACGAACCCTATCCCGACACATATTTTGATTTTCCGATCGTGTAG	MKDDFAFVDELVPGIRWDAKYATWDNFTGKPVDGYVANRIVGTKALCAALARAQEEAETLGFGLLLWDGYRPQRAVDCFMRWAEQPEDGRKKLRHYPNIGRPEMFEKGYVATKSGHSRGSTVDLTLYNLATGELASMGGDHDLMDPISHHGASGITPIEAKNREYLCSIMEGCGFARYDYEWWHYTLKNEPYPDTYFDFPIV	MNDDFVYVDDWVPGVRWDAKYATWDNFTGKPVDGYLANRIVGTRALCAALEQAREKAASLGFGLLLWDGYRPRRAVDSFLRWSEQPEDGQTKQRHYPNIDRPEMLEKGYVATQSGHSRGGAVDLTLYHLATGELAPMGGDHDLMDPISHHRARGIKPIESKNRELLRSIMEDCGFDRYDCEWWHYTLKREPYPDVYFDFPIT	100.00	gnl|BL_ORD_ID|1672|hsp_num:0	1699			0	606	vancomycin
BGC0000440.1|Teicoplanin_14 # 15038 # 15577 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=AGAAG;rbs_spacer=4bp;gc_cont=0.667	BGC0000440.1|Teicoplanin_14 	15038	15577	-	Loose	600	28.1054	emtA	26.42	3004669	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; orthosomycin antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGAGCGATGTGAGCGGCGCCGGCAAAGTGGTCGTGAACAGGGCGATGTCGCTGGACGGGTTCATCGCCGGTCCCGGCCACGCGATGGACTGGATCTTCGAATACCTGACTGGGGACATGTTCCCGGAGGTTATGGCGTCCACGGGCGCCATGCTCATCGGCCGAGGCACGTACGAGGTCGCCAAGCGTATGGCCGGCCAGGGCACCCCCTACGACGGGGGAGCACAGTTCGTCCTCACGCACGAGCCTCCCCACGAGCCGGACCCTGCCGTCACGTTCCTCAGCTGTGACATCGAGGAAGCCGTTGCCACGGCACGCAGCGCCGCGGGCGGCAAGAACTTGGAAATCCTCGGTGCTGACGTGGCCGCCCAGTGCCTGCGGCGCGGGCTCGTCGACGAGATCCTGGTGTATGTCGTACCGGTGCTGCTCGGCGACGGTGTCCGCTTCTCGCCCCCAAGCCTCGACAGGATCGACCTGGAACCTCTCAGCAACACCCGGTCCGGCGCCGTCACGATGCTGCGCTTCCGCGTGCGAAAGTAG	MSDVSGAGKVVVNRAMSLDGFIAGPGHAMDWIFEYLTGDMFPEVMASTGAMLIGRGTYEVAKRMAGQGTPYDGGAQFVLTHEPPHEPDPAVTFLSCDIEEAVATARSAAGGKNLEILGADVAAQCLRRGLVDEILVYVVPVLLGDGVRFSPPSLDRIDLEPLSNTRSGAVTMLRFRVRK	MTLYFASVLSGLEYVLSNEINNKVSDSEIIQINRGKVFFTTAESFTCLSSLRSADHLFQVIDQFQIGPHKKHLSQVSERISQLDLEFIDHKDLFWVNASRKGKQTYSRFELAKKAMEGINKRYPDWNIGTSQNHQIEFRLDIEHHNVIFSLRLTDATFRFRNQTRRFSRASLLPSVAHAMVWLSDPESKDVFVDFCCGSGTILSERATYPANQIIGGDISEAVTKIAKSNLDDSKVQVNVWDARKLPFSTGCVDKIVTNLPFGRQISPDEDLELFNHHIMIEVCRVLKPNGRAVILSESVNQLFWEAKRLGLFCLESYPLSLKGVNPTLFVFEKQDGLRRK	52.49	gnl|BL_ORD_ID|2212|hsp_num:0	3368			492	651	evernimicin
BGC0000440.1|Teicoplanin_15 # 15690 # 16763 # -1 # ID=1_15;partial=00;start_type=TTG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.650	BGC0000440.1|Teicoplanin_15 	15690	16763	-	Loose	650	412.92	vanS gene in vanO cluster	67.63	3002941	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	TTGAGCGTGCGCCTCAAACTCACGTTGAGCTACGCCGGCTTCCTCATGCTCGCCGGCGCCTCGTTGCTCGCCACCGTGTGGGTGTACCTCCTGCGCGGCCTACCGGACACCGCGATGAGCAGTCGTGGTCTCGTGCCCATCAAGACCATCGTCTTGCACGCCTTCGCCCCGGCGACGGCCGGAGTCCTGCTGTTCCTACTGGTGTTCGGCCTGCTCGGCGGGTGGCTTCTGGCCGGTCGGATGCTCGCTCCTCTGACCCGCATCACAGAGGCCACCCGCATGGCCGCGAACGGTTCGCTCTCGCACCGCATCGAGTTGGATGGCCGCAAGGATGAGTTCCGCGAGCTCGCCGACGCCTTCGACATCATGCTGACGCGACTCGAAGCACACATCGCCGAGCACCAGAGATTCGCAGCCAACGCCTCTCACGAGCTGCGTACGCCGCTGGCGATCACGAAAACGCTTCTCGACGTCGCCCGCACCGACCCGGCACGAAGCACCCACGAGCTCATCGGTCGCCTTCACACCGTCAACACCCGGGCAATCGACCTCACCGAGGCACTGCTTCTGCTGAGCCGCGCCGACCGGCGATCGTTCAAGCGCGAGTATGTCGACCTGTCGCTGAACGTCGAAGAAGCCATCGAGACGCTCCTACCGCTGGCGGAGAAGCACGGCGTCACCATCGAAGCCTCCGGCGACATCACCCCGACCGTCGGCTCACGTGCCCTGCTGTTACAAATGACGATCAACCTCTTGCACAACGCGATCGTGCATAACGTGGCGGAAGAGCGCATCGTGTGGGTCACGACCAGCGTCCATCCCAAGAGTGTGACCCTCACCGTGGAAAACACCGGCGAGCAGCTCTCCGCACAGCTGGTCTCGACACTCACCGAACCGTTCCAGCGCGGCACCGAGCGCATACACCACGATCATGCAGGTGTCGGCCTCGGCCTGGCGATCGTCAAGAGCATCGCCCACGCGCACGACGGAACACTCACCACCGCCCCGCGCGCTGGAGGCGGCCTGCACGTCACGGTGCAGCTGCCAGCCGCGACAACGCCTCCGAGAAACTGA	MSVRLKLTLSYAGFLMLAGASLLATVWVYLLRGLPDTAMSSRGLVPIKTIVLHAFAPATAGVLLFLLVFGLLGGWLLAGRMLAPLTRITEATRMAANGSLSHRIELDGRKDEFRELADAFDIMLTRLEAHIAEHQRFAANASHELRTPLAITKTLLDVARTDPARSTHELIGRLHTVNTRAIDLTEALLLLSRADRRSFKREYVDLSLNVEEAIETLLPLAEKHGVTIEASGDITPTVGSRALLLQMTINLLHNAIVHNVAEERIVWVTTSVHPKSVTLTVENTGEQLSAQLVSTLTEPFQRGTERIHHDHAGVGLGLAIVKSIAHAHDGTLTTAPRAGGGLHVTVQLPAATTPPRN	MLAGVLLLAAVWVFLLRGRSTNFQFPALADFARVFDPSNFGPVVFVPAAILALGFLLVFGLVGGWILAGRMLAPLARITRAAREAGSGSLSYRIELEGRNDEFRELADAFDAMLARLEARDAAQQRFAANASHELRTPLAITQTLLDVARNDPNRDGGELDERLRAVNARAIELTEALLLLSRTDQRSFSREDVDLSLIAEEAAETLLPFAEKHGVSIETSGDIAPVIGSHALLLQLTTNLLHNAIVHNVPEHGSVQISTAIGSESVMLTVENTGDKLSPQLVSTLTEPFQRGTARTRGDDARVGLGLAIVKSITQAHDGSLTLSPRAAGGLSVAVRLPAAQRRP	103.48	gnl|BL_ORD_ID|4732|hsp_num:0	465			0	1035	vancomycin
BGC0000440.1|Teicoplanin_16 # 16789 # 17436 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.671	BGC0000440.1|Teicoplanin_16 	16789	17436	-	Loose	400	342.813	vanR gene in vanO cluster	89.05	3002930	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGGCGGAGGCTATCCGGGATGGCCTCCGTTTGGAAGCGATCGCGGCAGACATCGCCGGTGACGGTGACACCGCTCTGGAAATGCTGAGCGTGAACGCCTACGACATCGTCATCCTCGACCGCGACATCCCCGGCACCTCGGGTGATCAGATCGCCGAACGCATCGTCGCCTCCCGGAGCGGTATGCCCATCCTCATGCTCACCGCTGCCGATCGGCTCGACGACAAAGCATCCGGGTTCGAGCTCGGCGCCGACGACTACCTCACCAAGCCGTTCGAACTGCGGGAGCTCGTGCTCAGGCTCAGGGCACTCGACCGCAGGCGCGCCTACAGCAGGCCACCTGTACGGGAGATCGCGGGCCTGCGACTGGACCCGTTCCGCCGCGAGGTCTACCGCGACGACCGCTACGTCGCGCTGACCCGGAAGCAGTTCGCCGTGCTCGCCGTCCTCGTAGCCGCCGAAGGCGGCGTCGTCAGCGCCGAGGAACTGCTGGAACGGGCTTGGGACGAGAACGCGGACCCGTTCACCAACGCCGTCCGCATCACCGTTTCGGCCCTGCGCAAACGGCTCGGCGAGCCCCAGATCATCGCCACCGTGCCCGGCGTCGGGTATCGCATAACCACGCAACCAGGCAGCGGGCGTGCGTGA	MAEAIRDGLRLEAIAADIAGDGDTALEMLSVNAYDIVILDRDIPGTSGDQIAERIVASRSGMPILMLTAADRLDDKASGFELGADDYLTKPFELRELVLRLRALDRRRAYSRPPVREIAGLRLDPFRREVYRDDRYVALTRKQFAVLAVLVAAEGGVVSAEELLERAWDENADPFTNAVRITVSALRKRLGEPQIIATVPGVGYRITTQPGSGRA	MASMRVLVVEDERFMAEAIRDGLRLEAIAADIAGDGDTALDLLGVNAYDIAVLDRDIPGPSGDEIAQRIVASGGGIPILMLTAADRMDDKASGFELGADDYLTKPFELQELVLRLRALDRRRAHSRPPVREIAGLQLDPFRREVYRDGRYVALTRKQFAVLEVLVAAEGGVISAEELLERAWDENADPFTNAVRITVSTLRKRLGEPWLIATVPGVGYRIDTEPDARGGGDGG	92.27	gnl|BL_ORD_ID|4742|hsp_num:0	1689			42	672	vancomycin
BGC0000440.1|Teicoplanin_17 # 18328 # 19509 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.730	BGC0000440.1|Teicoplanin_17 	18328	19509	+	Loose	600	352.058	rgt1438	55.39	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGCGCGTGCTGTTTTCGTCCTACGGGACACGCGGAGATGTCGAGCCCCTGGTGGCATTGGCCGTGCGACTGCGGGAACTCGGTGCGGAGGTCCGGATGTGCGCGTCGCCGGACTACGTGGAGCGGCTGGCCGAGGTCGAAGTGCCGATGGTGCCGATCGGCCAGCCGGTGCGCGCGGGGGCCCGCAAGGGTGCAGCGCCTCCGGGGGCGCCCGAGGCCGTGGCCGAGGTGATCGCCGAGCAGTTCGACAGGGTCCCGCCGTTCGCCGAAGGGTGTGACGCGGTGGTGGCCAGCGGTCTGGTGTCCACCGCCGTCGCCGTGCGGTCGGTCGCCGAGAAGCTGGGCATCCACCACTACGCCTACGCCGTGCTCTCGCCGTCCTTTCTGCGCGCGCCCGGCGTGACCGACAGCCGGGACCTGCGGGCCCGGGCCAACCAGGGCGCCTATCGACAGTTCGGTGGCCCGCTCAACAGCCATCGGGCCGCGGTCGGCCTGCCGCCGGTGGAGAAGGTCATCGACTACGCCTTCACCGAGCGCCCCTGGTTGGCGGCGGACCCGGTCCTGGACCCGCTGCGGCCGACGGACCCGGACGTGGTGCAGACCGGCGCGTGGATCCTGCCCGACCAGCGGCCGTTGTCGGCGGAGTTGGAGGGGTTCTTGAGGGCTGGCTCGCCTCCGGTGTACGTGGGTTTCGGCAGTGGGCCGGCGCCTGCCGAGGCCGCGCGGGTGGCCATCGAGGCGGTTCGGGCTCAGGGCCGCCGGGTGGTGCTGTCCAGTGGTTGGGCCGGGTTGGGCCGGATCGACGAGGGGGATGACTGTCTGGTGGTGGGCGAGGTGAACCATCAGGTGCTGTTCGGCCGGGTGGCCGCCGTCGTCCACCACGGCGGGGCGGGCACGACGACCGCGGTGACCCGGGCGGGCGCTCCGCAGGTCGTGGTGCCCCAGAAGGCGGATCAGCCCTACTATGCCGGTCGGGTGGCTGACCTGGGTGTCGGCGTGGCGCATGACGGTCCGACCCCGACCGTCGAGTCCCTGTCCGCGGCGCTGGCCACGGCGTTGACCCCGGGGATCCGGGCGCGAGCGGCGGCGGTGGCCGGCACGATCCGCACCGACGGGACGACGGTGGCCGCGAAACTGCTCCTCGAGGCGATCAGCCGGCAGAGATCGTCGGTTCCCGCGTGA	MRVLFSSYGTRGDVEPLVALAVRLRELGAEVRMCASPDYVERLAEVEVPMVPIGQPVRAGARKGAAPPGAPEAVAEVIAEQFDRVPPFAEGCDAVVASGLVSTAVAVRSVAEKLGIHHYAYAVLSPSFLRAPGVTDSRDLRARANQGAYRQFGGPLNSHRAAVGLPPVEKVIDYAFTERPWLAADPVLDPLRPTDPDVVQTGAWILPDQRPLSAELEGFLRAGSPPVYVGFGSGPAPAEAARVAIEAVRAQGRRVVLSSGWAGLGRIDEGDDCLVVGEVNHQVLFGRVAAVVHHGGAGTTTAVTRAGAPQVVVPQKADQPYYAGRVADLGVGVAHDGPTPTVESLSAALATALTPGIRARAAAVAGTIRTDGTTVAAKLLLEAISRQRSSVPA	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	95.62	gnl|BL_ORD_ID|116|hsp_num:0	134			0	1212	rifampin; rifaximin; rifabutin; rifapentine
BGC0000440.1|Teicoplanin_18 # 19702 # 20004 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=GAGG;rbs_spacer=9bp;gc_cont=0.657	BGC0000440.1|Teicoplanin_18 	19702	20004	+	Loose	450	23.0978	tet(45)	40.0	3003196	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGTCGTGATGCCGTCCGTCCGGAGGGTGACAAGGGTCGGCGTCGACCCCGATTCCGGGTCGTTCAGCATCCATCCCGGGACGTCACGCGGAGTGTTTTTCTTTCTCCGCCGGTACATCGGAAAGGTGGCGCTGTTTCCTTTTGTCGCCTTCCCGATATTGCTGATCGCGGTCGGAGCTGAATTGGTGCCGAAACAGGTCATCGACGGCGGCGTCCGCAGGACCGGTCGCGGCGGTGACGGGACCGCTCCGGGTCCGGACCGCCGGCCGGTGCGCCGGGTGGCTCTTGAAGGGGGACGATGA	MVVMPSVRRVTRVGVDPDSGSFSIHPGTSRGVFFFLRRYIGKVALFPFVAFPILLIAVGAELVPKQVIDGGVRRTGRGGDGTAPGPDRRPVRRVALEGGR	MNTPHSHSNLRHNQILLWLCVLSFFSVLNEMVLNVSLPDIASDFNKEPASINWVNSSFILTFSIGTAVYGKLSDQLGIKKLLLFGIIVNCFGSVIGFVGHFFFPVLILARFIQGVGAAAFPALVMVVIARYIPKENRGKAFGIIGSIVTMGEGVGPSVGGVIAEYAHWSYILLLPVVTIITVPFLAKLLKQEEVIKGSFDTKGIIFMSVGIVFFIMFTTCYRVSFLVVSIICFLIFVKNIRKVSNPFINPSLGKNVSFMIGIICGGLIFGTVAGFISMVPYMMKDVYQLSTAAIGSGIIFPGAMSVIVFGYIGGLLVDKKGSLFVLTTGVAFLSISFLVAALFIETTPWLITIILIFVFGGLSFTKTVISTIVSSSLEQKEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIHLLNRKLLPINAEPSTHLYSNLLLLFAGITIISWLVTIKMHKRSRGNI	21.83	gnl|BL_ORD_ID|146|hsp_num:0	17			294	405	tetracycline
BGC0000440.1|Teicoplanin_19 # 20001 # 26231 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.727	BGC0000440.1|Teicoplanin_19 	20001	26231	+	Loose	1000	117.472	almE	30.34	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAATTCCGCAGCGCAGGCCACATCGACGGTGCCGGAGCTGCTCGCCCGGCAGGTGACCCGGGCCCCCGATGCGGTGGCCGTGGTGGACCGGGACCGGGTTCTGACGTACCGGGAACTCGATGAGCTCGCGGGCCGGTTGTCCGGACGTCTGATCGGCCGGGGCGTCCGCCGCGGGGACCGCGTGGCGGTCCTGCTGGACCGTTCGGCGGACCTGGTGGTGACGCTGCTCGCGATCTGGAAGGCCGGGGCGGCGTATGTGCCGGTCGATGCCGGCTATCCCGCGCCGCGTGTGGCGTTCATGGTGGCGGACTCGGGAGCCTCCCGCATGGTGTGCTCGGCCGCGACGCGTGACGGCGTACCGGAGGGGATCGAGGCGATCGTCGTCACGGATGAGGAGGCGTTCGAGGCCTCGGCGGCCGGGGCGCGACCGGGAGATCTGGCGTACGTGATGTACACCTCCGGCTCGACCGGCATCCCGAAGGGCGTGGCGGTTCCGCATCGCAGCGTCGCGGAGCTGGCCGGGAATCCCGGCTGGGCGGTGGAGCCGGGCGACGCGGTCCTGATGCACGCGCCGTACGCCTTCGACGCGTCGCTGTTCGAGATCTGGGTGCCGCTGGTTTCCGGGGGCCGGGTGGTGATCGCCGAGCCGGGGCCGGTGGACGCCCGGCGCCTGCGGGAGGCGATCAGCTCCGGGGTGACCAGGGCGCATCTGACCGCCGGCAGCTTCCGCGCGGTGGCGGAGGAGTCGCCGGAGTCCTTCGCCGGGCTGCGCGAGGTGCTGACCGGCGGTGACGTGGTGCCGGCACACGCCGTGGCGCGGGTCCGCTCGGCCTGTCCCCGGGTGCGGATCCGGCACCTGTACGGCCCGACGGAGACGACGCTGTGCGCCACATGGCATCTTCTGGAGCCGGGGGACGAGATCGGCCCGGTGTTGCCGATCGGCCGTCCGCTCCCGGGCCGGCGCGCTCAGGTGCTCGACGCGTCGCTGCGGGCCGTGGCGCCGGGCGTGATCGGTGACCTGTACCTGTCCGGCGCCGGTCTGGCTGACGGCTACCTGCGCCGGGCAGGGCTGACAGCGGAGCGATTCGTGGCCGACCCGTCCGCGCCCGGGGCGAGGATGTACCGCACCGGCGACCTCGCGCAGTGGACCGCCGACGGTGCGTTGCTGTTCGCGGGCCGGGCCGACGACCAGGTGAAGGTTCGCGGCTTCCGGATCGAGCCGGCCGAGGTCGAGGCCGCGTTGACCGCGCAGCCGGGCGTCCACGAGGCCGTGGTCCGAGCGGTCGACGGGCGCCTGGTCGGCTATGTGGTGGCGGAGGGGGACGCGGAACCGGCTGTCCTGCGCGAGCGTGTCGGTGCGGTGCTGCCGGAGTACATGGTCCCGGCCGCGGTGATCACACTGGACGCGCTGCCGCTGACCGGCAACGGCAAGGTGGACCGGGCGGCTCTGCCGGCTCCGGTCTTCGCGGCGGACGCTCCGGGGCGCGAACCCGGCACCGAGGCGGAGCGCGTGCTGTGCGGGCTGCTGTCCGAGGTGCTCGGCCTGAACCGGGTCGGAGTCGACGAGAGCTTCTTCGAGCTGGGCGGAGACTCCATCGCGGCGATCCGGCTGGCGGCGCGTGCGTCCCGGGCGGGCCTGCTCGTGACGCCCGCCCAGATCTTCAAGGAGAGGACTGTCGCACGGCTGGCGGCCGTGGCGGGCGCTGTACCGGCCGGGCCACCCGTCGACCGCCCCCTCATCGCGCTGACCGCGGAGGAGGAGGTCGAGCTGGCGGCCGCCGTCCCGGGCGCGGTGGAGGTCTGGCCGCTGGCACCGCTGCAGGAGGGGTTGCTCTTCCAGTCGACCATCGACACCGAGGGCCTCGACATCTACCAGGCGCAGTGGATTCTCCAGCTGAACGCGCCGCTGGACGTGCGCCGGCTACGGGTCGCGTGGGAAGCGGTCTTCGCGCGGCACGCCGAGCTTCGAGTGAGCTTCGTCCGGCTGGCGTCCGGGAAGACGGTGCAGGCCGCCGCCGGGCACGTCGTCCTGCCGTGGCGGGAGGTGGATCTGACCGATGCGGGCGATGTCGACGCGGCCCTGCAGGAGCTGGCCGGGCGGGAGCAGGAACAGCGCTTCGACCTTGCCCGCGCGCCGTTGTTCCGGTTGGTGCTGGTCCGGTACGGCGAGGACCGGCACCGGCTGCTGGTCGTCCATCACCACATCCTGACCGACGGTTGGTCGGTGGCGGTCATCCTCAACGAGGTGGCCGAGGCCTATGCGGCCGGTGGGCGGCTGCCCGACCGGACGGGTCCGGTGTCCTATCGGAACTACCTGGCCTGGCTGGACCGGCAGGACAGGGAGGCGGCGCGCGCGGCCTGGCGGGCCGAGCTGTCCGGCCTCGACGAGCCCGTGCCGATCGCCAGGGCGGCCGCCGGGACCGGGTACGAATACCGTGTCGCGTTCCTGCCGGCGGATGTCTGCACGAGGCTGACGGCGTCGGTCCGTGACCACGGGCTGACGCTGAACACGGTGGTGCAGGGCGCGTGGGCGATGGTGCTGTCGCGACTTGTCCGGCGTACCGATGTGGTATTCGGCACCACGGTGGCCGTCCGTCCCGCGGAGCTCCCGGGCGTGGAGTCGATACCGGGCCTGATGATGAACACGGTGCCGGTCCGGGTGACGCTGGACGGTGGGCAATCGCTCCTCGACCTGCTCACCGGCCTGCAGCGGCGGCAGGCGGCCCTGATGCCGCACCAGCATCTGGGGCTGCCGGAGATCCAGAGGACGGCCGGGCCGGGCGCGACGTTCGACACGCTGCTGGTGTTCGAGAACTACCCGCGGGATTTCGCCGGCCAGTTCACCTACCTGGGCACGATCGAGGGGACGCACTATCCGCTCACCCTCGGCATCATCCCGGGAGAGCGTCTCAGGATCCAGCTCGCCTACCGGCACGGGCAGATCGAGGAGACCCTCGCCGCGTCGGTCCTGGACGGGTTCGTCGCAGCTCTCCGCGCGGTGGCCGCCGACCCGTCCGGGTTGGTGGGCCGGACCGGTGTGGGCCGCGGCCCGGTGCACGGCTTAGCCCCGGCACTGGTGGCGGCGGAGTCGCTGCCCGTGCTGGTGGGGCGGGTGGTGGAGCAGCGGTCGCACGAGGTGGCCGTGGTGGACGGCGACGGCGAACTGTCCTTCGGGCAGTTGTGGGACCAGGCGGTGGGCTTGGCGGACCTGCTGACGGCACGTGGAGTGGGACCCGAGTGCCGGGTGGGTGTGCTGGTGGGGCGGTCGGCGTGGTGGGTGGTCGGGATGCTGGGCGTCTCGCTGGCGGGTGGCGCCTTCGTCCCGGTGGATCCGGCGTACCCGGCCGAACGCATCCGGCTGATCCTGGCCGACGCCGATCCCGCGCTCGTGGTGTGTGCGGGGAAGACCCGCGAGGCGGTGCCCGCGGCGTTCGCGGATCGGCTGCTGGTGGTCGACGAGATGGATCTGACCGGGGGATCGGCGGCTCGATTGCCGCGGGTACGTCCGGGTGACGCGGCATATGTGATCTATACGTCGGGGTCGACGGGCAGGCCGAAGGGGGTCGTCGTCCCGCACGCGGGACTGGGGAACCTGGCGCTGGCGCAGATCGACCGGTTCGGTGTGTCGCCGTCGTCCCGGGTCCTGCAGTTCGCGGCGCTGGGCTTCGACGCGATGGTGTCGGAAGTGTTGATGGCGTTGCTGTCCGGGGCGCGGCTGGTGATGGCGCCGGAACACCAGCTGCCGCCGCGCGTGTCGCTGGCCGAGGCGCTGCAGCGGTGGGATGTCACGCACGTGACCGTTCCGCCGTCGGTGCTGGCCACGGCGGAGGCGTTGCCGGCCCGGCTGGAGACCGTGGTGGTGGCCGGGGAGGCATGTCCGCCAAGCCTGGCGGACCGCTGGTCGGCGGGTCTGCGGCTGGTCAATGCGTACGGGCCCACCGAGGCCACGGTGTGCGCGGCGATGAGCATGCCGCTGGTGGCGAGCCGGCCCGTGGTCCCGATCGGGACGCCGATCGCCGGGGGACGCTGCTATGTGCTGGACGCGTTCCTGCGGCCGCTGCCGCCGGGCCTCACCGGTGAGCTGTACGTGGCCGGGATCGGGCTGGCTCGCGGGTATCTGGGACGGGCCGCGTTGACGGCCGAGCGGTTCGTCGCCGACCCGTTCGTCCCGGGTGAGCGGATGTACCGGACCGGAGATCTGGCGTACCGGACCGGCGAGGGTGAGCTGGTGTTCGCCGGGCGTGCCGACGACCAGGTGAAGGTTCGTGGATTCCGGATCGAGCCCGGTGAGGTCGAGTCGGCCCTGTCCGGTCACCCCGGGGTTGCCCAAGCCGCGGTGATCGTGCGCGGTGACCGCCTACTGGCCTATGTGTCGCCGGCTGGCGTCGATCCGCAGGCGGTGCGCGAAGACCTCGCATCGCGGTTGCCGCCGTACATGGTGCCCGCGGTGGTGGTGCCGCTGGAGGCGTTGCCCACCACCCCGAACGGGAAGATCGACCGGGGCGCGCTGCCTGATCCCGACTTCGCGGCCGGGGCAGATGTCCGGGAGCCGCGCACCGAGGTCGAGCGGGCGTTGTGCGATCTCTTCGCCGAGGTGCTCGGTCTGGACCGGGTCGGCGTCACCGACAGCTTCTTCGAGGTGGGCGGCGACTCCATCACCTCGATGCAGTTGGTGGCACGGGCCCGGCGTGCGGGTCTGACGTTCGCCGCGCACGACGTGTTCGAGGAGCGGACCCCGGAGCGGCTCGCGCAGGTGGCGGCGCAGGCGCCGCGGCCGGAACGCGGCCACATGATCGGCGACGGTGTGGGCGAGGTGGCGCGGACGCCGGTCATGCGGTTGCTGGGCGATGCGGTGGTGGCCGCGGGATTCGCGCAGTGGGTCGTGGTCGCCGTGCCCGCAGGGCTCGGGGAGCGCGCGTTGGTGGCGGCGTTGACGGCGGTGGTGGACGCGCACGACATGCTGCGGGTGCGGGTGGACTCGGGGCGGTTGGTGGTGCGCGCCCGTGGGTCGGTCGATGTGGCCGGTGCGGTGGAGCGGGTCGAGGCCGACACCGGCGAGATCGACGAGGTGGCGCGTCGCTGTGCGGTGGCGGTGGCCGCACGGCTGGACCCCGCTGCCGGTGTGGTGGTGCGGGCGGCGTGGGTGGACGCCGGCCCGGATCGCTCCGGCCGCTTGGTGCTGGCCGCGCATCACCTGGCCGTCGACGGAGTGTCGTGGCGTGTTCTGGTACCGGACCTGCAGGCGGCGTGTGAGGCGGTGGCCGCCGGGCGGCAGCCGGCCCTGGAACCGGTGGGAGTGTCGTTCCGGCGGTGGGCGGACCTGTTGGGGCAGTGGGCGGTTTCGCCGGAGCGGGTGGGGGAGTTGGCGCGATGGCGGGCGGTGGTGGGTTCCGGGGACCGGCGGATCGGTGAGCCCGGCCCGTCCGCCGGGGCCGTGCGTTCCCGCTCGTGGGTGGTGTCGGGGTCACGGGCTCAGGTGCTGGTGGGACGCGCGCCGGTGGTGTTCTTCTGCGGGGTCCATGAGGTCGTGCTGGCCGGACTGGCGGGCGCGGTGGCACGGTGGCACGGCGGGGATGTGGTCCTGGTCGATGTCGAGGGTCACGGCCGTCACCCGGTGGGCGGACTGGACCTGTCCCGGACGGTGGGTTGGTTCACCAGCGTCCACCCGGTGCGGCTGGATGTCGCCGGCATCGACTGGGCGGGCGTGCTGGCCGGTGGACCGGCGGCCGGGGAGCTGTTGAAAAGGGTCAAGGAGCAGTCGCGGGCGGTGCCCGGCGACGGGCTCGGTTACGGGTTGCTGCGTTTTCTCAACGACGAGACGGGCCCGGTACTGGCGGCGTTGCCATCGCCGCAGATCGGATTCAACTTCATGGGACGGCATGTGGCCGGTGTGCGGGAGTGGCAGCCGGTCGGGGATGTGGGCGGCGCGCTGGGCCCGGGCGTCGGGTTGCCGCATGTCCTCGACGCCGACGCGGTGGTCGAGGACGGCCCCCGGGGCCCGCTGCTGAGGTTGGTGCTGAGCTGGCCGGACGGTGTGCTGCGGGAGGACGAGGTCGAGCGGCTGGGCCGCGGTTGGTCGGACATGTTGTCCGGACTGGCCGGCCAGGCAGATGATCCGTCGGCGGGGGGACACACCGCGTCCGATTTCGACCTCCTCGACCTGGACCAGGACGAGATCGAGAACTTCGAAGCAATAGCGGCCGAATTCGGTGGAGGTCAGGAATCGTGA	MNSAAQATSTVPELLARQVTRAPDAVAVVDRDRVLTYRELDELAGRLSGRLIGRGVRRGDRVAVLLDRSADLVVTLLAIWKAGAAYVPVDAGYPAPRVAFMVADSGASRMVCSAATRDGVPEGIEAIVVTDEEAFEASAAGARPGDLAYVMYTSGSTGIPKGVAVPHRSVAELAGNPGWAVEPGDAVLMHAPYAFDASLFEIWVPLVSGGRVVIAEPGPVDARRLREAISSGVTRAHLTAGSFRAVAEESPESFAGLREVLTGGDVVPAHAVARVRSACPRVRIRHLYGPTETTLCATWHLLEPGDEIGPVLPIGRPLPGRRAQVLDASLRAVAPGVIGDLYLSGAGLADGYLRRAGLTAERFVADPSAPGARMYRTGDLAQWTADGALLFAGRADDQVKVRGFRIEPAEVEAALTAQPGVHEAVVRAVDGRLVGYVVAEGDAEPAVLRERVGAVLPEYMVPAAVITLDALPLTGNGKVDRAALPAPVFAADAPGREPGTEAERVLCGLLSEVLGLNRVGVDESFFELGGDSIAAIRLAARASRAGLLVTPAQIFKERTVARLAAVAGAVPAGPPVDRPLIALTAEEEVELAAAVPGAVEVWPLAPLQEGLLFQSTIDTEGLDIYQAQWILQLNAPLDVRRLRVAWEAVFARHAELRVSFVRLASGKTVQAAAGHVVLPWREVDLTDAGDVDAALQELAGREQEQRFDLARAPLFRLVLVRYGEDRHRLLVVHHHILTDGWSVAVILNEVAEAYAAGGRLPDRTGPVSYRNYLAWLDRQDREAARAAWRAELSGLDEPVPIARAAAGTGYEYRVAFLPADVCTRLTASVRDHGLTLNTVVQGAWAMVLSRLVRRTDVVFGTTVAVRPAELPGVESIPGLMMNTVPVRVTLDGGQSLLDLLTGLQRRQAALMPHQHLGLPEIQRTAGPGATFDTLLVFENYPRDFAGQFTYLGTIEGTHYPLTLGIIPGERLRIQLAYRHGQIEETLAASVLDGFVAALRAVAADPSGLVGRTGVGRGPVHGLAPALVAAESLPVLVGRVVEQRSHEVAVVDGDGELSFGQLWDQAVGLADLLTARGVGPECRVGVLVGRSAWWVVGMLGVSLAGGAFVPVDPAYPAERIRLILADADPALVVCAGKTREAVPAAFADRLLVVDEMDLTGGSAARLPRVRPGDAAYVIYTSGSTGRPKGVVVPHAGLGNLALAQIDRFGVSPSSRVLQFAALGFDAMVSEVLMALLSGARLVMAPEHQLPPRVSLAEALQRWDVTHVTVPPSVLATAEALPARLETVVVAGEACPPSLADRWSAGLRLVNAYGPTEATVCAAMSMPLVASRPVVPIGTPIAGGRCYVLDAFLRPLPPGLTGELYVAGIGLARGYLGRAALTAERFVADPFVPGERMYRTGDLAYRTGEGELVFAGRADDQVKVRGFRIEPGEVESALSGHPGVAQAAVIVRGDRLLAYVSPAGVDPQAVREDLASRLPPYMVPAVVVPLEALPTTPNGKIDRGALPDPDFAAGADVREPRTEVERALCDLFAEVLGLDRVGVTDSFFEVGGDSITSMQLVARARRAGLTFAAHDVFEERTPERLAQVAAQAPRPERGHMIGDGVGEVARTPVMRLLGDAVVAAGFAQWVVVAVPAGLGERALVAALTAVVDAHDMLRVRVDSGRLVVRARGSVDVAGAVERVEADTGEIDEVARRCAVAVAARLDPAAGVVVRAAWVDAGPDRSGRLVLAAHHLAVDGVSWRVLVPDLQAACEAVAAGRQPALEPVGVSFRRWADLLGQWAVSPERVGELARWRAVVGSGDRRIGEPGPSAGAVRSRSWVVSGSRAQVLVGRAPVVFFCGVHEVVLAGLAGAVARWHGGDVVLVDVEGHGRHPVGGLDLSRTVGWFTSVHPVRLDVAGIDWAGVLAGGPAAGELLKRVKEQSRAVPGDGLGYGLLRFLNDETGPVLAALPSPQIGFNFMGRHVAGVREWQPVGDVGGALGPGVGLPHVLDADAVVEDGPRGPLLRLVLSWPDGVLREDEVERLGRGWSDMLSGLAGQADDPSAGGHTASDFDLLDLDQDEIENFEAIAAEFGGGQES	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	373.38	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1629	colistin A; colistin B
BGC0000440.1|Teicoplanin_20 # 26228 # 29413 # 1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=GAGG;rbs_spacer=9bp;gc_cont=0.715	BGC0000440.1|Teicoplanin_20 	26228	29413	+	Loose	1000	119.398	almE	25.1	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACAACTCCGACTACGTCCCCAGGATCGGCGCTCGCGGAGGTCTGGCCGCTGTCACCGATGCAGGAGGGGATGCTCTACCATGCCTCGTTCGACGACGCGGCCCCCGACATCTACGTCATCCAGCAATCGCAGATCATCGACGGCCCTCTGGACACCGAGCGATTCCGGAGGTCCTGGGAGGTCCTTCTCCACCGGCACGCGGCGCTGCGAGCGAGTTTCCACCGCCGGAAGTCCGGTGAGACCGTCCAGCTGATCCCCCGTGAGGTCCGGCTTCCCTGGGCCGAACGTGACCTGTCCGGCCTGCCCGAGAAGGCGGCGCTGGCCGAGGTGGGCGAGATCGCGGCGAAGGAGCGCGCCGAAAGGTTCGACCTCACGAAGCCTCCCCTGCTGCGGTTGATGCTGATCCGCCTCGGCCCGCAGCGGCACTGTCTGGTGACCACGAGCCATCACCTGCTCATGGACGGGTGGTCGCGGGCCATCCTGGAATCGGAGCTGCTCCATGTCTACGCGTCCGGTGGCACCGTCTCGGGGCTGCCGCCCGCCGGCTCGTACCGTCACTATCTGTCATGGTTGGGTCGGCAGGACCGGGAGGCCGCCCGATCGGCATGGCGCGCGGAGCTGTCCGGCGCCGACGGATCCGCGCTCGGAATCGCGGAGCGGCCAGGGAAGGCTCCGGAGCTGCCGGCACGCGAGGTGCTCCGCCATTCACCGGAGTTCACGTCCGCTCTCGTGGACTTCGCCCGCCGCCACGGGTTGACGCTCAACACGCTGGTGCAGGGCGCCTGGGCGGTGGTGCTGGCCCGATTGGCGCGCCGCACGGACGTGGTGTTCGGCGCGACGGTGTCGGGACGCCCCGCGGAGCTGCCCGGCGTGGAACAGCTTGTGGGCCTGTTCATCAACACCGTGCCGGTGCGAGTCCGGCTGGACGCCGGGCAGCCGGTCCTGGAGATGTTGACGGAGCTGCAGAAACGGCAGTCCGCGCTGATCTCGCATCAGCATCTCGGATTGCCGGAGATCCAGAAGCTCGGCGGGGCGAGTTTCGACACGATCGTCGTCTTCGAAAACTATGTCGATCCGGCCGCGGCGCCGGATTCTCCGCGCGGCCTGCGCCTGACCCTGCGAGAGTTCCACCAGGCGTCGCCGTATGCGATCACGCTGGGAGTGATGCCGGGCGAGAGCCTCGAGACCGACGTGCAGTATCCCCCGGAGACGCTCGATGCCCGGATCGCCGAGGAAGCCCTGTACGGGCTGGCCCGCGTCCTGGAACAGATCATCGCCGAGCCGGGAGCGGCGGTGGGCCGCCTCGACGTGGTGAGTGCGGCCGGCCGGCAGCTGACCGTCGAGCGGTGGAACGAGACCGGCGACGCGGTGGACGCGCCGTCCCCGGTCGATCTCTTCCGCCGGCAGGTGCGGCGGGCACCCGACGCGACGGCCGTGACGGCCGGGGACCGGGCCTGGTCGTTCAAGGAGCTCGACGAATGGTCCGGCCGGCTGGCGCGGGCCCTGACGGATCGGGGTGTCCGGCGCGGCGACCGGGTCGGGGTGATGCTGGAGCGGTCGGCCGAGGTGCTGGCGGCATGGCTCGGGGTGTGGAAGGCGGGAGCCGCGTTCGTGCCGGTCGATCCGGGCTACCCGGCGGACCGGGTGGAGTTCATGCTGGCCGACTCCGCGGTCGCGGCGGTGCTGTGCCGGGAGTCGACCGCGGGTGCGGTGCCGGCGGGTCACGAGCTGATCGACATGGACCGGGTCGGCGAGGGCGTGGCCGCGCCGGTCGCGATCGGAGCCGACGATCTGGCGTACGTCATGTACACGTCCGGATCCACCGGCAAGCCCAAGGGCGTGGCCGTCGCGCACGGGGGTGTGGCGGCATTGGCCGGTGATCCGGTCTGGGAGGTGGGGGCCGGCGACGCGGTGCTGATGCACGCTCCGCACACCTTCGACGCGTCGCTCTACGACGTGTGGGTGCCGCTGGTCTCCGGCGCGCGGGTGATGCTCGCCGAGCCGGGCGTGGTCGACGCGCAGCGGCTCGCCGCACACGTGGCGGATGGTCTCACCGCGGTGAACTTCACCGCCGGTCAGTTCCGGGCGCTGGCACAGGAGTCGCCGGAATCCTTCGCCGGACTGCGCGACGTGCTCGCGGGTGGAGACGTGGTGCCGCTCGGCGCGGTGGAGCGGGTCCGGCAGGCGTGCCCCGGGCTACGGGTCTGGCACACGTACGGCCCGACGGAGACCACGCTGTGCGCGACGTGGAAGAAGATCGAGCCGGGTGACCGGCTGGGCTCGACGCTGCCGATCGGCCGGCCGCTGCCGGGCCGTCGGCTGTACGTGCTGGACGTCTTCCTGCGTCCGCTGCCGCCGGGCGTCGCGGGTGATCTCTACATCGCGGGCGCCGGCGTGGCCCAGGGCTACCTCGGGCGTCCGGCGCTGACCGCCGAGCGGTTCGTCGCCGACCCGTTCGCCGCGGGCGAGCGGATGTACCGGACCGGGGACGTGGCGTACTGGACCGGTGACGGCGAGCTGGTGTTCGCCGGGCGCGCCGACAACCAGGTCAAGATCCGTGGCTATCGGGTGGAACCGGGCGAGATCGAGACGGTGCTGGCCGAGCAGCCGGGCGTCGACCAGGCGGTGGTGCTGGCCCGCGACGGCCGTTTGATCGGCTACGTGGTGCCCGGCGGCGAGGTGGATCCGGTACGGCTGCGCGAGCGGGTCGCCCGGGTGTTGCCGGAGTACATGGTCCCGGCGGCGGTGATGGTCCTGGACGCCCTGCCGGTGACTCCGAACGGGAAGCTGGACCGGGAGGCTCTGCCGGATCCGGACTTCAGCCGACGCGTCTCCGGCCGGGAGCCGCGTACCGGGGTCGAGCGGGCGCTGTGCGGTCTCTTCGCCGAGGTGCTGGGTCTGGAACGGGTCGGGGTCGACGACAGCTTCTTCGAACTCGGCGGAGATTCGATCACCTCGATGCAGCTCGCCGCACGCGCCCGCCGCGACGGGATGGCCTTCGGCGCGCGAGAGGTGTTCCAGCACCGGACGCCGGCCGGGATCGCGGCGATCGTCGATTCCGGGAACGAGCCGGCGGCCGGTGGCGACGGCGAGGCGACGTGGACGCCGGTGCGGCGGTTCGGCCTCGTCGACCTGGACCAGCAGGAGGTCGAAGAACTCGAGTCCGAGTTCGGCGACCGTTGA	MTTPTTSPGSALAEVWPLSPMQEGMLYHASFDDAAPDIYVIQQSQIIDGPLDTERFRRSWEVLLHRHAALRASFHRRKSGETVQLIPREVRLPWAERDLSGLPEKAALAEVGEIAAKERAERFDLTKPPLLRLMLIRLGPQRHCLVTTSHHLLMDGWSRAILESELLHVYASGGTVSGLPPAGSYRHYLSWLGRQDREAARSAWRAELSGADGSALGIAERPGKAPELPAREVLRHSPEFTSALVDFARRHGLTLNTLVQGAWAVVLARLARRTDVVFGATVSGRPAELPGVEQLVGLFINTVPVRVRLDAGQPVLEMLTELQKRQSALISHQHLGLPEIQKLGGASFDTIVVFENYVDPAAAPDSPRGLRLTLREFHQASPYAITLGVMPGESLETDVQYPPETLDARIAEEALYGLARVLEQIIAEPGAAVGRLDVVSAAGRQLTVERWNETGDAVDAPSPVDLFRRQVRRAPDATAVTAGDRAWSFKELDEWSGRLARALTDRGVRRGDRVGVMLERSAEVLAAWLGVWKAGAAFVPVDPGYPADRVEFMLADSAVAAVLCRESTAGAVPAGHELIDMDRVGEGVAAPVAIGADDLAYVMYTSGSTGKPKGVAVAHGGVAALAGDPVWEVGAGDAVLMHAPHTFDASLYDVWVPLVSGARVMLAEPGVVDAQRLAAHVADGLTAVNFTAGQFRALAQESPESFAGLRDVLAGGDVVPLGAVERVRQACPGLRVWHTYGPTETTLCATWKKIEPGDRLGSTLPIGRPLPGRRLYVLDVFLRPLPPGVAGDLYIAGAGVAQGYLGRPALTAERFVADPFAAGERMYRTGDVAYWTGDGELVFAGRADNQVKIRGYRVEPGEIETVLAEQPGVDQAVVLARDGRLIGYVVPGGEVDPVRLRERVARVLPEYMVPAAVMVLDALPVTPNGKLDREALPDPDFSRRVSGREPRTGVERALCGLFAEVLGLERVGVDDSFFELGGDSITSMQLAARARRDGMAFGAREVFQHRTPAGIAAIVDSGNEPAAGGDGEATWTPVRRFGLVDLDQQEVEELESEFGDR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	190.83	gnl|BL_ORD_ID|4935|hsp_num:0	5928			129	1629	colistin A; colistin B
BGC0000440.1|Teicoplanin_21 # 29457 # 41660 # 1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=GAGGAG;rbs_spacer=6bp;gc_cont=0.752	BGC0000440.1|Teicoplanin_21 	29457	41660	+	Loose	1000	108.612	almE	28.42	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACCCAGGCGCGCATCGAGGACATCTGGCCGCTGTCGCCGCTGCAGGAGGGACTGCTCTTCCACACCGTCTACGACGACGAGGGGCCGGACGTCTACGTGGGCCACTGGATCCTCGATCTCGACGGCCCGGTGGACGCGGCCCGGCTGCGCGCGGCGTGGGAGGCGCTGCTGGCCCGGCACGCCGCGCTGCGGGCCTGCTTCCGGCAGCGCCGGACCGGCGAGACCGTGCAGGTCGTCGCCGGCCGGGTGGAGCTGCCGTGGCGGGTGGTCGACCTGGCCCACCTCGACGATCCCGAGCACGCCGTGCGGGAACTGGCCGACGAGGACCGGCTGAGGCCCTTCGACGTCGCGAAGCCGCCGCTGCTGCGGCTGACCCTGATCCGGCTCGCCGACGACCGGCACCGCCTGGTGGTGACCTGCCATCACGCGGTCATGGACGGCTGGTCGTTGCCGATCGTCTTCGACGAGCTGACCGCGTTGTACGCGGCCGGCGACGGCCCGGCACAGCTGCCGGCGGTGACGCCCTACCGGGAGTACCTCGCCTGGCTGAGCCGGCAGGACAAGCCGAGCGCGCTGGCGGCGTGGGCCGCGGAGCTGCGTGGCGCGCAGGAGCCGACGTTGGTGGCCCCCGCCGATCCGGGACGGGCGCCGGGCATGCCGGAGAGCGTCGAGGTGCAGCTGTCGCCGGAGCTCACCCGCTCGCTGGCGGAGCTGGCCCGTGGCCGGGGGCTGACGCTGAACACGGTGATCCAGGGCGCCTGGGCGCTGGTGCTGGCGCGGCTGACCGGCCGGACGGACGTGGTGTTCGGGGCGACGGTGTCGGCGCGTCCGGCGCACCTGCCCGGCGTGGAGGCAATGGTCGGCCTGTTCCTCAACACCGTGCCGGTGCGGGTACGGCTGCGGGGTTCGGCGCCGGTCGTCGAGATGCTGGCGGAGCTGCAGAAGCGGCAGTCCGCTCTCATCCCCGAACAGTTCGTCGGACTGGCGGACATCCAGAAGGCGGCCGGGCCCGGCGCGGTCTTCGACACCCTGCTGGTCTTCGAGAACTTCCCCCGCGAGCTCGACGATTCGCGCTCGGCCGACGCGTTCGGCATCCGGGTGCACCAGGGCCGCGAAGCCGCGCACTATCCACTGACGCTGGTCGCGGTCCCCGGCGAGTCGATGCTGTTCAAGCTCGACTACCTGACGGAGCTGTTCGACGCGGCCACCGCGGCGTCCATCCTGGAACGGTTCACCCGGGTCCTGCGCCGGCTGACGGACGCGGGCGAGCTCACGGTGGCCGCGATCGACGTGACCAGCGCGGCGGAGCGCGACCGGGTGGCGCGATGGGGCGCGGCCGTCGGTGCGCGGCCGGACCGGCTGGCGCTGGACCTGTTCGCACGCCAGGTCGCGCAGCGCCCCGACGAGGTGGCGGTCGCCGATGGGGACCGGGTGATGTCGTTCGGGGAGCTGGCCGAGCGCGCGGAACGGCTCGCCGGTCACCTCAGCGCGCGCGGGGTCCGGCGCGGGGACCGGGTGGCCGTGGTGATGGAGCGGTCCGGCGAGCTGATCGCGACGTTGCTCGCGGTGTGGCGGGCCGGGGCGGCGTTCGTACCGGTGGATCCGGCCTATCCCGCGGAGCGGGTGAAGTTCCTGCTGACCGACGCGGAGCCGGTGGCGGCGGTGTGCACGGCCGCGTTCCGGGCCGCCGTGCTGGACGGCGGGCTCGAGGCGATCGTGGTGGACGATCCGGGGACGTGGCCGGCGGTGGCGCCGTGCCCGCCGGTCCCCACCGGACCCGACGACCTCGCCTACGTGATGTACACCTCGGGCTCGACCGGGACGCCCAAGGGCGTCGCGGTGTCGCACGGCGACGTCGCGGCGCTGGTCGGCGACCCGGGATGGCGGACCGGTCCCGGCGACACCGTGCTGATGCACGCCTCGCACGCGTTCGACATCTCGCTGTTCGAGATCTGGGTGCCGCTGCTGTCCGGCGCCCGGGTGATGATCGCCGGACCGGGCGCGGTGGACGGCGCGGCGCTGGCCGCTCAGGTGGCCGCCGGGGTGACGGCCGCGCACCTGACCGCGGGCGCCTTCCGGGTGCTGGCCGAGGAGTCGCCGGAGTCGGTCGCCGGGCTGCGCGAGGTGCTGACCGGCGGTGACGCGGTGCCGCTGGCGGCGGTCGAACGGGTGCGGCGGGCGTGTCCGGACGTCCGGGTGCGGCACCTGTACGGCCCGACCGAGACCACCCTGTGCGCCACCTGGTGGCTGCTCGAACCGGGCGACGAGACCGGCCCGGTGCTGCCGATCGGTCGCCCGCTCGCGGGCCGGCGCGTCTACGTCCTCGACGCGTTCCTGCGGCCCCTGCCGCCCGGGACGACCGGCGAGCTGTACGTCGCCGGGGCCGGTGTGGCGCAGGGCTACCTGGGCCGCCCGGCGCTGACCGCCGAGCGGTTCGTCGCCGACCCCTTCGCTCCCGGTGGCCGGATGTACCGCACCGGCGACCTGGCGTACTGGACCGAGCAGGGCACGCTGGCGTTCGCCGGACGGGCCGACGACCAGGTCAAGATCCGTGGCTACCGGGTGGAGCCCGGCGAGGTCGAAGCGGTCCTGGGCGGCCTGCCGGGTGTCGCCCAGGCCGTGGTGTGCGTCCGCGGCGAGCACCTGATCGGTTATGTGGTGGCCGAGGCCGGCCGGGACCTCGACCCGGAACGCCTGCGCGCCAGGCTCGCCGCGACCCTGCCCGAGTTCATGGTCCCGGCCGCGGTGCTGGTGCTGGCGGACCTGCCGCTGACGGTCAACGGCAAGGTGGACCGGCCGGCCCTGCCCGAGCCGGACTTCGCCGCCAAGTCGACCGGCCGGGCCCCGGCCACCGCGGCCGAGCGGATCCTCTGCGACGTGTTCGCCGGCGTCCTGGGCCTGGACCGGGTCGGCGTCGAGGACAGCTTCTTCGCGCTGGGCGGCGACTCGATCTCGTCGATGCAGGTGGCCGCCCGCGCCCGGCGCGAGGGCATCGCCCTGACCCCGCGGCAGGTGTTCGAGCACCGGACCCCGGAACGGCTGGCCGCGCTGGCGCCGGCGGCCGGATCGGCACGACCGGACCGGTCCGCGGCGGATGCCGGCCTCGGCGAGATCCCGTGGACGCCGGTGATGCGAGCCCTCGGCGACGACGCGGTGCGCCCCGGCTTCGCGCAGGCCCGAGTCGTCGTCGCGCCGGCCGGCCTCGACCCGGACGCGCTCACCGGCGCCCTGCGGGCGGTGCTGGACACCCATGACGTGCTGCGCGCGCGGGTGGAGCCGGACCGGCGGCTGATCGTGCCCGAGCGCGGCGCGGTGGCCGCGGCGGACCTGCTGACGCGGGTGGCGGTCGACAGTGACGGCATCGACGCCCGCGCCGAGCGCGAGGCGGCGACGGCGGCGGGCACGCTGGATCCGTCGGCCGGGATCATGCTGCGGGCGGTGTGGCTCGACGCCGGCGACGCCGAGCCGGGCCGGCTGGCGCTCGTGGCGCATCACCTGGTGGTCGACGCGGTGTCGTGGAGCATCCTGCTGCCGGACCTGCAAGCGGCGTACCAGGAGGTGCTCGCCGGCGCGACCCCGGCTCTGGAACCCGCGGCGACGTCGTACCGGCAGTGGGCGCGGCGGCTGACCGAGCAGGCGTCCAGCCCGAGCACCCTGGCCGAGCTCGACCACTGGGTCACCGTGCTGGACGCGGCGGAACCACCGCTGGCGGAGCACCACGGGCAGGCGCACTCGTGGTCGGCGACCCTGTCCGGCGCCGTGGCGGGCCACCTGGTCAGCCGGATGCCGGGCGCGTTCCACTGCGGGATCCAGGAGGTGCTGCTCGCCGGCCTGGCCGCGGCGGTGGCCCGCTGGCGCGGCGACGACGCCGGGGTGCTGGTGGACGTGGAGGGCCACGGCCGGCACGCCGCCGACGGCGAGGACCTGTTGCGTACGGTGGGGTGGTTCACCAGCGTGCACCCGGTCCGCCTGGACGTCTCCGGCGTCGACCTGGCGGCCGCGGCGGCCGGCGACGCGGCCGCGGGTGAGCTGCTGAAATCGGTGAAGGACCAGGTCCGCGCGGCGCCCGGCGACGGGTTCGGGTTCGGGCTGCTGCGCCACCTCAACCCGGACACCGCCGAGCGGCTCGCCGCGTTGCCCGCCCCGCAGATCGGGTTCAACTACCTCGGCCGGTCCGGGGTGGCCGCCGAGGCCGTCCCGTGGCAGGTGCGCGGCGGATCGCTCGGCGCCGGGGAAGCCGGACCGGACCTGGTCCTGGCACACCCGCTGGAGGCCGGCGCGGACGTGCGGGACACCCCGGACGGCCCGCTGCTGCGGCTCACCCTGGACGGCCGGGATCTCGCCCCGGTCACGGTGGAGCTGCTCGGCGAGGCCTGGCTGGAGTTGCTGACCGGTCTGGCCACCCACGCCGGCGACCCGCGGGCCGGCGGGCACACCCCGGCCGACTTCGACCTGGTCGAGGTGACGCAGCGGGACGTGACGGCGCTGGAGGCCGCGGCGCCGGGCCTGACCGACATCTGGCCGCTGTCGCCGCTGCAGCGGGGCATGCTCTTCGAGCGGGCGCTGGACGAGGACGGCGTCGACGTCTACCAGAGCCAGCGCATCCTGGACCTCGACGGGCCGCTCGACGCGGACCGGCTGCGCGCGGCCTGGCGGACGCTGGTCGCCCGGCACGAGTCGCTGCGCACCAGCTTCCATCAGCTGGAGTCCGGCGAGACGGTGCAGGTCGTCGTGGACCAGGCGGACATCGGCTGGCGGGTGGCCGACGTGTCACACCGGGCTGAGGCGGACGCGGCCGCGGAGGTCGGACGACTGCTCGCCGAGGACCAGGCGCAGCGGTTCGACGTCACCCGGGCGCCGCTGCTGCGGCTGTTGCTGGTCCGGCTCGGCGCGGACCGGCACCGGCTCGTGGTGACGTCGCACCACATCGTCCTGGACGGCTGGTCGACGCCGATCATCCTGGGCGAGATGTCGGCGGCGTACGCGGGTGCGCCGAGCACGGCGACGGCGCCCTCGCCGCGGGACTACCTGGCGTGGCTGAACCGCCAGGACGACGCGGCGACCCGCGCGGCGTGGCGCTCCGAGCTCGCCGGCTGCGACGAACCGACCCTGGTGGACGCCGACGCGGACAAGACCATGGTGATGCCGGGGGAGCACTGCGAAGGACTGTCGGAGCAGGCCACCCGCCGTCTCACCGAGTTCGCACGGGGTCATGCGGTGACGCTGAGCACGATCCTGCAGGGCGCCTGGGCGCTGGTGCTGGCGCGGCTGGCGGGCCGGACCGACGTGGTGTTCGGGACGGTGGTGTCCGGACGCCCCGCCGAGGTGCCGGACGTCGACCGGATGGTGGGGATGTTCATCAACACCGTCCCGGTCCGGGTGCGCCTCGACGGCGGCCGGCCGGTGCTGGACCTGCTGCACGACCTGCAGGCACGCCAGTCCGCGCTGACCGAGCACCAGCACCTGGGGCTGCCGGACATCCAGCGGGCGGCGGGTCCCGGCGCGCTGTTCGACACCATCATGATGGTCGAGAACTACCCGATGGACGCCGCCGGCCTGGGCGGCGAGGGTGGTGTCAGGATCGGCTCGGTCCTCACCCGGACCGGCACCAGCTATCCGCTGACGATGAGCGCGAGCCCCGGCGAGCGCCTGCAGATCCGGGTGTCCTACCGGCCCGACCGCATCGAGCGGGAGACCGCCGCCGAGGCGGCCGGGCAGGTCGTACGGGTCATCGAACGCATCGTGGCGGAGCCGTCGCTCGCGGTGGGCCGCCTGGGTGTGACCGGCGAATCGGTGCGCGAGCGCGTGGTGGAGCGCTGGAACGCGACCGGCGTGGCGGCCGGCGGGTCGTCGGTGCTGACCGGGTTCCGGCGGCGTGCGCGCAGCTCACCGGACGCGGTGGCGGTCAGCGGCGGCGGGCGGACCCTGTCCTACGCCGCCCTGGACCGGGAATCCGACCGGCTCGCGGGGCATCTGGCCGGCCGGGGTGTGCGGCGTGGCGACCGCGTCGGCGTGGTGATGGAACGCGGCACCGATCTGTTCGTCGCCCTCCTCGCGATCGGCAAGGCGGGCGCGGCGTACGTCCCGGTGAACCTGGACTACCCCCGGGACCGGATCGAGCGGATGCTGACCGACGCCGGCGTATCGGTGGCGGTCTGCGTGCAGGCGACCAGCGGCGCGGTGCCGGACGGCCTCGCGCCGGTGGTCATGGACTCACCGGCGATCGCCGCGGCGCCGTCCGAGGCCCCGCCGATCACGGTGGGCGCGCACGACCTGGCGTACGTGATGTACACCTCCGGGTCCACCGGGGTGCCGAAAGGCGTCGCGGTGCCGCACGGCAGCGTGGCGGCGCTGGCCGGTGACCCGGGCTGGTCGGTCGGCCCCGGCGACGGCGTGCTGATGCACGCCCCGCACGCGTTCGACGCGTCGTTGCTGGAGATCTGGGTGCCGCTGCTGAGCGGGGCCCACGTGGTGGTCGCGGACCCGGGCGCGGTGGACGCGCAGCGGCTGCGCGAGGCGATCGACCGCGGGGTGACCACCGTCCATCTGACGGCCGGGTCGTTCCGGGTGCTGGCGGAGGAGTCGCCGGACGCCTTCCGCGGACTGCGGGAGGTTCTGACCGGCGGCGACGCGGTGCCGCTCGCCTCCGTCGTACGGTTGCGCGAGACCTGCCCCGAGATCCGGGTCCGGCACCTCTACGGCCCCACCGAGACCACCCTGTGCGCCACCTGGCACCTGATCGAGCCGGGGGTCGCCACCGGCGACACCCTGCCGATCGGCCGGCCGCTGGCCGGGCGGCGAGCGTACGTGCTCGACGCGTTCCTGCAACCGGTGGCCCCGAACGTGACCGGCGAGCTCTATCTGGCCGGCGCCGGGCTGGCGCGCGGCTATCTGGGCGCCGCCGCCGCGACCGCGGAGCGGTTCGTCGCCGACCCGTTCGCCGCCGGTGAGCGGATGTACCGCACCGGGGACCTGGCGCGCTGGACGGAACAGGGCGAGCTGCTGTTCGCCGGCCGCGCCGACGCCCAGGTGAAGATCCGCGGCTACCGGGTCGAGCCGGCGGAGATCGAGGCGGCGCTGACCGCGATCCCCGAGGTCGCGCAGGCGGTCGTGGTGGCCCGCGAGGACGGCCCGGGCGAGAAACGGCTGATCGCCTACGTCACCGCGGCCGGGCAGCCGGGACCGGACCCCGCCGCGGTACGCGAACACCTGGGCGAGCGGCTGCCGGAGTTCATGGTGCCGGCCGCGGTGGTGGTGCTGGACGGCTTCCCGCTGACGATCAACGGCAAGATCGACCGAGCGGCCCTGCCCGCCCCCGAACGCAGCGGGAAGCCGGCCGGCCGCGAGCCGCGTACCGAGGTCGAGCGGGTGTTGTGCGACCTGTTCGCCGACCTCCTCGGGCTGGACCGGGTCGGGGCCGACGACAGCTTCTTCGAACTGGGCGGCGACTCGATCGTGTCGATGCAGCTGGCCGCCCGCGCACGTCGCGAGGGCGTCGTCTTCGGCGCGAAGGACGTCTTCGAGCAGAAGACGCCGGCGGCCATCGCCGCGGTCGCGGTGCGCGGCGGTCAGCGGCCGGCCGGTCCCGACGACGGGGTCGGCGAGGTCGCCTGGACGCCGGTGATGCGGGGCCTGCTCGACCGTGACCCCGGCACGATGAACCGCAGCGCCATGGCGCAGTGGGTGACCGTGGGCGCGCCCGACACCCTGTCGCGCGACGTGCTGGCGGCCGGGCTGGGAGCCGTGCTCGACGCCCATGACATGCTGCGCAGCCGCGTCGTCGCGGCCGGGACGGAAGAGCCGCGGCTGGTGGTGGCGCCGCGGGGCGCGGTGCACGCGGCCGGGCTGGTGGACCGGGTCGAGGCGGGCGCCGGCGAGGTCGACGACCTCACCGAGCGCAGCGCCGCCGAGGCGGCCACGCGGTTGGATCCGGGCGCCGGCGTGATGGTCCGGGCGGTGTGGGTCGACGCGGGCCCCGGCCGCGTCGGACGGCTCGTGGTGGTGGCGCACCACCTGGTGGTCGACGCGGTGTCGTGGCGGATCCTGCTGCCGGACCTGCGCGCGGCGTGCGAGGCGGTGGCCGCGGGCCGGGAGCCGGCGCTCGATCCGGTGGACGTCTCGTTCCGGCGCTGGGCGCGGACGCTGACCGATCAGGCGGCCACCCGGACCGCGGAGCTGGCCACGTGGACGCGGATCCTGGGCGGGGCGCAGCCGCGGTTCGGCGCGCTCGACCCCGGACGCGACACCATCTCGACCGCCGGCCGCCGGACGTGGACGGTGCCGCAGGACCGGGCCGGCGTGCTGGTGGAGAGGGTCACCTCGGCCTTCCACTGTGGTGTGCACGAGGTGCTGCTGGCCACCCTGGCGGGCGCGGTGGCCCGATGGCGCGGCGGCGCCGCCGTCGTGGTGGACGTCGAAGGTCACGGCCGCCGGCCGCTCGGCGAGATGGACCTGTCGCGCACGGTCGGCTGGTTCACCGACGTGCACCCGCTCCGGCTGGACGTGACCGGGATCGACACGGCCGAGGTGATCGCCGGTGGCGGCGCGGCCGGCCGCCTGCTGAAGACCGTCAAGGAGAACGTGCGTGCCGTGCCCGACGGCGGGCTCGGCTACGGGATGCTGCGCCACCTCAACGCCGAGACCGGGCGGGTGCTGGCGGCACAGCCGGCAGCCGAGATCGGGTTCAACTACCTGGGCCGCTTCTCCGAGGGGCCCGGCGGTGACGTGCAGCCCTGGCAGCAGCTGGGGACGATCGGCGGTACGGCGGAGCCGGACATGCCGTTGCGGCACGCCGTGGAGATCGACGCGGCCGTGCTCGACGCGGCCGACGGGCCCCGGCTGGAGCTGACCGTCACCTGGGCCGGGCGGCTTGTCGGCGCGGCCGAGGCCGAGTCGCTCGGCAGGGCTTGGCAAGACGTGCTGGCCGGTCTGGCGGTACACGCCGGCGACGTCCGCGCCGGCGGGCACACCCCGTCCGACTTCCCGCTGACCGCGCTGAGCGGGCAGGAGGTGGCGCAGATCGAGGCCGCCGTGCCGGACCTGCTCGACATCTGGCCGCTCTCCCCGCTGCAGGAGGGCCTGCTGTTCCATGCCGTCGACGAGCGCGGCCCGGACGTCTACGCCAGCATGCGGACCCTGGCCGTCGACGGCCCGCTGGACGTGGCCCGGTTCCGCGCGTCCTGGCAGGCCGTGCTGGACCGGCACGCCGCCCTGCGGGCGAGTTTCCATCAGCTCGAGTCCGGCGCGGCCGTGCAGGCGATCGCCCGCGAGGTGACGCTGCCCTGGCAGGAGACCGACCTGTCGGATCTGCCCGAGGACGTGGCGCTGGCGGAGTTCGACCGGCTCGCGGCGCAGTTGCGCGACGAGCGGTTCGACCTGACCCGGGCGCCGCTGCTGCGCCTGCACCTGGTGCGTCTCGGCGAGCGCCGGCACCGGCTGGCCTTCGCGTCGCACCACATCTCGTGCGACGGGTGGTCACTCCCGATCGTCTCCACCGAGGTGATGGCGGCGTACGAGGGTCGCGGCCTGCCGGCGCCGACGTCGTACCGTGACTACCTGGTCTGGCTGGCCCGCCAGGACAAGGAGGCCGCCCGGCAGGCGTGGCGCGGCGAACTGGCCGGGCTCGACGAGGCCACCCACGTCGTGCCGCCGGACACGATCACCGCGCCGATCGCGCCGCAGCGGGTACGGTTCGGGCTCGACGACGAGCTGAGCCGGCGCCTGGTGCGGTTCACCCGCCGCCACGGCGTCACGATGAACACCCTCTTCCAGGGGATCTGGTCGTTGCTGCTGGCCCGGCTGACCGGCCGCGACGACGTGGTCTTCGGTTCCGCCGTGGCCGGGCGGCCCGCGGAGATCCCCGGCGTCGGGTCCGTGGTCGGGCTGTTCATGAACACGCTGCCGGTCCGGGTGCGCCTCGACGGCGCCGAACCGTTCCTGGACATGCTGACCGACCTGCAGCGGCGGCAGGTCGCGATGATGGCCCACCAGCACCTCGGGCTGAGCGAGATCAAACAGGTCGCCGGTCCGGGGGCGGCGTTCGACACGCTGGTGGTGTTCGAGAACTACCCGCGCCCGCCGCGCCCGTCCGACGACCCGGACGCGGTGGTCATGCGCCCGGCGGAGATCCCGGAGGACAGCGGGCACTACCCGGTGTCGATGCGCGCCTCCGAGGACGGCGGCGTCCACGGCGAGTTCATCTTCCGTCCGGACGCGTTCGACCGGGCCGAGGCCGAGGGGATGCTCGCCGCGATCATCGAGGCCCTGCGGCAGGTGGTGGCCGAACCGGGGATTGCGGTGGGGCGCATCGGTCTGGTCGGCGCGGCCGAGCGCCGGCAGGTGGTGCGGGAGTGGAACGAGACCGATGCGCCGCTGACCGCGCAGCCGCTGCCGATGCTGTTCCGCCGGCAGGCGCAGCGCTCCCCGGACGCGGTGGCGGTGCGCGACGCGGCGCGCAGCCTGTCGTTCGGCGCGCTGCTGGGCGAGGCCGAGGGGCTCGCCCGGCGGCTGGTGGCCTCCGGCGTACGGCGCGAGACCCGGGTGGCCGTGCTCGTGGAACGCTCGGCGGAGCTGGTGGTGGCCCTGCTCGGGGTGTCGCTGGCCGGCGGGGTGTTCGTGCCCGTCGACCCGGACTACCCCGGCGACCGGATCGCGCTGATGCTGGCGGATGCGGCGCCGCAGGTGCTGGTGTGCACGGCGCGGACCCGCTCGGTCGTGCCGGGCGACTTCGCCGGCGCGGTGCTGGCGCTGGACGAGCCGTCCGCGGCCGGCCCGCAGGTGTCGCTGCCGCGGGTGGCGGCGCGGGACGGGGCGTACGTGATCTACACGTCCGGGTCGACGGGTGTGCCCAAGGGCGTGCTGGTCACCCACGCCGGGCTCGGCAACCTGGCGAGCGCGCAGATCGAGCGGTTCGGCGTGACGTCGTCCTCGCGGGTCCTGCAGTTCGCCGCGCTCGGGTTCGACGCCGCCATCTCCGAGGTGTGCATGGCCCTGCTCTCGGGCGGGAGCATCGTGCTGGCCGACGCCGAGCACATGCCGCCGCGGGTGTCGCTGGGCGACGCGGTACGCCGGTGGGACATCACCCACGTCACCGTGCCGCCGAGCGTGCTGGCCGTCGAGGACGACCTGCCGGACGACCTCACCCTGATCGTGGCCGGCGAGGCCTGCCCGCCCGCGCTGGTGGACCGCTGGTCGCCGGGCCGCCGGATGATCAACGGCTACGGGCCCACCGAGACGACCGTGTGCGCGACGATGAGCTCCCCGCTGTCCCCGGGACGCGGCGCGGTGCCCATCGGCGGCCCGATCGCCAACATGCGGACCTACGTGCTCGACGCCTTCCTGCAGCCGGTGCCGCCGGGCATGACCGGCGAGCTCTACGTCACCGGGGTCGGGCTCGCCCGCGGATATCTCGGGCGTCCGGGGCTGACCGCGGAACGGTTCGTGGCCGACCCGTTCTCGCCGGGTGGCCGGATGTACCGCACCGGCGACCGGGCCCGCTGGACCGGCGACGGCGAGCTGGTCTTCGCCGGCCGGGTCGACGCGCAGGTCAAGGTGCGCGGATACCGGATCGAGCCGGGGGAGATCGAGGCCGTGCTGGCCGAGCACCCGGGGGTCGCCCAGGTGGTCGTCGTGGCCCGCCAGGACGGGCCGGGCGAGAAGCAGCTGGTGGCCTATGTCGTCCCGGCGGCCGGCCCGACCGCCGAGGCGAGCACCCTGATCTCCGCGCTGCGCGAGGCGGCGGCCGCCCGCCTGCCGGAGCACATGGTGCCGGCGGCGTTCGTGCCGCTGGACGCGATGCCGCTGACGCCCAACGGCAAGGTCGACCACCGGGCGCTGCAGGCTCCCGACTTCGCCGGGATGTCGGCCGGGCGGGACCCGCGTACGGCCTTGGAGGCCAAGCTGTGCGAGCTGTTCGCCGAGGTGCTCGGCCTGGAGCAGGTGGGCGCCGACGACAGCTTCTTCGAGCTCGGCGGCGACTCGATCACCTCGATGCAGCTGTCCACCCGGGCCCGCCGGGAGGGGCTGGAGCTGACCCCGTGGCAGGTGTTCGACGAGAAGACGCCGGAACGGCTGGCGGCGCTCGTCAAAGAGATCCCGGCCGACGGCGGGGCCACCGGGGCGCCGGAGCCCGCGGCGGGCACGCTCGTCGCGCTCTCGCCTGAACAGATGGACCAACTCGAGGCCGGACCGGCCGGCGAATGA	MTQARIEDIWPLSPLQEGLLFHTVYDDEGPDVYVGHWILDLDGPVDAARLRAAWEALLARHAALRACFRQRRTGETVQVVAGRVELPWRVVDLAHLDDPEHAVRELADEDRLRPFDVAKPPLLRLTLIRLADDRHRLVVTCHHAVMDGWSLPIVFDELTALYAAGDGPAQLPAVTPYREYLAWLSRQDKPSALAAWAAELRGAQEPTLVAPADPGRAPGMPESVEVQLSPELTRSLAELARGRGLTLNTVIQGAWALVLARLTGRTDVVFGATVSARPAHLPGVEAMVGLFLNTVPVRVRLRGSAPVVEMLAELQKRQSALIPEQFVGLADIQKAAGPGAVFDTLLVFENFPRELDDSRSADAFGIRVHQGREAAHYPLTLVAVPGESMLFKLDYLTELFDAATAASILERFTRVLRRLTDAGELTVAAIDVTSAAERDRVARWGAAVGARPDRLALDLFARQVAQRPDEVAVADGDRVMSFGELAERAERLAGHLSARGVRRGDRVAVVMERSGELIATLLAVWRAGAAFVPVDPAYPAERVKFLLTDAEPVAAVCTAAFRAAVLDGGLEAIVVDDPGTWPAVAPCPPVPTGPDDLAYVMYTSGSTGTPKGVAVSHGDVAALVGDPGWRTGPGDTVLMHASHAFDISLFEIWVPLLSGARVMIAGPGAVDGAALAAQVAAGVTAAHLTAGAFRVLAEESPESVAGLREVLTGGDAVPLAAVERVRRACPDVRVRHLYGPTETTLCATWWLLEPGDETGPVLPIGRPLAGRRVYVLDAFLRPLPPGTTGELYVAGAGVAQGYLGRPALTAERFVADPFAPGGRMYRTGDLAYWTEQGTLAFAGRADDQVKIRGYRVEPGEVEAVLGGLPGVAQAVVCVRGEHLIGYVVAEAGRDLDPERLRARLAATLPEFMVPAAVLVLADLPLTVNGKVDRPALPEPDFAAKSTGRAPATAAERILCDVFAGVLGLDRVGVEDSFFALGGDSISSMQVAARARREGIALTPRQVFEHRTPERLAALAPAAGSARPDRSAADAGLGEIPWTPVMRALGDDAVRPGFAQARVVVAPAGLDPDALTGALRAVLDTHDVLRARVEPDRRLIVPERGAVAAADLLTRVAVDSDGIDARAEREAATAAGTLDPSAGIMLRAVWLDAGDAEPGRLALVAHHLVVDAVSWSILLPDLQAAYQEVLAGATPALEPAATSYRQWARRLTEQASSPSTLAELDHWVTVLDAAEPPLAEHHGQAHSWSATLSGAVAGHLVSRMPGAFHCGIQEVLLAGLAAAVARWRGDDAGVLVDVEGHGRHAADGEDLLRTVGWFTSVHPVRLDVSGVDLAAAAAGDAAAGELLKSVKDQVRAAPGDGFGFGLLRHLNPDTAERLAALPAPQIGFNYLGRSGVAAEAVPWQVRGGSLGAGEAGPDLVLAHPLEAGADVRDTPDGPLLRLTLDGRDLAPVTVELLGEAWLELLTGLATHAGDPRAGGHTPADFDLVEVTQRDVTALEAAAPGLTDIWPLSPLQRGMLFERALDEDGVDVYQSQRILDLDGPLDADRLRAAWRTLVARHESLRTSFHQLESGETVQVVVDQADIGWRVADVSHRAEADAAAEVGRLLAEDQAQRFDVTRAPLLRLLLVRLGADRHRLVVTSHHIVLDGWSTPIILGEMSAAYAGAPSTATAPSPRDYLAWLNRQDDAATRAAWRSELAGCDEPTLVDADADKTMVMPGEHCEGLSEQATRRLTEFARGHAVTLSTILQGAWALVLARLAGRTDVVFGTVVSGRPAEVPDVDRMVGMFINTVPVRVRLDGGRPVLDLLHDLQARQSALTEHQHLGLPDIQRAAGPGALFDTIMMVENYPMDAAGLGGEGGVRIGSVLTRTGTSYPLTMSASPGERLQIRVSYRPDRIERETAAEAAGQVVRVIERIVAEPSLAVGRLGVTGESVRERVVERWNATGVAAGGSSVLTGFRRRARSSPDAVAVSGGGRTLSYAALDRESDRLAGHLAGRGVRRGDRVGVVMERGTDLFVALLAIGKAGAAYVPVNLDYPRDRIERMLTDAGVSVAVCVQATSGAVPDGLAPVVMDSPAIAAAPSEAPPITVGAHDLAYVMYTSGSTGVPKGVAVPHGSVAALAGDPGWSVGPGDGVLMHAPHAFDASLLEIWVPLLSGAHVVVADPGAVDAQRLREAIDRGVTTVHLTAGSFRVLAEESPDAFRGLREVLTGGDAVPLASVVRLRETCPEIRVRHLYGPTETTLCATWHLIEPGVATGDTLPIGRPLAGRRAYVLDAFLQPVAPNVTGELYLAGAGLARGYLGAAAATAERFVADPFAAGERMYRTGDLARWTEQGELLFAGRADAQVKIRGYRVEPAEIEAALTAIPEVAQAVVVAREDGPGEKRLIAYVTAAGQPGPDPAAVREHLGERLPEFMVPAAVVVLDGFPLTINGKIDRAALPAPERSGKPAGREPRTEVERVLCDLFADLLGLDRVGADDSFFELGGDSIVSMQLAARARREGVVFGAKDVFEQKTPAAIAAVAVRGGQRPAGPDDGVGEVAWTPVMRGLLDRDPGTMNRSAMAQWVTVGAPDTLSRDVLAAGLGAVLDAHDMLRSRVVAAGTEEPRLVVAPRGAVHAAGLVDRVEAGAGEVDDLTERSAAEAATRLDPGAGVMVRAVWVDAGPGRVGRLVVVAHHLVVDAVSWRILLPDLRAACEAVAAGREPALDPVDVSFRRWARTLTDQAATRTAELATWTRILGGAQPRFGALDPGRDTISTAGRRTWTVPQDRAGVLVERVTSAFHCGVHEVLLATLAGAVARWRGGAAVVVDVEGHGRRPLGEMDLSRTVGWFTDVHPLRLDVTGIDTAEVIAGGGAAGRLLKTVKENVRAVPDGGLGYGMLRHLNAETGRVLAAQPAAEIGFNYLGRFSEGPGGDVQPWQQLGTIGGTAEPDMPLRHAVEIDAAVLDAADGPRLELTVTWAGRLVGAAEAESLGRAWQDVLAGLAVHAGDVRAGGHTPSDFPLTALSGQEVAQIEAAVPDLLDIWPLSPLQEGLLFHAVDERGPDVYASMRTLAVDGPLDVARFRASWQAVLDRHAALRASFHQLESGAAVQAIAREVTLPWQETDLSDLPEDVALAEFDRLAAQLRDERFDLTRAPLLRLHLVRLGERRHRLAFASHHISCDGWSLPIVSTEVMAAYEGRGLPAPTSYRDYLVWLARQDKEAARQAWRGELAGLDEATHVVPPDTITAPIAPQRVRFGLDDELSRRLVRFTRRHGVTMNTLFQGIWSLLLARLTGRDDVVFGSAVAGRPAEIPGVGSVVGLFMNTLPVRVRLDGAEPFLDMLTDLQRRQVAMMAHQHLGLSEIKQVAGPGAAFDTLVVFENYPRPPRPSDDPDAVVMRPAEIPEDSGHYPVSMRASEDGGVHGEFIFRPDAFDRAEAEGMLAAIIEALRQVVAEPGIAVGRIGLVGAAERRQVVREWNETDAPLTAQPLPMLFRRQAQRSPDAVAVRDAARSLSFGALLGEAEGLARRLVASGVRRETRVAVLVERSAELVVALLGVSLAGGVFVPVDPDYPGDRIALMLADAAPQVLVCTARTRSVVPGDFAGAVLALDEPSAAGPQVSLPRVAARDGAYVIYTSGSTGVPKGVLVTHAGLGNLASAQIERFGVTSSSRVLQFAALGFDAAISEVCMALLSGGSIVLADAEHMPPRVSLGDAVRRWDITHVTVPPSVLAVEDDLPDDLTLIVAGEACPPALVDRWSPGRRMINGYGPTETTVCATMSSPLSPGRGAVPIGGPIANMRTYVLDAFLQPVPPGMTGELYVTGVGLARGYLGRPGLTAERFVADPFSPGGRMYRTGDRARWTGDGELVFAGRVDAQVKVRGYRIEPGEIEAVLAEHPGVAQVVVVARQDGPGEKQLVAYVVPAAGPTAEASTLISALREAAAARLPEHMVPAAFVPLDAMPLTPNGKVDHRALQAPDFAGMSAGRDPRTALEAKLCELFAEVLGLEQVGADDSFFELGGDSITSMQLSTRARREGLELTPWQVFDEKTPERLAALVKEIPADGGATGAPEPAAGTLVALSPEQMDQLEAGPAGE	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	731.47	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1632	colistin A; colistin B
BGC0000440.1|Teicoplanin_22 # 41680 # 47277 # 1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.744	BGC0000440.1|Teicoplanin_22 	41680	47277	+	Loose	1000	105.531	almE	26.65	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACCGTTGACGACACTCGTGCAAAGCCCCGCTCCAGCGTGGAAGACGTCTGGCCGCTGTCGCCGCTGCAGGAGGGCATGCTTTACCACACCGCCCTGGACGGGGACGGGCCGGACACCTACACCGTGCAGACCGTCTACGGCATCGACGGCCCGCTGGACGCCGGGCGGCTGAGAGCGTCGTGGCAGGCCCTGGTGGACCGGCATGCCGCCCTGCGGGCCTGCTTCCGCTACGTCAGCGGCGCGCAGATGGTGCAGGTCATTCAGCGGGACGTCGAGCTCCCGTGGCGGGAGACCGACCTGTCCGGGCTGCCGGAGGACCTCGCCGACGGTGAGGTGGCCCGCCTGGCGGAGCAGGAGATGGCCGAGCGCCTGCGCCTGGAGGCCGCGCCGCTGATGAAACTGCACCTGATCCGGCTCGGCCCGCAGCGCCACCGGCTCGTGCACACCCTGCACCACGTGCTGGTGGACGGCTGGTCGATGCCGATCCTGCACCGTGAGCTCGCGGCGATCTACGCGGCGGGCGGGGACGCGTCCGGGCTGCCGCCCGCGGTGTCGTACCGCGACTATCTGGCCTGGCTGGGCCGGCAGGACAAGGAGTCGGCGCGGGCGGCGTGGCGGGACGCGCTCGCCGGGCTGGACACCCCGACCACGGTCGCGCCGGCCGATCCGGCCCGCGTGCCGGACATCGACACGGCGATGGTGGAGCTGTCCCCCGAGCTGACCGACGACCTGCTCCGGCTGGCGCATGGCCACGACCTCACGCTCAACACCGTCGTGCAGGGCGTGTGGGCGGTCGTGCTGGCGCAGCTGGCCGGCCGTACCGACGTGGTGTTCGGCGCGACCGCCTCGGGGCGGCCGGCCGAGCTGGCCGGGGTGGAGGCGATGGTCGGGCTGCTGCTGGCCACCCTGCCGGTGCGGGTCCGGCTCGACGGGCGCCAGCGGGTCGTCGACATGCTCGCCGACCTGCAGCGCGACCAGTCGGCGCTGCGCGCGCACCAGCATCTCGGGCTGCAGGAGGTGCAGGCCGTCGTCGGGCCCGGAGCGGTCTTCGACACGCTGGTCATCTACGAGAACTTCCCGCGTACGGGCCTCGGCGGATCGGCCGACGACGGCCTGGTCATGCGGCCGGTGCAGAAGGGGCGCGACTCCTCGCACTACCCGTTCACACTGGTCACCGGTCCGGGCGAGCGGATGCCGGTGATCCTCTACTACGACCGGGGGCTGTTCGACCAGGCGGCCGCCACATCGGTGCTCGGCGCGATCGTCCGCGTGCTGGAGCGGCTGGTCGCCGAGCCCGGTGTGCTCGTCGGCCGGCTGACGCTGCTGGGCGAGGCCGAGCGCGCCGTGGTGGTCGGCGACTGGAACGCGACCGCGGGCCCGGTCCCCGGCGACTCCATGGTCGAGCTGTTCGACCGGCGGGTGGCCGCCGCGCCGGACACGGTGGCGATCACCGACGCCGACGGCGCCGACCTCACCTATGCCGAGGTCGATCAGGCGTCGAACCGGTTGGCGGCCCACCTCGCCGATCGGGGCGTCCGCCGCGGCGACCGCGTCGGGGTGGCCGTGGAGCGGTCCGCGGACCTGCCGATCGTGTTCCTGGCGATCTGGAAGGCCGGCGCCGCGTACGTCCCGGTGGACGTCGGGTACCCGGCCGAGCGGATCGCGCTGATCCTCGCCGGCTCCGCGGTCTCGACGGTGATCTGTACGCAGGCCACCGAGGCGGCGGTGCCGCAGAACGTGCCGCAGCGCGCCACGATCGTCCTCGATGCGCCGCCGACGCGGGCGGCCGTGGACGCCTGTGCCGGCACCGCGCCGACGTTCCGGCCGAGCGCCGCCGACCTGGCGTACGTCATGTACACCTCGGGCTCCACCGGCGTCCCGAAGGGCGTGGCCGTCCCGCACGGCGCGGTCGCCGGCCTGGCCGGCGACGCGGGCTGGCGGATCGGCCCCGGCGACGGCGTGCTGATGCACGCGACGCACGTGTTCGACCCCTCGCTCTACGAGATGTGGGTGCCGCTGGCCACGGGTGGCCGGGTCCTGGTGGCCGCTCCCGGAGTGGTCGACGCGGGCGGGATCCGGCAGGCCGTGGCACGCGGCGCGACCGCCGTCCACCTCACCGCCGGCACCTTCCGCGCGCTGGCGGAGGCGTCCCCGGACTGTTTCGCCGGCCTGCGCGAGGTCGGCACCGGCGGCGACGTGGTGCCCGCGCACACCGTGGCCCACCTGCGGCGGGCCCAGCCACAGCTGCGGGTGCGCAACACGTACGGGCCGACCGAGACCACCCTGTGCGCCACCTGGAAGCCGATCGAGCCGGGCGCGCAGCTCGGGCCGGAGCTGCCGATCGGCCGTCCGATGACCAACCGCAGGATCTACATCCTGGACGCCTTCCTGCGCCCGGTCGCCCCCGGGGTGGCCGGCGAGCTGTACATCGCCGGCACCGGACTGGCCCGCGGATATCTCTCCCGGCCGGACCTGACCGCCGAGCGGTTCGTGGCGTGTCCGTTCCTCGCCGGCGAGCGCATGTACCGGACCGGGGACCTGGCGCGCTGGAACCGCGACGGCGAGGTGGTCTTCCTCGGGCGCGCCGACGACCAGGTGAAGATCCGCGGCTACCGGGTGGAGCTGGCCGAGGTGGAGGCGGTGCTGGCGGCCCAGCCGGGAGTCCGCGAGGCGGTCGTCGTGGCCCGCGAGGACCGGCCGGGCGAACGGCGTCTGGTCGGCTACGTCGTCTCCGACGCCGGTGAGCTGGACACCGAACAGATCCGCCAGCAGATGGCCCGGGTGCTGCCCGGCTACATGGTTCCGGTGGCGGTCATCGGGCTGGTCAGCCTGCCGATCACCGCCAACAGCAAGGTGGACCGCCGGGCCCTGCCCGCCCCGGACCTCGCCGGCCACGCGTCGGCGAAGGCGCCGGAGAGCGCGACCGAGAAGGTGCTGTGCGCGCTCTACGCCGAGATCCTCGGCGTCGAGCGGGTGGGCGTCGACGACGCCTTCCACGACCTGGGCGGCAGTTCGGCGCTGGCCATGCGGCTGATCGCGCGGATCCGCGAGGAGCTGGGCGTGGACCTGCCGATCCGCCAGCTGTTCTCCTCGCCCACACCCGCGGGGGTGGCCCGGGCGCTGGCCGCGAAGTCGCGCCCCGCGCTGGAGGCGGTCACCCGGCCGGAGCGGGTGCCGCTCACCGCCCGGCAGCTGCGCGCCTGGCTGCTGGCCCGCCCGTCGGAGGAGACCCGGGGCCGGCACCTCTCGGTCGCGCTGCGCCTGCGCGGCCGGCTGGACGTGGCCGCCCTGGAGGCGGCGCTGCGCGACGTCGCGGCCCGGCACGAGATCCTGCGGACCACCTTCCCGGGCGACGCGCAGACCGTCCACCAGCACATCCACGACGCCGCGCCGGTCCGGCTGACGCCGGTCCCGGCCACCGAGGAGGACCTCCCCGCACGGCTGGCCGAGCGGGGCGAGCAGCTGTTCGACCTCACCCGGGACATGCCGTGGCGGTGCGAGCTCTTCGCGCTGTCGGAGAAGGAGCACGTGCTGTCGGTGACGGTGCACCGCATCGCCGCCGACGACGACTCGATGGACGTGTTCTTCCGGGACCTCGCGGCCGCGTACGGCGCGCGGCGGGCCGGCCGGGCCCCGGAGCGCGCGCCGCTGGCCCTGCAGTTCGCCGACTACGCGATCTGGGAGCAGCGGCTGCTCGACGGCGAGCGCGAGCAGGACAGCCTGATCAACGACCAGATCACCTTCTGGCGCAACCACCTGGCCGGCATCGACCAGGAGACCGTGCTGCCGTTCGACCGAGCGCGGCCGGCCATCCCGTCGCGCCGGGCCGGCACGGTCGCGCTGCGGCTGGACGCCGGTCCGCACGCCCGGCTGGCCGAGGCGGTGGAATCGGCCGGCGCGGACATGCCGCAGCTCGTGCAGGCCGCGCTGGCCATGCTGCTGACCCGGTACGGCGCGGGCACCGACCTGGTGATCGGCACGACGCTGCCGCGCGACGAGGACCTGATCGACCTGGAGCCGATGATCGGGCCGTTCGCCCGGCCGTTCCCGGTGCGTACCGACCTGTCGGCGGATCCGACCTTCCTGGAGGTCGTCGCCCGGGTGCAGGAGGCGGTCCGCGAGGCGCGCCAGCACCTGGACGTGCCCTTCGAGAAGATTCCCGAGCTGCTGGCCCTGCCCGGCTCGCTGTCGCGCCACCCGGTGTACCAGGTCGGGCTGCAGGTGCGCGAGGAGGACAACGGCGCGTGGGACGCCGCGGAACTGCCCGCCCTGCGCACCAGCGTCGAACCCACCGGGGTCGAGGCCATCGAGCTGGACCTGGCGTTCGCGCTCACCGAGCGCCGCAACGACGATGACGACGAGGACGGCATCGAGGGCGCCCTGCACTATGCCGCCGACCTGTTCGACCACGACACGGCCGCGTCGCTGGCCCGGCGGCTGGTCCGCGTCCTGGAACAGGTGGCCGAGGATCCCGGGCGGCGGATCAGCGACCTGGACATCCTCCTCGACGACGCCGAGCGCGGCGCTCCGGCGATCGCGCCGGCGCGCTGGGCCGGGGCGGTGCCGGCGGCGGTCGCCGACCTGGTCGCGGCCGGCCCGCTCGGTGCGCTGGTGCTCGACGAGGCACAGCGCCCGGTGGCGCCCGGGACCGTCGGCGACCTGTGGGTGACCGGTCCCGCGGTGGACGCGGACACCGGCGGCCGGCCGAGCGTGCCGTGTCCGTTCGGGACCCCGGGGCACCGGATGCTGCACACCGGTCTGCTCGCCCGTAAGTCGCCGGCCAGGACGCTGGTCGTCGTGGGGGAGCGGCGCGGGGCGAGCGCCTCGGCGAAGACCGGTGACTACGAGGTGCTGCTGCCGCTGCGCGCCGCGGGTGACCGGGCGCCGCTGTTCTGCATCCACGCCAGCGGCGGCCTGAGCTGGAACTACGGTCCGCTGCTGCGGCACCTGCCGCCGAACCAGCCGGTCTACGGGGTGCAGGCGCGTGGCCTGGCCCGTACCGAGCCGCTGCCCGGCAGCGTGGAGGAGATGGCCGCCGATTACGTCGAGCAGATCCGCACCGTGCAGCCGACCGGGCCGTACCACCTGCTCGGCTGGTCTCTGGGCGGGCGGATCGCGCAGGCGATGGCCGTGCTGCTGGAGGCGGACGGGGAGAAGGTCGGCCTGCTCGCCCTGCTCGCGGCCTATCCCGTCTACATGGGAAGGAAGGCCACCGGCACGGTCACCGAGGAGGCCGCCCGCGACGAAGACGCCCTGGAACGGCGCAAGCAGCAGGAACTGGAGCTCGCCGGTCAGCTGGTCCAGGGGGCCGGCGCCCGGTCCCGCTTGGAGGCGGTCATGCGCAACCTCTGGGAGGTCGGGCCGGCCCACACCGCCTCGCCGTTCGCCAGTGATGTCCTCCTCTTCGTCGCCTCCGTGGACCGTCCCGCGCATCTGCCGGTGTCCGAGGCGATAGCCAGCTGGAAAGACTTCACCGGGGGGACGATCGAGCCCCACGAGATCGCGACCAACCACTACGAGATGGTGCAGCCCGCGGCGTTGGCCCAGATCGGGGCCATCGTCGCCGAGAAACTCCGGTCCCGGCCGGATGCGTGA	MTVDDTRAKPRSSVEDVWPLSPLQEGMLYHTALDGDGPDTYTVQTVYGIDGPLDAGRLRASWQALVDRHAALRACFRYVSGAQMVQVIQRDVELPWRETDLSGLPEDLADGEVARLAEQEMAERLRLEAAPLMKLHLIRLGPQRHRLVHTLHHVLVDGWSMPILHRELAAIYAAGGDASGLPPAVSYRDYLAWLGRQDKESARAAWRDALAGLDTPTTVAPADPARVPDIDTAMVELSPELTDDLLRLAHGHDLTLNTVVQGVWAVVLAQLAGRTDVVFGATASGRPAELAGVEAMVGLLLATLPVRVRLDGRQRVVDMLADLQRDQSALRAHQHLGLQEVQAVVGPGAVFDTLVIYENFPRTGLGGSADDGLVMRPVQKGRDSSHYPFTLVTGPGERMPVILYYDRGLFDQAAATSVLGAIVRVLERLVAEPGVLVGRLTLLGEAERAVVVGDWNATAGPVPGDSMVELFDRRVAAAPDTVAITDADGADLTYAEVDQASNRLAAHLADRGVRRGDRVGVAVERSADLPIVFLAIWKAGAAYVPVDVGYPAERIALILAGSAVSTVICTQATEAAVPQNVPQRATIVLDAPPTRAAVDACAGTAPTFRPSAADLAYVMYTSGSTGVPKGVAVPHGAVAGLAGDAGWRIGPGDGVLMHATHVFDPSLYEMWVPLATGGRVLVAAPGVVDAGGIRQAVARGATAVHLTAGTFRALAEASPDCFAGLREVGTGGDVVPAHTVAHLRRAQPQLRVRNTYGPTETTLCATWKPIEPGAQLGPELPIGRPMTNRRIYILDAFLRPVAPGVAGELYIAGTGLARGYLSRPDLTAERFVACPFLAGERMYRTGDLARWNRDGEVVFLGRADDQVKIRGYRVELAEVEAVLAAQPGVREAVVVAREDRPGERRLVGYVVSDAGELDTEQIRQQMARVLPGYMVPVAVIGLVSLPITANSKVDRRALPAPDLAGHASAKAPESATEKVLCALYAEILGVERVGVDDAFHDLGGSSALAMRLIARIREELGVDLPIRQLFSSPTPAGVARALAAKSRPALEAVTRPERVPLTARQLRAWLLARPSEETRGRHLSVALRLRGRLDVAALEAALRDVAARHEILRTTFPGDAQTVHQHIHDAAPVRLTPVPATEEDLPARLAERGEQLFDLTRDMPWRCELFALSEKEHVLSVTVHRIAADDDSMDVFFRDLAAAYGARRAGRAPERAPLALQFADYAIWEQRLLDGEREQDSLINDQITFWRNHLAGIDQETVLPFDRARPAIPSRRAGTVALRLDAGPHARLAEAVESAGADMPQLVQAALAMLLTRYGAGTDLVIGTTLPRDEDLIDLEPMIGPFARPFPVRTDLSADPTFLEVVARVQEAVREARQHLDVPFEKIPELLALPGSLSRHPVYQVGLQVREEDNGAWDAAELPALRTSVEPTGVEAIELDLAFALTERRNDDDDEDGIEGALHYAADLFDHDTAASLARRLVRVLEQVAEDPGRRISDLDILLDDAERGAPAIAPARWAGAVPAAVADLVAAGPLGALVLDEAQRPVAPGTVGDLWVTGPAVDADTGGRPSVPCPFGTPGHRMLHTGLLARKSPARTLVVVGERRGASASAKTGDYEVLLPLRAAGDRAPLFCIHASGGLSWNYGPLLRHLPPNQPVYGVQARGLARTEPLPGSVEEMAADYVEQIRTVQPTGPYHLLGWSLGGRIAQAMAVLLEADGEKVGLLALLAAYPVYMGRKATGTVTEEAARDEDALERRKQQELELAGQLVQGAGARSRLEAVMRNLWEVGPAHTASPFASDVLLFVASVDRPAHLPVSEAIASWKDFTGGTIEPHEIATNHYEMVQPAALAQIGAIVAEKLRSRPDA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	335.43	gnl|BL_ORD_ID|4935|hsp_num:0	5928			168	1629	colistin A; colistin B
BGC0000440.1|Teicoplanin_24 # 47979 # 48626 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.623	BGC0000440.1|Teicoplanin_24 	47979	48626	+	Loose	920	26.1794	OpmD	31.25	3000809	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCACACGATCTGGGGCCTCGCGCCGGACGACGACGCGGTGCTCTACCGCCGGAAAGAAGACATCGCCGCTCTTGATCACCTGAGGGTGGCTCATCGGCACGGCCGGTTCCTCGACTCCATCTACCGTAAGTTGCCGGACGGTCGTTGGCTGACCGCCCATGTGGAGGGCAGGCAGAAGCTGGCCGTCAACGATCACTCGCCGGACAGCGACCATGACCTGGTTGGCGAGGTGGCGGACGACATCAGGTCGATCATCGACGAGTTCGACCCGACGCTTGTCGTCACCTGTGCGGCCATCGGCGAACACCCCGACCATGAGGCGACGCGAGATGCCGCGCTGTTCGCCACGCACGAGAAGAACGTTCCGGTACGGCTGTGGGAGGACCTGCCGTATGCGGTCTTCAAATCAGGTGCGGTCGAATTGCCGCAGGGTTTTCGTCTCGGCTCTGCGGATGTCAGCTCGGTGAAGCCGGAGATGCGGTCGCAGAAATTCCAAGCTGTGGAGCGGTATTCGTCTCAAATGGTGCTGCTCAACGGAAGTGAAAACAATCTGTTCGACCGGCTGGACGAGCATGCTCGGCAGAATGCACCACACGGCGGATACGGCGAGACGACCTGGCCGGTCGTCCGCAGCGACGACAGCTGA	MHTIWGLAPDDDAVLYRRKEDIAALDHLRVAHRHGRFLDSIYRKLPDGRWLTAHVEGRQKLAVNDHSPDSDHDLVGEVADDIRSIIDEFDPTLVVTCAAIGEHPDHEATRDAALFATHEKNVPVRLWEDLPYAVFKSGAVELPQGFRLGSADVSSVKPEMRSQKFQAVERYSSQMVLLNGSENNLFDRLDEHARQNAPHGGYGETTWPVVRSDDS	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	44.15	gnl|BL_ORD_ID|450|hsp_num:0	442			1053	1230	acriflavine; tetracycline; norfloxacin
BGC0000440.1|Teicoplanin_26 # 50747 # 52693 # 1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=GAGG;rbs_spacer=7bp;gc_cont=0.684	BGC0000440.1|Teicoplanin_26 	50747	52693	+	Loose	1190	383.645	novA	39.59	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGGACGTGGTGTTGCGCTTCGGGGGGGTGTCGAAGAACGATGACGACCCCGATCCCTGGCAGACCCTGATCGGGCCGGGGACGCTGCGCAGAGTGCTCGCCTACTTCCGCCCGCACATCGGCAAGGTGGCGCTCTTCGTTCTCGTCGCCGCGCTGGAGTCGCTTGTCGTCGTCGTAGTTCCGTTGTTGCTGATGGAACTGGTCAACGGCGGCATCCTCAAGGACGACGCCGGGGTCGTGGCATCGATGGCCGGCCTGGCCGCCGGCCTCGCCCTGGTGGGCGCGCTGTTGCAGCTGGTGTCAGCCTATATTTCCGGGCAGATCGGGCAGGGGGTCAGCTACGACCTCCGGGTTCAGGCGCTGCGTCACGTTCAGCAGCTGCCGATCGCGTTCTTCACCCGTACCCAGACCGGGGTGCTGGTGGGCCGGCTGCACACGGAACTGATCATGGCGCAGCAGGCGTTCAGCCAGCTCCTGATGGCAGCCACCAGCGCCGTCACGGTGATCCTGGTGATGGCCGAGCTGTTCTACCTGTCATGGCTTGTCGCCGTGGTCACCCTGGTGCTGATTCCGCTGTTCCTCGTGCCCTGGATCTACGTGGGCCGGGTGATCCGGCGGCGCACCGGACGGCTGATGGACGCGAATACCGGCCTTGGTGGACTCCTCCAGGAGCGGTTCAACGTTCAGGGGGCGATGCTCTCCAAACTCTTCGGCCGTCCCCGCGAGGAGATGGCCGAGTACGCCGATCGTGCCGAGCGCATCCGCCGCATCGGCGTGAGTCTCTCGGTGTACGGGCGGCTCGCCTTCGTCATGATGGCGCTGATGGCCTCGCTCGCCACGGCGCTCGTCTACGGCATCGGTGGCGGGCTCGTGCTCGCCGGGGCGTTCCAGCTCGGCACGCTCGTCGCCCTCGCCACTCTGCTCGGGCGGTTGTTCGGGCCGATCACGCAGCTGTCCGGGATGCAGGAAACCGCGCAGACCGTCGTGGTGAGCTTCTCCCGGATCTTCGAGGTGCTCGATCTGAAGGGGCTGATCGAGGAGCGTCCCGGTGCGGTCGCGCTCGCCAAGGACACGGCGCCGGAGATCGAGTTCGACGACGTGGCGTTCCGCTATCCGACCGCCGACGAGGTCTCGCTGCGCTCGCTGGAGTACGTACGCGCCGAACGGGAGCGCGGGGAGACGACGCCGGAGGTGCTGCGCGGTGTCAGCCTGCACGTGCCGGCCGGCACCCTCACCGCGCTCGTCGGCCCGTCCGGCGCCGGCAAGAGCACGCTCACCCACCTGGTGTCACGGCTGTACGACCCGACCGGCGGGGTCATTCGCGTCGGTGGGCACGATCTGCGCGACCTCACCTTCGACTCGCTGCGCGAAGCGGTGGGCGTGGTCAGCCAGGACGCCTACTTCTTCCACGACACGATCCGGCAGAACCTGCTCTACGCCCGCCCCACCGCCACCGAGGACGAACTGATCGAGGCATGTCGAGGGGCCCAGATCTGGGACCTGATCGCCTCGCTCCCGGGCGGGTTCGACACCGTCACCGGCGATCGTGGCTACCGCCTGTCGGGCGGCGAGAAGCAACGCCTGGCCATCGCCCGGCTGCTGCTGAAGGCGCCGACGATCGTCGTGCTCGACGAAGCCACCGCTCACCTGGACTCCGAGTCCGAGGCCGCCGTGCAGCGGGCACTCAAGACCGCCCTGCACAACCGCACCTCGTTGGTGATCGCCCACCGGTTGTCCACGATTCGCGAGGCCGACCAGATCCTCGTGATCGACGACGGACGGGTCCGGGAGCGCGGAACGCACGACGAGCTGCTGGCCGAGGGGGGTCTGTACGCGGAGCTTTACCACACGCAGTTCGCCAAGGCCGGAAGCGACGCAGCCGAACCGGCGAGCGACGCAGCCGAGCTGCACCACAGGGAGCCCGAGCCGGTGCACGGCGGAGGATGA	MDVVLRFGGVSKNDDDPDPWQTLIGPGTLRRVLAYFRPHIGKVALFVLVAALESLVVVVVPLLLMELVNGGILKDDAGVVASMAGLAAGLALVGALLQLVSAYISGQIGQGVSYDLRVQALRHVQQLPIAFFTRTQTGVLVGRLHTELIMAQQAFSQLLMAATSAVTVILVMAELFYLSWLVAVVTLVLIPLFLVPWIYVGRVIRRRTGRLMDANTGLGGLLQERFNVQGAMLSKLFGRPREEMAEYADRAERIRRIGVSLSVYGRLAFVMMALMASLATALVYGIGGGLVLAGAFQLGTLVALATLLGRLFGPITQLSGMQETAQTVVVSFSRIFEVLDLKGLIEERPGAVALAKDTAPEIEFDDVAFRYPTADEVSLRSLEYVRAERERGETTPEVLRGVSLHVPAGTLTALVGPSGAGKSTLTHLVSRLYDPTGGVIRVGGHDLRDLTFDSLREAVGVVSQDAYFFHDTIRQNLLYARPTATEDELIEACRGAQIWDLIASLPGGFDTVTGDRGYRLSGGEKQRLAIARLLLKAPTIVVLDEATAHLDSESEAAVQRALKTALHNRTSLVIAHRLSTIREADQILVIDDGRVRERGTHDELLAEGGLYAELYHTQFAKAGSDAAEPASDAAELHHREPEPVHGGG	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	105.37	gnl|BL_ORD_ID|1112|hsp_num:0	1210			75	1779	novobiocin
BGC0000440.1|Teicoplanin_30 # 55442 # 56638 # 1 # ID=1_30;partial=00;start_type=TTG;rbs_motif=GAGGAG;rbs_spacer=7bp;gc_cont=0.677	BGC0000440.1|Teicoplanin_30 	55442	56638	+	Loose	850	27.7202	tet(K)	38.0	3000178	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGAGTGGTGACGGCTCGCCTCCGATCCACACCCGCCGGCAGGGTTTCGATCCGGCCGACGAACTGCGCGCCGCCGGAACGCTGACGAAGATTTCCATCGGCTCCGGAGCGGACGCCGAGACCACCTGGCTGGCGGCCGGGCACGCCGTCGTGCGCCAGGTTCTGGGCGATCACAAGCGATTCAGCACCCGGCGCCGCTTCGACCGACGTGACGAGATCGGCGGGACGGGCGTCTTCCGCCCGCGTGAGCTGGTCGGCAACCTGATGGACTACGACCCACCGGAGCACACCCGGCTCCGGCACCTGCTGACCCCGGGATTCACCCAGCGCCGGATGCGTCGTCTGGCGCCGCGCATCGAAGAGATCGTGACCGACCGCCTCGACGCCATGGAGCAGGCGGGGCCGCCGGCGGACCTGATCGAGCTGTTCGCCGACGAGGTGCCCGGAGCCGTGCTGTGCGAGCTGATCGGAGTACCCCGCGACGATCAGGCCATGTTCCTGCAGCTGTGTCACCGGCATCTCGACGCCTCGCTGAGTGCCAGGAAACGGGCGGCCGCCGGGGAGGCGTTCGCCCGCTACCTGGTGGCCATGATGGCCAGGGAACGCAAGGACCCCGGCGACGGGTTCATCGGCTCGATCGTCGCCGAACACGGCGACACGATCACGGATGAGGAGCTGAGAGGCGTCTGTGTGCAGCTGATGCTGGCCGGTGACGACAACGTCTCCGGCATGATCGGGCTGGGGGTGCTGGCGTTGCTGCGACATCCCGAGCAGATCGCCGCGTTGCGCGGGGACGATCAGTCGGCGGATCGAGCTGTCGACGAGCTGATCCGGTACCTGACGGTCCCATACGCCCCGACACCGCGGACCGCCGTGGAGGACGTCATGGTTGCCGACCAGGTGATCAAGGAGGGCGAGACGGTTCTCTGCTCTCTCCCGATGGCCAACCGTGACCGCGCCCTGCTGCCGGATGCCGACCGCCTCGACGTGACCCGTACGCCCGTTCCGCATGTCGCGTTCGGACACGGTATCCATCACTGTCTGGGCGCCGCTCTGACGCGCCTGCAACTGCGAATCGCCTATACCGCCCTGTGGCGGCGCTTTCCCGCTTTGCAACTGGCGGACCCCGCCCAGGAAATAATGTTCCGGACGAGTACCCCGGCGTATGGATTAACCAGTCTGCTGGTTGCCTGGTAG	MSGDGSPPIHTRRQGFDPADELRAAGTLTKISIGSGADAETTWLAAGHAVVRQVLGDHKRFSTRRRFDRRDEIGGTGVFRPRELVGNLMDYDPPEHTRLRHLLTPGFTQRRMRRLAPRIEEIVTDRLDAMEQAGPPADLIELFADEVPGAVLCELIGVPRDDQAMFLQLCHRHLDASLSARKRAAAGEAFARYLVAMMARERKDPGDGFIGSIVAEHGDTITDEELRGVCVQLMLAGDDNVSGMIGLGVLALLRHPEQIAALRGDDQSADRAVDELIRYLTVPYAPTPRTAVEDVMVADQVIKEGETVLCSLPMANRDRALLPDADRLDVTRTPVPHVAFGHGIHHCLGAALTRLQLRIAYTALWRRFPALQLADPAQEIMFRTSTPAYGLTSLLVAW	MFSLYKKFKGLFYSVLFWLCILSFFSVLNEMVLNVSLPDIANHFNTTPGITNWVNTAYMLTFSIGTAVYGKLSDYINIKKLLIIGISLSCLGSLIAFIGHNHFFILIFGRLVQGVGSAAFPSLIMVVVARNITRKKQGKAFGFIGSIVALGEGLGPSIGGIIAHYIHWSYLLILPMITIVTIPFLIKVMVPGKSTKNTLDIVGIVLMSISIICFMLFTTNYNWTFLILFTIFFVIFIKHISRVSNPFINPKLGKNIPFMLGLFSGGLIFSIVAGFISMVPYMMKTIYHVNVATIGNSVIFPGTMSVIVFGYFGGFLVDRKGSLFVFILGSLSISISFLTIAFFVEFSMWLTTFMFIFVMGGLSFTKTVISKIVSSSLSEEEVASGMSLLNFTSFLSEGTGIAIVGGLLSLQLINRKLVLEFINYSSGVYSNILVAMAILIILCCLLTIIVFKRSEKQFE	86.71	gnl|BL_ORD_ID|1337|hsp_num:0	1345			297	447	tetracycline
BGC0000440.1|Teicoplanin_31 # 56933 # 58408 # 1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.685	BGC0000440.1|Teicoplanin_31 	56933	58408	+	Loose	600	57.3806	Streptomyces venezuelae rox	29.89	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGCCGGTGGAAGAGTTCGACGTGGTGGTGGCCGGTGGCGGGCCGGCCGGTTCGACCGTGGCCACGCTGGTGGCCATGCAGGGCCATCGGGTGCTGCTGCTGGAGAAGGAGACCTTCCCCCGGTACCAGATCGGCGAGTCGTTGCTGCCCTCCACCGTCCACGGGGTGTGCCGGATGCTCGGCGTCTCGGACGAGCTGGCGGCAGCCGGCTTCCCCGTCAAGCGCGGCGGCACCTTCCGCTGGGGCGCCCGCCCGGAGCCGTGGACGTTCTCCTTCGCCGTCTCGCCCCTGATGAACGGCCCGACGTCGTTCGCGTACCAGGTCGAACGGGCGCGCTTCGACGAGATCCTGCTGCGTAACGCGCAGCGCAAGGGCGTCGACGTGCGCGAGGGATGCTCGGTCACCGGGGTGATCGAAGGCGACGAGCGGATCACCGGGGTGCGTTACACCGACCCCGACGGCGGCGAGCACGAGGTGTCGGCGCGGTTCGTGGTCGACGCGTCGGGCAACAAGAGCCGGCTGTACTCCCAGGTCGGCGGCGTCCGCAACTATTCGGAGTTCTTCCGCAGCCTGGCGCTGTTCGGTTACTTCGAGAACGGCAAGCGGCTGCCGGAGCCGTACTCGGGCAACATCCTGAGCGTCGCGTTCGACAGCGGCTGGTTCTGGTACATCCCGCTGAGCGACACGATGACCAGCGTCGGCGCGGTGGTGCGCCGGGAGATGGCGGAGAAGATCCAGGGCGACCGGGAGAAGGCGCTCCAGGCCCTGATCGCCGAATGCCCGCTGATCTCCGACTACCTCGCCGACGCGCGCCGGATCACCACCGGCCGGTACGGAGAACTGCGGGTCCGCAAGGACTACTCGTATCACCAGACCAGCTACTGGCGGCCCGGGATGATCCTGGTCGGGGACGCCGCGTGCTTCGTGGACCCGGTGTTCTCCTCGGGCGTGCACCTGGCGACCTACAGCGCGCTGCTGGCGGCGCGGTCGATCAACAGCGTGCTCGCCGAGGACCTGGACGAGAAGACCGCGCTGAGTGAGTTCGAGGCCCGCTACCGCCGCGAGTACGGGGTGTTCTACGAGTTCCTGGTGTCCTTCTACCAGATGAACGTCAACGAGGAGTCGTACTTCTGGCAGGCCAAGAAGGTCACCAACAACAAGCACACCGAGATCGAGTCGTTCGTGGAGCTGATCGGCGGGGTGTCGTCGGGTGAGGCGGCGCTGGCCACGGCCGGCCGGATCGCCGAGCGCAGCGCCGAGTTCGCCGCGGCCGTGGACCAGATGGCCGCCAGCGCCGACGGCAACATGGTGCCGATGTACAAGTCGGAAGTGGTCAAGCAGGTGATGCAGGAGGGCGGCCAGGTGCAGATGAAGGCGGTGCTCGGCGCGGACGCCGAGCCCGAGCTGCCGCTGTTCCCCGGCGGGCTGGTGGTCTCGCCCGACGGGATGAAGTGGCTGCCCTACCGTCCCGCCTGA	MPVEEFDVVVAGGGPAGSTVATLVAMQGHRVLLLEKETFPRYQIGESLLPSTVHGVCRMLGVSDELAAAGFPVKRGGTFRWGARPEPWTFSFAVSPLMNGPTSFAYQVERARFDEILLRNAQRKGVDVREGCSVTGVIEGDERITGVRYTDPDGGEHEVSARFVVDASGNKSRLYSQVGGVRNYSEFFRSLALFGYFENGKRLPEPYSGNILSVAFDSGWFWYIPLSDTMTSVGAVVRREMAEKIQGDREKALQALIAECPLISDYLADARRITTGRYGELRVRKDYSYHQTSYWRPGMILVGDAACFVDPVFSSGVHLATYSALLAARSINSVLAEDLDEKTALSEFEARYRREYGVFYEFLVSFYQMNVNEESYFWQAKKVTNNKHTEIESFVELIGGVSSGEAALATAGRIAERSAEFAAAVDQMAASADGNMVPMYKSEVVKQVMQEGGQVQMKAVLGADAEPELPLFPGGLVVSPDGMKWLPYRPA	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	103.15	gnl|BL_ORD_ID|4833|hsp_num:0	5820			3	486	rifampin; rifaximin; rifapentine
BGC0000440.1|Teicoplanin_32 # 58516 # 59748 # 1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=12bp;gc_cont=0.680	BGC0000440.1|Teicoplanin_32 	58516	59748	+	Loose	2000	26.9498	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	30.0	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGGATCACGACATCGATGAGGTCGCGCCGGTCGTGGAGCCGACGGCGAACTACATGAGGAGAACGGTCTGCGACCCGCACGAGGACATGTTCGCTCTGCGGGCGCACGGTCCGCTGATCCGGATCGGCGGGGATGCCGCGGTCCAGATGGGCGCGGATTATCTCTGGCAGGCGATGGGCTACGACGTCGTGCGGCAGATCCTCGGTGATCATGAGAACTTCACGACGCGGCTGCGGCTGACCGCGTCCGAACCGATCAGCGGGGAAGGCGCGACCAAACCGCAGGAGCTGGTCGGACAGATCTCGACCTACGATCCGCCCGAGCACACCCGCCTGCGCCGGATGCTCACGCCGGAGTTCACGGTCCGGCGCGTCCGCCGGCTGGAGCCCGCGATCCAGGAGCTCATCGACGACCGCATCGATGCGATGGAGGCCGCGGGACCGCCCGTGGACGTGCAGACGGTCTTCGCCGATCCGGTCGGCGGCGGCGCGCTGTGCGAACTGCTCGGCATCCCACGCGATGATCGGAACCAGTTCATGCGCCGGGTCCGGCAGAACGTCGATCTCAGCCGCGGATACAAGGCCCGGGCGGCCGACAGCGCGGCGTTCAACCGGTACCTGCAGAGCCTCATCACCCGGCAGCGCAAGGACCCCGACGAGGGGTTCCTCGGCATGCTGGTGCGCGACCACGGCGACGACATCACGGACGAGGAGCTCAAGGGCGTGTGCACGGCGCTGCTCCTCGGCGGTGTCGAGACCGTCGCGGGGATGCTGGGCTTCGGGGTCCTCGCGCTGCTGGACCATCCCGACCAGAGGCGGCTGCTCTTCGCCGGCCGCGAGGAGGCCGACCGCCTGGTCAACGAACTGTTGCGGTATCTGTCGGCGGTGCAGCAGCCGACTCCGCGGATGGCCGTCAAGGACGTGGTCGTCGATGGGCAACAGATCAGGGCGGGGGAGTACGTGCTGTGCTCGATCCTCATGGCCAACCGGGACGAAGCGCTGACACCCCATCCCAACGTTCTGGACGCGGAGCGTGAGCCGGCGCCACACATCGGATTCGGGCACGGCATCCATCACTGCATCGGGGCGGCGGTGGCGAGAACCGTGCTGCGGATGGCCTACCAGACCCTGTGGCGACGACTTCCCGGGCTGCGCCTCGCGATACCCGCCGGGCAGGTGAAGCTCAGGAACGCGTTCATCGACAGTCCGGATCAGTTGCCGGTCACCTGGTAG	MDHDIDEVAPVVEPTANYMRRTVCDPHEDMFALRAHGPLIRIGGDAAVQMGADYLWQAMGYDVVRQILGDHENFTTRLRLTASEPISGEGATKPQELVGQISTYDPPEHTRLRRMLTPEFTVRRVRRLEPAIQELIDDRIDAMEAAGPPVDVQTVFADPVGGGALCELLGIPRDDRNQFMRRVRQNVDLSRGYKARAADSAAFNRYLQSLITRQRKDPDEGFLGMLVRDHGDDITDEELKGVCTALLLGGVETVAGMLGFGVLALLDHPDQRRLLFAGREEADRLVNELLRYLSAVQQPTPRMAVKDVVVDGQQIRAGEYVLCSILMANRDEALTPHPNVLDAEREPAPHIGFGHGIHHCIGAAVARTVLRMAYQTLWRRLPGLRLAIPAGQVKLRNAFIDSPDQLPVTW	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	34.57	gnl|BL_ORD_ID|4719|hsp_num:0	2914			201	381	rifampin
BGC0000440.1|Teicoplanin_33 # 59865 # 61091 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.729	BGC0000440.1|Teicoplanin_33 	59865	61091	+	Loose	600	408.297	rgt1438	58.5	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGCGTGTGTTGTTGTCGACGACCGGAGGGCGCGGCGACGTCGAACCGCTGGTCGCGCTGGCGGTGCGGTTCCGCGAACTGGGTGTGGACGCGCGGGTCTGCGCACCGCCGGACTGCGCGGACCGGCTGGCCGGCGTCGGTGTGCCACTGGTGGAGGTCGGCGAGTCGGTGCGCGCGATGATGCACGGAGGGAAGCGGCCGTCGCCCGAGGACGCGCCCCGGCTCGACGCCGAGGCCATCGCTACGCAGTTCGACAAGGTCCCGGCGGCCGCCGAGGGCTGCGCCGCGGTGGTGACGACCGGCCTGTTGTCCGCCGCGGTCGCGGTGCGGTCCGTGGCCGAGAAGCTGCGCATCCCCTACGTCTACGCCGCCTACTGCCCGATCTATCTGCCGTCGCCGTACTACCCGCCGCCGCCGGCCCTGGGCGGCCCGCCCGTACCGGAACTGACCGACAACCGGGCGCAGTGGAACAGGCACAGCCAGGGTGCCTACCGGCGGTTCGGCGCCGCGCTCAACAGCCACCGGGCGGCGATCGGCCTGCCGCCGGTGGAGAACATCTACGACTACGCCTTCAGCGATCACCCGTGGCTGGCGGCCGATCCGGTCCTGGCCCCGCTGCAGCCGACCGATCTCGACGTGGTGCAGACCGGCGCGTGGATCCTGCCCGACCAGCGGCCGTTGTCGGCGGAGTTGGAGGGGTTCTTGAGGGCTGGCTCGCCTCCGGTGTACGTGGGTTTCGGCAGTGGGCCGGCGCCTGCCGAGGCCGCGCGGGTGGCCATCGAGGCGGTTCGGGCTCAGGGCCGCCGGGTGGTGCTGTCCAGTGGTTGGGCCGGGTTGGGCCGGATCGACGAGGGGGATGACTGTCTGGTGGTGGGCGAGGTGAACCATCAGGTGCTGTTCGGCCGGGTGGCCGCCGTCGTCCACGCCGGCAGTGCGGGCACGACGACCGCGGTGACCCGGGCGGGCGCTCCGCAGGTCGTGGTGCCCCAGATGACGGATCAGCCCTACTATGCCGGTCGGGTGGCTGACCTGGGTGTCGGCGTGGCGCATGACGGTCCGACCCCGACCGTCGAGTCCCTGTCCGCGGCGCTGGCCACGGCATTGACCCCGGGGATCCGGGCGCGAGCGGCGGCGGTGGCCGGCACGATCCGCACCGACGGGACGACGGTGGCCGCGAAACTGCTCCTCGAGGCGATCAGCCGGCAGAGATCGTCGGTCTCCGCGTGA	MRVLLSTTGGRGDVEPLVALAVRFRELGVDARVCAPPDCADRLAGVGVPLVEVGESVRAMMHGGKRPSPEDAPRLDAEAIATQFDKVPAAAEGCAAVVTTGLLSAAVAVRSVAEKLRIPYVYAAYCPIYLPSPYYPPPPALGGPPVPELTDNRAQWNRHSQGAYRRFGAALNSHRAAIGLPPVENIYDYAFSDHPWLAADPVLAPLQPTDLDVVQTGAWILPDQRPLSAELEGFLRAGSPPVYVGFGSGPAPAEAARVAIEAVRAQGRRVVLSSGWAGLGRIDEGDDCLVVGEVNHQVLFGRVAAVVHAGSAGTTTAVTRAGAPQVVVPQMTDQPYYAGRVADLGVGVAHDGPTPTVESLSAALATALTPGIRARAAAVAGTIRTDGTTVAAKLLLEAISRQRSSVSA	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	99.27	gnl|BL_ORD_ID|116|hsp_num:0	134			0	1230	rifampin; rifaximin; rifabutin; rifapentine
BGC0000440.1|Teicoplanin_34 # 61237 # 62208 # 1 # ID=1_34;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.683	BGC0000440.1|Teicoplanin_34 	61237	62208	+	Loose	450	25.409	ANT(9)-Ia	31.25	3002630	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(9)	ATGGATCCCGAGACCGTACGCATCGCGCTGGGGTTGGAGGAACGGACCGCGGCGTGGCTCACCGAGCTCGATGAGCTCGGTCCGCCCGCCGAGCCGGTACGGCTGCCGCGCGGCGAGGAGGCACGTGATCTGCTACGGCGTCTGGAGGTGCCGGAGCTCGACGCCGAGGAGATCGTGGCGGCCGCTCCCGATCCGGATCGTGACCCGGCCCTGTGGTGGCTGCTCGAACGCACCCACCACGCGATCGTCCGGCACATGGGCGACCACCGGGCGAAGCCACGCGGCGGTCCGCCCCTGCCGTACGAGGGCGGCGCCGCCGCACGCTACTTCCACGTGTACGTCTTCCTCGCGACGGTGCCGGCGGTGCGCCGCTTCCACGCGGAACGGGGTATCCCCGACGAGGTCGGCTGGGAGACCCTGACGCAGTTGGGGGAGCTGGTGGCCATTCATCGCCGCAAGTACGGCCAGGGCGGCATGAACATGCAGTGGTGGACCACCTACCACCTGCGCGGCATCCTCTACCGGCTCGGCCGCCTGCAATTCAGTCTGGCCACCGGAAAGGACGGCACGCCGCACCTCGGCCTGCACGTTCCCGAGTGGGGCGGACCGCTGTTGCCCAAGGCCTATGACGAATCGTTGCATCGTGCCCGCCCGTTCTTCGACCGGCATTTTCCCGAGCACGGCGCCCGGGTGGCCTGGGGAAGCTCGTGGATGCTCGATCCGCAACTGGAGGAGTATCTCACCGAGGACTCCAACATCATTCAGCTTGCGCGGTTCTGGACGCTCACCGACTCCGCGCCGGAGCCCGGTAACGCGGACGGGGACTCCTCGATCCTGGAGTTCGTGTTCCGCTACAACGGCCAGCCGCTGGATGAACTTCCGCAGCGTTCCTCGCTGGAGCGCGCGGTGATCGCCCATCTGAAGGCCGGACGTCACTGGCACATGCGGACCGGCTTCGTGAAGCTGCCGTAA	MDPETVRIALGLEERTAAWLTELDELGPPAEPVRLPRGEEARDLLRRLEVPELDAEEIVAAAPDPDRDPALWWLLERTHHAIVRHMGDHRAKPRGGPPLPYEGGAAARYFHVYVFLATVPAVRRFHAERGIPDEVGWETLTQLGELVAIHRRKYGQGGMNMQWWTTYHLRGILYRLGRLQFSLATGKDGTPHLGLHVPEWGGPLLPKAYDESLHRARPFFDRHFPEHGARVAWGSSWMLDPQLEEYLTEDSNIIQLARFWTLTDSAPEPGNADGDSSILEFVFRYNGQPLDELPQRSSLERAVIAHLKAGRHWHMRTGFVKLP	MSNLINGKIPNQAIQTLKIVKDLFGSSIVGVYLFGSAVNGGLRINSDVDVLVVVNHSLPQLTRKKLTERLMTISGKIGNTDSVRPLEVTVINRSEVVPWQYPPKREFIYGEWLRGEFENGQIQEPSYDPDLAIVLAQARKNSISLFGPDSSSILVSVPLTDIRRAIKDSLPELIEGIKGDERNVILTLARMWQTVTTGEITSKDVAAEWAIPLLPKEHVTLLDIARKGYRGECDDKWEGLYSKVKALVKYMKNSIETSLN	124.23	gnl|BL_ORD_ID|1270|hsp_num:0	1386			543	678	spectinomycin
BGC0000440.1|Teicoplanin_35 # 62352 # 63944 # 1 # ID=1_35;partial=00;start_type=GTG;rbs_motif=GAGGAG;rbs_spacer=5bp;gc_cont=0.683	BGC0000440.1|Teicoplanin_35 	62352	63944	+	Loose	500	27.7202	L1 beta-lactamase	30.91	3000582	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	L1 family beta-lactamase	GTGAATGAGGAGCGCCTCTTTCTCCGGCCCAACACCATTATCGAGCCTCTGGTAGACAGATTTTATGCCTCGATGTACGCGACGGCTCCGGTCACGGCCACCATGAGTCTCGCGTTCCGGTGGATTCCGATGCTGGAGTCCTACCTGCAGGCCCCGGAATGGCATTACAAGGGCAGCCGGGACCCGAAGTTCCGCGGCGGGTTCTTCGTCAACATCGAGGACTCCCGGGCGGACGAGGTGCGGGCGCTGCTCGCCGCGATCCGGCGCGACCGCGCCGACATGATCCGCTTCGCCGAGGCGATCGCGGAGGCCGAGAAGATCGTCCGGGAGGAGGCGACCGGGTACGACCTCCGGCCGCTCTACCCGAAGCTGCCCGCCGAGCTGGCGGGCCTGGTGGAGATCGCCTACGACACCAGCAACGCCGCCTCGCTGCACTTCCAGGAGCCGCTGGTCTACCACAGCAAGGCCTACACCGAGCAGCGGCAGTCGGTGCAGCTGTCCGTGGAGACCGGCATCGAGCGGCCGTTCGTGATGAGCACGCCGCGGCTGCCCTCGCCGGACGTGCTGGAGCTGCCCATCCCGTTCCGGCACCCGGGCCTGGAGCAGCTGTTCCTGTCCCGGATCCGGCCCACCACCCTGACCGCGCTGCGGGAGGCGCTGGAACTCGGCGATTCGCAAGCGGCCCAGCTCGCCGGCCTGCTGGTCCCGGAGCCCGCGCTCGCCGCGGACCGGCACATCGCGGCCGGCGCCCGGATCCGCTACTGGGGGCACGCCTGCCTGCTCATGCAGACCCCGGACGTGGCCATCATGACCGACCCGTTCATCAGCGCGGACACCGACGCGACCGGCCGGTACACCTACAACGACCTGCCCGACCGCATCGACTACGTGCTGATCACCCACGGGCACTCCGACCACCTCGTCCCGGAGACGCTGCTGCAGCTGCGCGGCCGGGTGGGCACGTTCGTGGTGCCGAGGACCTCCCGCGGCAATCTGTGCGACCCGTCGCTGGCGCTCTACCTCAAGAGCTTCGGGTTCTCCGCCGTCGAGGTGGACGACTTCGACGAGATCTCCTTCCCGGGTGGCAAGATCGCGGCCACGCCGTTCTTCGGCGAGCACGCCGACCTGGACATCCGCGCCAAGGCGACGTACTGGATCAACCTCGGCGGGAAGTCGATCTATGTGGGGGCGGACTCCTCCGGCCTCGACCCGGCGCTCTACCGCTACGTCCGCCGGCACCTCGGGCGGGTCGACATCGCCTTCCTCGGCATGGAGTGCGACGGCGCCCCGCTGAACTGGCAGTACCAGGCGTTCCTCACCAAGCCGATCCCGAACAAGATGAGCGACAGCCGCAAGATGTCCGGCTCCAACGCGGAACAGGCCAGCGCGATCGTCACCGAGCTCGGCGCCGACGAGGTGTACATCTACGCGATGGGCGAGGAGAGCTGGCTCGGCCACGTCATGGCCACCAGCTACAACGAGGACTCCTTCCAGCTGCGGCAGATCGCCGAGTTCGAGACCTGGTGCGCGAACAACGGGGTGAAGTCGGGCCACCTGCTCGACCGGCACGAATGGCACTGGTCGCACCCCTGA	MNEERLFLRPNTIIEPLVDRFYASMYATAPVTATMSLAFRWIPMLESYLQAPEWHYKGSRDPKFRGGFFVNIEDSRADEVRALLAAIRRDRADMIRFAEAIAEAEKIVREEATGYDLRPLYPKLPAELAGLVEIAYDTSNAASLHFQEPLVYHSKAYTEQRQSVQLSVETGIERPFVMSTPRLPSPDVLELPIPFRHPGLEQLFLSRIRPTTLTALREALELGDSQAAQLAGLLVPEPALAADRHIAAGARIRYWGHACLLMQTPDVAIMTDPFISADTDATGRYTYNDLPDRIDYVLITHGHSDHLVPETLLQLRGRVGTFVVPRTSRGNLCDPSLALYLKSFGFSAVEVDDFDEISFPGGKIAATPFFGEHADLDIRAKATYWINLGGKSIYVGADSSGLDPALYRYVRRHLGRVDIAFLGMECDGAPLNWQYQAFLTKPIPNKMSDSRKMSGSNAEQASAIVTELGADEVYIYAMGEESWLGHVMATSYNEDSFQLRQIAEFETWCANNGVKSGHLLDRHEWHWSHP	MRSTLLAFALSSLALAATLFTFDGAAADASLPQLQAYTVDPSWLQTMAPLQIADHTWQIGTHDLTALLVQTADGLVLIDGGMPQMASYLLTNMKARGTNTGPLRMVLLSHAHTDHAGPVAEIKRRTGAQVVVNAETAVLLARGGSDDLHFGDEITFPPVNADRIVMDREVVKLGGIAFTAHFMPGHTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQGNARYPRLVEDYRRSFATVRGLPCDLLLTPHPGASNWNYAAGSNASEKVLSCKAYADAAEKKFDAQLAKETAGAR	179.66	gnl|BL_ORD_ID|1480|hsp_num:0	1619			195	471	
BGC0000440.1|Teicoplanin_36 # 64161 # 65957 # 1 # ID=1_36;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=9bp;gc_cont=0.711	BGC0000440.1|Teicoplanin_36 	64161	65957	+	Loose	1000	49.2914	almE	23.12	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGGCTACGACATGGCCACCGCACCCGATCTCGTAACTCTGATCCGTCAGCATGTCGCCGGGCGGCCGGACGCCGACGCCGTCGGCTTTCTCACCGACCCGGACGACATCCGCGGCGGGGTCGTGTCGTGGACCTACGGGCAGCTCGACCGGGAGGCTCGCGGGTACGCGGCCTGGTTGCAGCAGCGCCTGCCCGCCGGCTCGCGGGTGCTGCTGCTGTATCCCAACGGGCTCGACTTCGTCGCGGCGTTCTTCGGCTGCCTGTATGCCGGCATGATCGCGGTACCGGCGCCGCTGCCCGGCCGTTATCGCCATCACCAACATCGGGTCGCGACCATCAGCGCCGATGCCCGGGTCAGCGCGGTCCTGACCACGGCGGCGCATCTGGGGGAGGTCCGCGACTGGGCTCGGGCGTGCGGACTGGACCACCTGCTGATCGCGGTCGGCGACGAACCGGAGTTCGGCGATCCGGCGGGCTGGACGCCGGCGTCACCGGAACGTGCGACCATCGCGCTGTTGCAGTACACGTCCGGGTCGACCGGCGACCCGAAGGGAGTCGTGGTCACCCACGACAACATCCTGTACAACTTGGATGCCTGCGTCCGGGGCCTGCGCTGGCCGGACGACTGGCGGGTGGGCGGGTGGCTTCCGCTCTACCACGACCTGGCGATGCAGGGGCTGCTCAACATGGCCGTCGTGCGCGGCGGCTATGCCTTGCTGATGGAGCCGGTCTCGTTCGTGCGCGATCCGGTGCGCTGGCTGCGGACGATAGCCGAACACGACATCCAGGTGACGTTCGCGCCCACCTTCGCGTACCAACTGTGCCTCGACCGGGTCACCGACGAGCAGCTGGCCGCTCTCGATCTGTCCGGCTGGAAGATCGCCGGGAACGCCGCGGAGCCGGTGAACCCGGCGATCCTGGCCGCGTTCGCTGAGAAGTTCGCGCCGGCCGGGTTCCGCCCCGAGTCCTTCGCGCCCATCTACGGGATGGCGGAGGCCACCGGCTACATCAGCGGGGAGGTGGGGCGTGCGCCGCTGGTGCGTACCGTCGGCCTCGACGCGCTCGCCCATGGCCGGCTCGCCGACCCGGCGCCGGACGAGCCGGTACGCGAAATCGTCAGCTGCGGCACTCCGAACGAGGCGTGCGACATCCGTGTGGTGGACCCGGAGACGTCGCGCGTGCGGCCCGACGGGTGGTTGGGCGAGATCTGGATACGCGGGCGCAGCGTGTCCCCGGGCTACTGGAGCGATGCCGGGCCGGCCTTCGCCGCGGTGACGGCCGAGGGGGAGGACGGCTTCCTGCGTACCGGCGACCTCGGCGTGCTGCAGGACGGTGAGCTGTACGTGCACGGCCGGCTCAAGGAGACGTTCACCGTGCACGGTCGCCACCTCTACCCGCACGACGTCGAGCAGGAACTGCGCGCACGGCACCCGGAACTCGGCAAGTGCGGCGCGGTCTTCCCGGGACGGGCTCCCGGCGCCGGCGGCGCGCGGGGCGTGGTCGTGACCCATGAGGTGACCAACGCGGCGCGGGATCGGCTGCCGGAGCTGGCCGCCGGGTTACGGCATACCGTGGGGCGGGCATTCGGCGTCGAGGTCTCCGCGGTGCTGCTGCTACGTCCGGGTGCCGTGCTGCGTACCACCAGCGGGAAGATCCGCCGCTCGGCCATGCGTGAGCTGTTCCACGAGGGAAAGCTGACCGCTCTCTACCAGCATCCTCCGGCGCCGCGGGAGCCGCTGCCCTACGTGGGGGATCCGTCGCCGGCGACCAGGGTGACCAGCCTTTCGCGTCCGTGA	MGYDMATAPDLVTLIRQHVAGRPDADAVGFLTDPDDIRGGVVSWTYGQLDREARGYAAWLQQRLPAGSRVLLLYPNGLDFVAAFFGCLYAGMIAVPAPLPGRYRHHQHRVATISADARVSAVLTTAAHLGEVRDWARACGLDHLLIAVGDEPEFGDPAGWTPASPERATIALLQYTSGSTGDPKGVVVTHDNILYNLDACVRGLRWPDDWRVGGWLPLYHDLAMQGLLNMAVVRGGYALLMEPVSFVRDPVRWLRTIAEHDIQVTFAPTFAYQLCLDRVTDEQLAALDLSGWKIAGNAAEPVNPAILAAFAEKFAPAGFRPESFAPIYGMAEATGYISGEVGRAPLVRTVGLDALAHGRLADPAPDEPVREIVSCGTPNEACDIRVVDPETSRVRPDGWLGEIWIRGRSVSPGYWSDAGPAFAAVTAEGEDGFLRTGDLGVLQDGELYVHGRLKETFTVHGRHLYPHDVEQELRARHPELGKCGAVFPGRAPGAGGARGVVVTHEVTNAARDRLPELAAGLRHTVGRAFGVEVSAVLLLRPGAVLRTTSGKIRRSAMRELFHEGKLTALYQHPPAPREPLPYVGDPSPATRVTSLSRP	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	107.55	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1479	colistin A; colistin B
BGC0000440.1|Teicoplanin_37 # 66328 # 67383 # 1 # ID=1_37;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=6bp;gc_cont=0.717	BGC0000440.1|Teicoplanin_37 	66328	67383	+	Loose	1000	25.7942	MCR-9.1	26.47	3004684	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGGTCGTTGTGATGGCGCCGGAGGCCACTTCGGCGGATGTGGACGCGGTCGTCCGGCTGGTCGAGTCGGTGGGCGGGCAGGCGTTCGTCAGCCGCGGGCTGTCCCGGACCATCGTCGGCCTGGTCGGCGACGTGGCCGACTTCGAGGCGCTCAACCTGGGCAGCCTGGCGGGCGTGCTGCGGGTGATCCGGGTGTCGGTGCCGTACAAGCTGGTCAGCCGGGAGCACCACCCGGCGCGCTCGGTGATCCGGGCCGGCGGCGTGCCGATCGGTCCCGGCACGCTGACCGTGATCGCCGGGCCGTGCGCGGTGGAGTCCCCGGAGCAGACGCTGGAGGCGGCCCGGATGGCGCGCTCGGCCGGGGCCTCGATGCTGCGCGGCGGGGCGTTCAAGCCGCGGACCTCACCGTACTCCTACCAGGGGTTGGGGGAGCGGGGCCTGCGCATCCTGGCCGACGTGCGGGCCGAGACGGGGCTCGCCGTGGTCACCGAGGTGATCGATCCCGGCAGTGTGGACATGGTCGCGTCGTACGCCGACATGCTCCAGATCGGCGCCCGGAACATGCAGAATTTCGCGCTGCTGCAGGCGGTCGGGTCGGCCGGCAAACCGGTGCTGCTCAAGCGCGGGTTCAGCGCCACGATCGAGGAATGGCTCAGCGCCGCCGAGTACATCGCGCAGCGCGGCAATCTGAACATCGTGTTGTGTGAGCGCGGGATCCGGACGTTCGAGACCGCTACCCGTAACACGCTGGACATCAGCGCGGTGCCGGTCGCCCAGCGGCTCTCCCACCTGCCGGTGATCGTGGATCCGTCGCACTCCGGCGGCCGCCGCGATCTGGTGGTGCCGCTGACCCGCGCGGCGATCGCGGTGGGCGCGGACGGGTTGCTCATCGACGTCCACCCGGAGCCGAAGACCGCTCTGTGCGACGGTGACCAGGCGCTGCCGGAAGCCGACATCCGGGAGATCGCCGACATCGTGGCGAGCCTGCCCGCGTTCCTGGGGCGGGAGCCGGCCGTGCCCTCGGGTGAATTCCGACACGTTCCCGCCGCGGTGTGA	MVVVMAPEATSADVDAVVRLVESVGGQAFVSRGLSRTIVGLVGDVADFEALNLGSLAGVLRVIRVSVPYKLVSREHHPARSVIRAGGVPIGPGTLTVIAGPCAVESPEQTLEAARMARSAGASMLRGGAFKPRTSPYSYQGLGERGLRILADVRAETGLAVVTEVIDPGSVDMVASYADMLQIGARNMQNFALLQAVGSAGKPVLLKRGFSATIEEWLSAAEYIAQRGNLNIVLCERGIRTFETATRNTLDISAVPVAQRLSHLPVIVDPSHSGGRRDLVVPLTRAAIAVGADGLLIDVHPEPKTALCDGDQALPEADIREIADIVASLPAFLGREPAVPSGEFRHVPAAV	MPVLFRVKVIPLVLLLAMIFAFLLNWPILLHFYEILSHLEHVKIGFVISIPFVLVAALNVVFMPFSVRFLLKPFFALLFITGSLVSYSTLKYKVMFDQTMIQNIIETNPQEAHSYLNGSIIIWFVFTGILPAILLFSIKIQYPEKWYKGIAYRLLSVLASLSLIAGVAALYYQDYASVGRNNSTLNKEIIPANYAYSTFQYVKDTYFTTKVPFQTLGNDAKRVVAHEKPTLMFLVIGETARSQNFSMNGYSRDTNAFTSKSGGVISFKNMHSCGTATAISVPCMFSNMNRTEYDSKKASNSENFLDIVQKTGVSLLWKENDGGCKGVCSRIPTVEIKPSDNPKLCDGKTCHDEVMLENLDDEIAKMPGDKLVAFHIIGSHGPTYYLRYPAEHRHFMPECARSDIENCTQEQLVNTYDNTLRYTDYVLAEMIEKLKNYSDQYNTVLLYVSDHGESLGESGLYLHGTPYKLAPDQQTHIPMQVWMSPGFIAGKHINMSCLENNAAKKSYSHDNLFSSILGLWDVSTSVYNPDRDLFRECRG	65.12	gnl|BL_ORD_ID|2245|hsp_num:0	3383			999	1101	colistin A; colistin B
BGC0000440.1|Teicoplanin_39 # 69881 # 72259 # 1 # ID=1_39;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=4bp;gc_cont=0.746	BGC0000440.1|Teicoplanin_39 	69881	72259	+	Loose	390	29.6462	evgA	28.57	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCTGCTCGTCAGCGGCGCGGTGGGCACCGGGAAGACCGCGCTGCTGCAGGCGATGGCCGCGCGTGCCGGCCGCCGGGGCGGCTGGTCGTTCGTGGTCACCGGTTCGGCCCGCGAGCGCGGGCACCCGTTCGGCGTGCTGGACCGCCTGATCCGGTCGATGTGCGCGGCCGGGATGGCCGAGCCGTTCCCGGGCGGCATGGACTGCGGCGAGAACTTCTTCGTGATGATGGACCGGGTGGGCGCCGCGATCCGGGAGTTCGCCGGCGACCGGCCGGTGCTCGTCGGTATCGACGACGTTCACTTCGTCGACGAGCAGTCGCTGCGGGCCGTCAGCTACCTCATCCGGCGGATCGAGTCGAGCGGTGTGGTGCTGGTGCTCAACGAGAGCACCTCGTACGAGCGTGACATGGCCGGTCTGCGCGCCGAGATGCTGCACCTGCCGTTCTGCTACCGGATCCGGCTCACCCCGCTGACCTCCACCGAGGTCGCCGAGCGGCTGAGCGAGCGGTTCGGCGGCGTGCCCGACCGGGCGTCCGTGCAATTCGGCGTGCAGGTCAGCGGGGGGATCCCGCTCATCCTGCAGGCCCTGATCGACGATCTCGCCGACTCCGGCCCGGGCGTGTGCGAGCCGGGCGCCAACTTCCGCCAGGCCGTGTTGCGCAGCCTGCACCGGTGCGCGCCGTCGACCACCGCGGTGGCCCAGGCCATCGCGGTCCTCGGCGACTACGCGGCGCCGGAGCTGGTCGCCGAGCTCGGCGGTGTGGACGCCGCCCTGATCGAGGAGAGCATCCGCGACCTGCGGGAGATGGGCCTGCTGGAGCACGACTGGTTCCGGCACCCGCACACCCGGGCCGCGGTGCTGGCCGGCATCCCGGTGCCGCAGCTGCCCGAGATGCACCGGCGCGCCGCGGAGCTGCTGCATCAGAGCGGGGCGCCGGCCGGCGCCGTGGCGGAGCACCTGATCGCCGCGCAGGACGGCGGCCGGGCGCCGTGGCGGGTGGTCATCCTGTCGGAGGCGGCCCGCGAGGCGCTGGCCGCCGGCGACGTGGACAGCGCGGTGCTGAGCCTGCGACATGCCGTCGCGGCCAGCTCCGACGAGACGCAGCGGGCGCACGCGGGCGTGCTGCTCGCCGAGGCGCAGTGGCACACCGACCCCAGCCGGGCGGCGCGCCGCCTGGGCGAGCTGAGCCAGGACGCGCGGGCCGGCCGGTTCACCGGCCCCGACACCCTGATCGCGGTCAACCAGCTGCTCTGGTGGGGCGAGTTCGCCGAGGCCGACGAGCTGCTGCGGCTGGCCGGGGACGAGGAGTGCGGCGACTCCAGCCTCGCTCACCTGTGGGCGATCTTCAGCCGGGCCGCCGGGGGGACGGAGATCTGCGACGAGCACACCCCGTCCGGCGGCTCGCCGCTGGCGCGATCCGGTCCGATGGCCGTGGTCACCTACCTGAGCTCGGCGGCGAGCCTGGCCTCCGAGAGCGTGGCGGCCGATCGCACCGAGATGCTGCTCGGCATCCGGGCCGGCGCCCCGCTCACTCCCGCCCTGTACGCCCTGGTCGTCCTGGTGCAGTCCGGCCGGCTGGAGGAGGCGATCACCTGGTGCGGTCGCCTGCTGAAGGAGGAGTGGATCCACCGGACGCCGATGCGGCGGGTGATGATCCAGACGATCGAGTCGGTGGCCATGCTCCGGGCCGGCGACAGCGCGGGCGCCCTGCGGGGCATCCGGGAGGTGTTCGACGCCGTTCCGCCACCGGCGTGGGGCGTGGTGGCGGGCCTGCCGCTGTCGGTCGCGGTGCGGGCCAGCACCGAACTGGGCGACACCCATGCCGCCCGGTCGTACCTGGCGGTCCCGGTGCCACCGGCGATGTTCGACACGCCGTTCGCGCTGCCGTACCTGCTGGCGCTCGGCTGGTACCACCTGGCCATGGGCCACCCGGAGAGCTCGCTGAGGCACACCCGGTCGTGTCTGGACCTGACCGCGCGCTGGGGCGTCGACGCGGGGCGGATCACCGCCGGGCCGGCCGGGCTGGACGTGTCCCGGCCGTCGCCGCCACCGGCCGCGGACCGGGTGGACGCGGGCCACCGGACCCCGGCCGCGGTCCGGGAACCGGCGCCGGATCAGCGGGAGGCCACGCCGGTGCCGCCGCACGCCGGCCCGGACCCGGCGGAGCCCGCGGCGGCGCACCGCGGAGCCGAGGACGGCGCCAGGCTCACCGACGCGGAACAGCGGGTGGCCGCGCTGGCCGCCGCCGGCAACACCAACCGGCAGATCGCCGAGCGCCTGTTCATCACCGTGAGCACCGTCGAGCAGCATCTCACGAAAATCTATCGGAAGCTGAATCTGCGCAGCCGTTCCGGGTTGCGGCGATACAGCCACTGA	MLLVSGAVGTGKTALLQAMAARAGRRGGWSFVVTGSARERGHPFGVLDRLIRSMCAAGMAEPFPGGMDCGENFFVMMDRVGAAIREFAGDRPVLVGIDDVHFVDEQSLRAVSYLIRRIESSGVVLVLNESTSYERDMAGLRAEMLHLPFCYRIRLTPLTSTEVAERLSERFGGVPDRASVQFGVQVSGGIPLILQALIDDLADSGPGVCEPGANFRQAVLRSLHRCAPSTTAVAQAIAVLGDYAAPELVAELGGVDAALIEESIRDLREMGLLEHDWFRHPHTRAAVLAGIPVPQLPEMHRRAAELLHQSGAPAGAVAEHLIAAQDGGRAPWRVVILSEAAREALAAGDVDSAVLSLRHAVAASSDETQRAHAGVLLAEAQWHTDPSRAARRLGELSQDARAGRFTGPDTLIAVNQLLWWGEFAEADELLRLAGDEECGDSSLAHLWAIFSRAAGGTEICDEHTPSGGSPLARSGPMAVVTYLSSAASLASESVAADRTEMLLGIRAGAPLTPALYALVVLVQSGRLEEAITWCGRLLKEEWIHRTPMRRVMIQTIESVAMLRAGDSAGALRGIREVFDAVPPPAWGVVAGLPLSVAVRASTELGDTHAARSYLAVPVPPAMFDTPFALPYLLALGWYHLAMGHPESSLRHTRSCLDLTARWGVDAGRITAGPAGLDVSRPSPPPAADRVDAGHRTPAAVREPAPDQREATPVPPHAGPDPAEPAAAHRGAEDGARLTDAEQRVAALAAAGNTNRQIAERLFITVSTVEQHLTKIYRKLNLRSRSGLRRYSH	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	388.24	gnl|BL_ORD_ID|936|hsp_num:0	1015			429	597	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0000440.1|Teicoplanin_40 # 72458 # 73561 # 1 # ID=1_40;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.707	BGC0000440.1|Teicoplanin_40 	72458	73561	+	Loose	500	26.5646	SMB-1	29.03	3000854	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SMB beta-lactamase	ATGACGGCCACCCTCGAACGCGCTTCCGCCTCGCCCGTCGGCATCCCGCCGGCCATCTCCCGGATGGTCGGGGTGGGCACCGCCGTCGCCGGGACGACGGTCTCCCAGCCGGCATTGCTGGATCTTCTCGGCATCGAGGACCCGAAGATCCGCTCGATCTACCTGAACAGCGCCATCGGCACCCGCCGCCTCACCCTGCCGGAGCCCGACGCGTCCGGCGTGCGCCGCCCCGAGCCGCAGGGCGCGCTGCTGGCCAAGCACAAGCGCCTCGCCGTCGAGATGGGCGGGCAGGCGCTGCAGGCCTGCCTCAAGAACATCGGCGCCTCCCTCTCCGACCTGCGGCACCTGTGCTGCGTGACGTCGACCGGCTTCCTCACCCCGGGCCTGAGCGCCCTGATGATCAAGGAACTCGGCATCGACCCGCACTGCAGCCGCTCCGACATCGTGGGGATGGGCTGCAACGCCGGCCTCAACGCGCTCAACGTCGTCGCCGGCTGGTCCGCCGCCCACCCCGGCGAGCTCGGCGTGGTCCTGTGCACCGAGGCGTGCTCGGCCGCGTACGCCCTGGACGGCACCATGCGCACCGCGGTGGTCAACAGCCTCTTCGGCGACGGCGCCGCCGCCCTGGCGCTGATCAGTGACGCTCCCGGGCAGTCGAGGCCCGGACCGCGGATCCTCAAGTTCGCCAGCTTCCTGATCACCGACGCGATCGACGCCATGCGCTACGACTGGGACAGCGACCTGGGCCGGTTCAGCTTCTTCCTGGACCCGCAGATCCCGTACGTCGTCGGCGCCAACGCGGAGACCGTGGTGGACCGCCTGCTCGCCGGCACCGGCCTGCGCCGCCGTGACATCGCGCAGTGGCTGGTGCACTCCGGCGGCAAGAAGGTGATCGACGCGGTCGTGGTCAATCTCGGACTGACCCGCCACGACGTCCGGCACACCACCCGGATCCTGCGCGACTACGGCAACGTCTCCAGCGGCTCGTTCCTCTTCTCCTACGAGCGGCTGGTCGAGGAGGGCGTCACCCGCCCCGGAGACTACGGAGTGCTGATGACCATGGGCCCCGGCTCGACCATCGAAACGGCGCTGGTCCAGTGGTGA	MTATLERASASPVGIPPAISRMVGVGTAVAGTTVSQPALLDLLGIEDPKIRSIYLNSAIGTRRLTLPEPDASGVRRPEPQGALLAKHKRLAVEMGGQALQACLKNIGASLSDLRHLCCVTSTGFLTPGLSALMIKELGIDPHCSRSDIVGMGCNAGLNALNVVAGWSAAHPGELGVVLCTEACSAAYALDGTMRTAVVNSLFGDGAAALALISDAPGQSRPGPRILKFASFLITDAIDAMRYDWDSDLGRFSFFLDPQIPYVVGANAETVVDRLLAGTGLRRRDIAQWLVHSGGKKVIDAVVVNLGLTRHDVRHTTRILRDYGNVSSGSFLFSYERLVEEGVTRPGDYGVLMTMGPGSTIETALVQW	MKIIASLILAAFASVAQAQDRDWSSPQQPFTIYGNTHYVGTGGISAVLLSSPQGHILVDGTTEKGAQVVAANIRAMGFKLSDVKYILSTHSHEDHAGGISAMQKLTGATVLAGAANVDTLRTGVSPKSDPQFGSLSNFPGSAKVRAVADGELVKLGPLAVKAHATPGHTEGGITWTWQSCEQGKCKDVVFADSLTAVSADSYRFSDHPEVVASLRGSFEAVEKLSCDIAIAAHPEVNDMWTRQQRAAKEGNSAYVDNGACRAIAAAGRKRLETRLASEKR	131.07	gnl|BL_ORD_ID|751|hsp_num:0	753			132	309	
BGC0000440.1|Teicoplanin_41 # 73558 # 74223 # 1 # ID=1_41;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.782	BGC0000440.1|Teicoplanin_41 	73558	74223	+	Loose	700	26.9498	vanK gene in vanI cluster	31.51	3003727	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanK	GTGACCGCGGCCGGCGTCGACGACCTGGTGCTGCGGATCGACGGGAGCGAGCCGGTCACGCCGGCCACCGTCGAGGCGGTGCTGGGCATCTGTGATCGGGCCGAGGACGGGTACGCCGCCGGGCTGCTGACCGTCCACGTCTCGGGCGTCCCGGCTCCCGGCTGGACGAGCGACCTCAGCGTCGGCCTGACGACCAAGTGGGAGCGCGCCGTCCGCCGGCTGGAGCGCCTCGGCCTGCTCACCGCCGGGGTGGCCACCGGCGACTGCGGCGGCGCGGCGCTGGACCTGCTGCTGGCCACCGACGTGCGGATCGCCGTCGCCGGCGCCCGGCTGGTCGTCCCGGTGAGCGGCGACGCGACCTGGCCGGGCATGGCGCTGTACCGGCTCGCCCGGCAGGGCGCCACCGCCGGGCTGCGCCGGGCCGCCCTGCTCGGCACCCCGCTCGACGCCGCTCGGGCGGTGGCGGCCGGGGTGATCGACGTGGTGGTGGACCGGCCCGAGCCGGCGCTCGCCGAGATCGCCGCCGCGGCGGCCGGCATCACCGGCACCGAGCTGGCCATCCGGCGGCAGCTGATGCTCGACGCCGCGGAGCACAGCTTCGAGGAGGCGGTCGGCTCGCACCTGGCCGCGTGCGACCGGACCCTGCGCCGGGCGGCGGCGTCATGA	MTAAGVDDLVLRIDGSEPVTPATVEAVLGICDRAEDGYAAGLLTVHVSGVPAPGWTSDLSVGLTTKWERAVRRLERLGLLTAGVATGDCGGAALDLLLATDVRIAVAGARLVVPVSGDATWPGMALYRLARQGATAGLRRAALLGTPLDAARAVAAGVIDVVVDRPEPALAEIAAAAAGITGTELAIRRQLMLDAAEHSFEEAVGSHLAACDRTLRRAAAS	MLNVDKISEETYYAFISQADLGNFMQYPSWAKVKTEWTSDLLGWFTPDNKLAGCGLILYRKMPCLNRYLAYCPRGPLIDWQSPNLREWFEPLVAYLRSKQVFSIKIDPPVVQAKWSAPTIKTFLGQAREQGSKGKVLRDLPPDEDYTTVQQVQQQLRQMGWRKQRGDTGFAATQPQYVYRLPLEGRSLEEVFAGFHTNWRRNVKKAERLGVKVRVGTEQDLPAFYELLKVTSERDHFKVRSFSYFSNLYRSLKAEAADRIALYLAEDEEELLAATLAVHSNAHSWYLYGASSNVKREKAPNHAIQWRMIQDAYQLKAYTYDFRGISPTLDESDPLFGLLRFKLGFGGEACEMISAWDYPLQPLLYRAFQLYLKRR	58.93	gnl|BL_ORD_ID|4747|hsp_num:0	2245			489	702	vancomycin; teicoplanin
BGC0000440.1|Teicoplanin_43 # 75550 # 76356 # 1 # ID=1_43;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.743	BGC0000440.1|Teicoplanin_43 	75550	76356	+	Loose	500	24.6386	ANT(6)-Ib	46.88	3002629	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(6)	GTGTCCAGCGTGACCGCGGCCCGGGTGCGGTACCACAGGACCGGCCACGTCGCCCGGGTCACGCTCGACCGTCCCGACGTGCTCAACGCCATGGATCTGCGGATGCACGAGGAACTGGCGCGGATCTGGGACGACATCGAGGCCGACGACCGGATCCGGGTCGTGGTGCTGACCGGCGCCGGGGACCGCGCGTTCTCGGTGGGCCAGGACCTCAAGGAGCGTGCCCGCCGCGACGCGGCGGGCACCCCGGGGTCCAGTTTCGGCAGCCGCGGCCAGCCCGGCTGGCCGCGGCTCACCGAGCGGTTCGGGTTCAGCAAGCCGGTGGTCGCGCGCGTCGACGGGTACGCCCTCGGCGGCGGCTTCGAGCTCGCGCTGGCCTGCGATCTGATCATCGCATCGGACCGCTCGGTGTTCGGGCTGCCGGAGGTGCGGCTCGGGCTCGTGCCGGGGGCCGGCGGCGTGTTCCGGCTGGTCCGGCAGCTGCCGCAGAAGACGGCGATGGGCTACCTGCTGACCGGCCGTCGCTTCGACGCGGCGACCGCGCTCCGGTTCGGGCTGGTCAACGAGGTGGTGCCGGCGCAGCGGTTGGACGCTTGCGTGGACGGCTGGGTCGATGATCTCGTCACAAGCGCGCCACTGTCGGTCCGGGCGATCAAGGAAGCCGCGCTGCGCTCGGTCGACCTGCCGCTGCCGGACGCCTTCACCGCCACGTACCGCTGGGAGCAGCGGCGCCGCGCCAGCGCGGACGCCGTCGAGGGGCCCCGGGCGTTCGCCGAGCGCCGGGCGCCGCGCTGGTCCGGCACCTGA	MSSVTAARVRYHRTGHVARVTLDRPDVLNAMDLRMHEELARIWDDIEADDRIRVVVLTGAGDRAFSVGQDLKERARRDAAGTPGSSFGSRGQPGWPRLTERFGFSKPVVARVDGYALGGGFELALACDLIIASDRSVFGLPEVRLGLVPGAGGVFRLVRQLPQKTAMGYLLTGRRFDAATALRFGLVNEVVPAQRLDACVDGWVDDLVTSAPLSVRAIKEAALRSVDLPLPDAFTATYRWEQRRRASADAVEGPRAFAERRAPRWSGT	MKMRTEKQIYDTILNFAKADDRIRVVTLEGSRTNINIIPDDFQDYDITFFVTDMQSFINSDEWLNVFGERLIMQKPEDMELFPKEEKGYSYLMLFWDGVKIDLTLLPLEVLDEYFTWDKLVKLLLDKDNRVTNIPVPTDEDYYIEHPTARSFDDCCNEFWNTVTYVVKGLCRKEILFAIDHLNNIVRMELLRMISWKVGIEQGYSFSLGKNYKFLERYISPELWKKILATYNMGSYTEMWKSLELCMGIFRMVSKEVAQCLNYLYPDYDKNISNYVIRQKEKYQR	94.04	gnl|BL_ORD_ID|1018|hsp_num:0	1113			0	93	streptomycin
BGC0000440.1|Teicoplanin_44 # 76395 # 77756 # 1 # ID=1_44;partial=00;start_type=ATG;rbs_motif=GAGGAG;rbs_spacer=9bp;gc_cont=0.728	BGC0000440.1|Teicoplanin_44 	76395	77756	+	Loose	1080	60.8474	rosB	25.36	3003049	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCCTTCGAAGCGCCGCCGTCGTCACTGGGCGGCCATGCCCTGCTCGCTTTCCTGATCGCGGTGGCGACGCTGCTGCTGGTCGCCCACCTGCTGGCCCGCCTGGCGGAACGGGTGCGGATGCCGGCCGTCGTGGGTGAGCTGGCCACCGGCGTCATCCTGGGCCCGTCCCTGCTGGGCCACCTGCTGCCCGGACTGACCGACTGGGTCTTCCCGCCCGGCACCGACCAGATGCACCTGCTCGACGCGGTAGGTCAGATCGGCATCCTGCTCCTGGTCGGACTCACCGGCACCCACCTGGACGTCGCCATGGTGCGGCGGCGCAAGGCCACCGCCGCGCGGATCAGCCTGGGCGGCCTGCTGCTGCCGCTGGCTCTCGGGGTCGGCGTCGGCTACCAGCTGGCCGGCTGGCTCAGCGGCGCCGTGGTCGGTGACCGGCTGGTCTTCGCCGGATTCATGGGCGTCGCGATGTGCGTGACAGCCATCCCGGTGATCGCCAAAACCCTCTCCGACATGCGGCTGCTGCACCGCGACGTGGGCCAGATGACGCTGGCGGCGGGCACCATCGACGACGCGGTCGGCTGGTTCCTGCTGTCCGTGGTGTCGATGGCCGCGACCGCCGGGCTCACCACCGGACACGTCGTCCAGGCGGTCGCCTACCTGCTCGGCTTCGTCGTCCTCGCGGTTCTGCTCGGCCGGCCGCTGGTCCGCCGCGTCATGCGGCTGGCCGACCGCGGCGAGGGATCCGGCTCCAGCATCGTCACCGCGGTCGTCGTCGTCCTGACCGGCGCGGCGATCACCCAGGCGCTGGGCATGGAGCCGGTCTTCGGCGCCTTCGTGGCGGGCATCCTGGTCGGGCTGCCCGCGGCGGCGAACCAGGCGAAGCTGGCGGCGCTGCGCACGGTCGTGCTCAGCGTGCTGGCGCCGCTCTTCCTCGCCACGGCCGGCTTCCGGATGGACCTGACCGCGCTGGCCGACCCGCAGGTCGCGATCGCCGCGGTGCTCGTGCTGGCCATCGCCATCGTCGGCAAGTTCGCCGGGGCGTACGCCGGGGCCCGCCTCAGCCGGCTGTCCCGCTGGGAGGGCCTGGCGATCGGCGCCGGGATGAACTCGCGCGGCGTGGTCGAGGTGGTGGTGGCGCTCACCGGCCTGCGACTGGGCGTGCTGAACACCGCCACCTACACGATCGTCGTCCTGGTCGCCATCGTCACCTCGGTGATGGCCCCGCCGCTGCTGCGCTACGCCTGTGCCCGCATCGCCCAGAACGAGGACGAGCGGCTGCGCAAGCTGCACCACGACACCTGGAACGGCGTCCCGGCCGGCGCCGGCCAGTCCCCCTCACCCGCAGGAGAGCAGGCATGA	MSFEAPPSSLGGHALLAFLIAVATLLLVAHLLARLAERVRMPAVVGELATGVILGPSLLGHLLPGLTDWVFPPGTDQMHLLDAVGQIGILLLVGLTGTHLDVAMVRRRKATAARISLGGLLLPLALGVGVGYQLAGWLSGAVVGDRLVFAGFMGVAMCVTAIPVIAKTLSDMRLLHRDVGQMTLAAGTIDDAVGWFLLSVVSMAATAGLTTGHVVQAVAYLLGFVVLAVLLGRPLVRRVMRLADRGEGSGSSIVTAVVVVLTGAAITQALGMEPVFGAFVAGILVGLPAAANQAKLAALRTVVLSVLAPLFLATAGFRMDLTALADPQVAIAAVLVLAIAIVGKFAGAYAGARLSRLSRWEGLAIGAGMNSRGVVEVVVALTGLRLGVLNTATYTIVVLVAIVTSVMAPPLLRYACARIAQNEDERLRKLHHDTWNGVPAGAGQSPSPAGEQA	MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSCTVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIANSMLNMLKIETLTEEDKRPLCPI	80.46	gnl|BL_ORD_ID|466|hsp_num:0	507			42	1185	polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4
BGC0000440.1|Teicoplanin_46 # 78487 # 79584 # 1 # ID=1_46;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=8bp;gc_cont=0.723	BGC0000440.1|Teicoplanin_46 	78487	79584	+	Loose	450	26.9498	CfiA23	37.93	3006915	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CfiA beta-lactamase	GTGGAATCGTCTGCGCTGCGCAAGTCGGAATTGCATCCGAGCATTTCGGACCCGGTTCTGGACACGATGAATTTCCTCAACGAGGTGACCCTGCGCTATCCCGAGGCGATCTCGTTCGCGCCGGGCCGCCCGTACGACGGCTTCTTCCAGACCGAGGAGGTCCTCGCCCACCTGCGCCGCTTTCTCGACCACCTGGCCGACCAGGGCGCCTCGCCCGCGCAGGTGCGCACGGCGGTCTACCAGTACGGCCCGACCGCCGGCCAGATCCGCGAGATCATCGCCGACTCGCTGCGCCGGGACGAGGGGATCGACGTGCCGGCCGAGTCCATCGTGGTCACCGTCGGCGCGCAGGAGGCGATGATGCTGGTCGTCCGCGCGCTGATCCGTGACCCGCGGGACGTGCTGCTGGTGCCCAGCCCCTGCTACGTGGGCATCACCGGGGTGGCCCGGCTGCTCGACGTGACGCTCGGCCCGGTGCCCGAGTCGCCGGACGGCTTCTCCCTGGAGAACGTGGCGGCGGCGATCCGGGCGCAGCGGGCCGCCGGGCGCCGGCCGCGAGCCTTCTACCTGGTGCCCGACCACGCCAACCCGTCCGGCACCACGCTGTCCGAGTCGGACCGGGCCGGGTTGCTGCACCTGGCCGCGAAGGAGGATCTGCTGATCCTGGAGGACACCCCGTACCGGCTGGTCAGCCCCGGCGAGCCGGTGCGCACGCTGAAGGCGCTGGACCGCCGCCGCTCGGTGGTGCACCTGGGGTCGTACTCAAAAACGATCTTTCCGGGCGCGCGGGTGGGCTTCGCCGTGGCCGACCAGACGGTGGTCGGCGACGACGGCCGGACCGGCCTGCTCGCCGACGAGCTCTCGAAGATCAAGAGCATGGTGACGGTCAACACCTCGTCGCTGAGCCAGGCGGTGGTGGCCGGCGCGCTGCTCGCGGCCGGCGGCCGGGTCTCCGAGCTGAACGCCAAGGCGGCCGGGCACTACGGCGACGCCATGCGCCGGGTGCTCGACCGGCTCGCCGACCGGTTGCCCGCGGCGCGGCGCGCGGAGCTGGGCGCGCGGATCCGTACCGACGAGGCGGGGACGACGGGCGCGTAA	MESSALRKSELHPSISDPVLDTMNFLNEVTLRYPEAISFAPGRPYDGFFQTEEVLAHLRRFLDHLADQGASPAQVRTAVYQYGPTAGQIREIIADSLRRDEGIDVPAESIVVTVGAQEAMMLVVRALIRDPRDVLLVPSPCYVGITGVARLLDVTLGPVPESPDGFSLENVAAAIRAQRAAGRRPRAFYLVPDHANPSGTTLSESDRAGLLHLAAKEDLLILEDTPYRLVSPGEPVRTLKALDRRRSVVHLGSYSKTIFPGARVGFAVADQTVVGDDGRTGLLADELSKIKSMVTVNTSSLSQAVVAGALLAAGGRVSELNAKAAGHYGDAMRRVLDRLADRLPAARRAELGARIRTDEAGTTGA	MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVINNHQAALLDTPINDAQTEMLVNWVTDSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYANQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGGCMLKDNQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGNYGGTELIEHTKQIVNQYIESTSKP	146.59	gnl|BL_ORD_ID|3385|hsp_num:0	4454			621	708	
BGC0000440.1|Teicoplanin_47 # 79670 # 80725 # 1 # ID=1_47;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=5bp;gc_cont=0.720	BGC0000440.1|Teicoplanin_47 	79670	80725	+	Loose	600	26.5646	ALG11-1	30.3	3006892	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ALG11 beta-lactamase	ATGACCGGCCACTTCCAGGACCTGACCGTCGACCACGTACGGATCTACTGCGCGGACCTCGACCCGTTGATCGCCCAATTCGGCAGCTACGGCCTCGACGTGCGGGCCGAGGGCGTCGGGCCGGGCGCGGAGCACTCGGTCGTTCTCGGGCACGGCGACATCCGGCTGGTGCTGACCCGGCCCGGCACCGGCGACCACCCCGGCGGGATGTACACCGCGCAGCACGGCTACGGCGTGTCCGACATCGCGCTCGGTACGGCCGACGCGGCCGGCGCCTTCCACGAGGCGGTCCGGCGCGGGGCACGGCCGATCGCCGCCCCCGAGCGGACCGCCGGCGTGGTCACCGCCTCGGTCGCCGGCTTCGGCGACGTCATCCACACCTTCGTCCAGCGCGAGCCGGGAGGACCGTGGTCGCTGCCGGGGCTGAACCCGGTGCACCGGCCCGGCACGCCCGGCATCGGCCTGCGGCTGGTCGACCACTTCGCGGTGTGCGTCGAGGCCGGCCGGCTCACCGAGGTCGTCGAGCACTACGAGCGGGTGTTCGGCTTCTCGGCCATCTTCACCGAGCGGATCGTGGTCGGCGAGCAGGCGATGGACTCCCAGGTCGTGCAGAGCGCCGGCGGGGCCGTGACGCTCACCGTGATCGCGCCGGACACCACCCGCCGGCCGGGGCAGATCGACACCTTCCTCAAGGACCACGGCGGCCCGGGGGTCCAGCACATCGCGTTCGAGACCGACGACGTGACCCGCTCGGTCGGCGCCATGAGCGACGCCGGCATCGAGTTCCTCACCACACCGGCCGCCTACTACGAGAGGCTGCGGGACCGGCTGCAGCTCACCCGGCACTCGGTCACCGAGCTGAGCCGGCTCAACGTGCTCGCCGACGAGGACCACGACGGCCAGCTCTACCAGATCTTCACCAAGTCCACGCACCCGCGGGGAACGCTGTTCTTCGAGATCATCGAGCGGGTCGGGGCCCGGACCTTCGGCTCCGGCAACATCAAGGCCCTGTACGAGGCCGTGGAGCTGGACCAGGCCGCGGCAGACGGCCGATGA	MTGHFQDLTVDHVRIYCADLDPLIAQFGSYGLDVRAEGVGPGAEHSVVLGHGDIRLVLTRPGTGDHPGGMYTAQHGYGVSDIALGTADAAGAFHEAVRRGARPIAAPERTAGVVTASVAGFGDVIHTFVQREPGGPWSLPGLNPVHRPGTPGIGLRLVDHFAVCVEAGRLTEVVEHYERVFGFSAIFTERIVVGEQAMDSQVVQSAGGAVTLTVIAPDTTRRPGQIDTFLKDHGGPGVQHIAFETDDVTRSVGAMSDAGIEFLTTPAAYYERLRDRLQLTRHSVTELSRLNVLADEDHDGQLYQIFTKSTHPRGTLFFEIIERVGARTFGSGNIKALYEAVELDQAAADGR	MAASAAVSLVVFLFVFVFTFAHAQDQPASWAQPQKPVRIFGNTWYVGTRGLSAILITSPTGAVLIDGAVREAASDIASNITSLGVRLEDIKLIVNSHAHNDHAGAIAELQRRTGATVAALPWSAEALRSGRKHQGDPQFESPTSPPDRVANVKTIQDGEVLRAGGVEVTAHKTAGHTPGGTTWTWRSCEENRCVDIVYADSLTAVSADGFRFTDNKTYPQAIDDFNKGYAFLRSASCDILVTPHPEASDFWGRIAKRDAGERDALIDRSQCARYADRADAQLQKRLATERAERPK	118.98	gnl|BL_ORD_ID|3289|hsp_num:0	4358			264	462	
BGC0000440.1|Teicoplanin_48 # 80722 # 81816 # 1 # ID=1_48;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.760	BGC0000440.1|Teicoplanin_48 	80722	81816	+	Loose	300	28.1054	AAC(3)-Xa	32.0	3002544	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGACCACCGCTGTGCTGCGGCTGGACACGGTCGACGATTTCCGGCTGCGCGCCGAGGCGACGCTGACCGCCGCGGTCCGTGACTTCGTGGCCGGCGGCAGCGACTCGGAGACCACCCTGGCGGCCAACCGGGCGGCGCTGGACCGGGTGACGATCGTCCCGCGGGTGCTGACCGGCGGGCCCGACCCGGAACCGGGCGCCACGCTGGCCGGGGCCCGCAGCGCGCTGCCGCTGGCCGTGGCGCCGATGGCGTACCAGCGGCTGTTGCACCCGGAGGGGGAGCTGGCGACGGCGCGCGCCGCGGCGGCCGCCGGTGTCCCCTTCGTGGTCAGCACGCTCAGCAGCGTCCCGGTCGGCGAGCTGGCCGCGGCCGGCGGCGAACAGTGGTTCCAGTTGTACTGGCTCAACGACGACCGCGACACGATGAACCTGGTCCACCGGGCCGAGGACGCCGGCTGCCGGGTGCTGATGGTGACCGTGGACGTTCCGGTGATGGGCCGGCGCCTGCGGGACATCCGCAACGAGTTCGTGCTGCCCGCCGAGGTGCGGGCGGCGAACGTCGCGTCCGGGGCGATGAGCGCGGCGCACGATCGCGCCGACGCCGGCTCCGCCTTGATCGCGCACACCAACCGCGCGTTCCATCCGGCGCTCACCTGGGCGCACCTGGAGGCGCTGCGCTCGCGGACCACCCTGCCGATCGTGGTGAAGGGCATCCTGGACCCCGCGGACGCCCGCCGCGCGGCCGAGATCGGCGCGACCGGCGTGGTGATCTCCAACCACGGCGGCCGCCAGCTCGACGGCGCGCCGGCCAGCGTCACCATGCTGCCCGCCGCCGTCGCGGCCGTCCCGGACACCTGCCAGGTGTTCGTGGACAGCGGCATCCGCAGCGGCACCGACATCCTGCGGGCGCTGGCGCTCGGCGCGCACGGTGTGCTGATCGGGCGGCCGATGCTGTGGGGGCTGGCGGCGGGTGGCGAGACCGGCGCCGCCGGGGTGCTGGCCGTGCTGGACGCCGAGTTGCGCGCGGCGATGCGGCTGGCCGGTTGCGCCGACGTCGCGGCGGCCCGGCGGCTGACCGCCACCACCGGGTGCTGA	MTTAVLRLDTVDDFRLRAEATLTAAVRDFVAGGSDSETTLAANRAALDRVTIVPRVLTGGPDPEPGATLAGARSALPLAVAPMAYQRLLHPEGELATARAAAAAGVPFVVSTLSSVPVGELAAAGGEQWFQLYWLNDDRDTMNLVHRAEDAGCRVLMVTVDVPVMGRRLRDIRNEFVLPAEVRAANVASGAMSAAHDRADAGSALIAHTNRAFHPALTWAHLEALRSRTTLPIVVKGILDPADARRAAEIGATGVVISNHGGRQLDGAPASVTMLPAAVAAVPDTCQVFVDSGIRSGTDILRALALGAHGVLIGRPMLWGLAAGGETGAAGVLAVLDAELRAAMRLAGCADVAAARRLTATTGC	MDETELLRRSDGPVTRDRIRHDLAALGLVPGDTVMFHTRLSAIGYVSGGPQTVIDALLDVVGPTGTLLVTCGWNDAPPYDFTDWPPAWQEAVRAHHPAFDPRTSEAEHANGRLPEALRRRPGAVRSRHPDVSLAALGASAPALMDAHPWDDPHGPGSPLARLVALGGRVLLLGAPRDTMTLLHHAEALAQAPGKRFVTYEQPIEVAGERVWRTFRDIDSEHGAFDYSSAVPEGQDPFAVIVGSMLAAGIGREGFVGAARSRLFDAAPAVEFGVRWIEEHLNRDR	128.17	gnl|BL_ORD_ID|1365|hsp_num:0	1483			372	660	kanamycin A
BGC0000440.1|Teicoplanin_49 # 81952 # 82704 # 1 # ID=1_49;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=9bp;gc_cont=0.760	BGC0000440.1|Teicoplanin_49 	81952	82704	+	Loose	500	25.0238	SPG-1	33.33	3003720	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SPG beta-lactamase	ATGCCCGTACCTTGGTTCAGCGCGCCGCGCCCGCTCGCGGCCCCACGGTTGCGGCTGGTCTGTTTCCCGTACGCCGGGGGCAACGCCGCCACCTACCGCTCCTGGGCCGGACTCCTGCCGCCCGGGGTGGAGCTGGTCGCCGCGCTGCTGCCCGGCCGCGCCGAGCGCCTCGACGAGCCGCCCCTGGTGGATCTGGACGTGCTGCTGTCCGAGCTGGTGGCGGCGGCCGGCCCGCTGCTCGGCCCGGTCCCGCTGATCCTGTTCGGACACAGCCTCGGCGCGACCGTCGCGTACGAGTTCGGCCGCGCCCTGGCCACCGAGCACGGTTGCGTGCCCGCGGCCCTGCTGGTCTCCGGCGCCCCGGCGCCCCCGGTGCGCCGGCGCCGCACCGGCCGCGGCCTCTCCGACGACGACCTCGAACGGATCCTGGGCAAACGCACCGATCTCCCGGCCGGGTGGCTGACCGCCGAGCTCAAGCCGTTCGTGTTCCCGGCCCTGCGGGCCGACCTGCAGCTGCTCGACGGCTACCGCTGGCGGCCCGGCCCGCTTCCCGGCGTGCCGGTGGTCGCCTTCGGCGGGGATGCCGATCCGGACGTGTCCGCCGCCGATCTGCGGGCGTGGCAGCGGTGCACGACCGGCCCGGCCCGCACCCACGTGCTGGCCGGCGACCATTTCTTCATCGCGCACCAACCGTTCCGCGAGCTTCTCGCCGCCACGGTGGGCGAGTTCGCCGCCAGCCCGATCGCCCGGTGA	MPVPWFSAPRPLAAPRLRLVCFPYAGGNAATYRSWAGLLPPGVELVAALLPGRAERLDEPPLVDLDVLLSELVAAAGPLLGPVPLILFGHSLGATVAYEFGRALATEHGCVPAALLVSGAPAPPVRRRRTGRGLSDDDLERILGKRTDLPAGWLTAELKPFVFPALRADLQLLDGYRWRPGPLPGVPVVAFGGDADPDVSAADLRAWQRCTTGPARTHVLAGDHFFIAHQPFRELLAATVGEFAASPIAR	MRPLILLASALAMTAPSGALAQSAEQRAKWNGPREPFRITGNLYYVGTSGLSAYLIAGPRGHVLIDGALPESAPLIAANIRKLGFKLSDVKYLLSNHSHVDHAGGLAELKRLTGAQMVANVADKPDLEAGTTIGRTDIADFPAVKVDRVIGDGDRLTLGPIALVAILTPGHTKGATSWTTRIGSKNVIFTSSISVAGQNLINNINYPNAAADFRASFAKLRALKADIFLSFHAEAFALDEKRARAQAGATDAFVDPNELSRQVDLAEKAFDATLAKQQAANADRR	87.72	gnl|BL_ORD_ID|2032|hsp_num:0	2235			375	501	
BGC0000440.1|Teicoplanin_50 # 82813 # 83229 # -1 # ID=1_50;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.681	BGC0000440.1|Teicoplanin_50 	82813	83229	-	Loose	500	28.4906	OXA-54	27.85	3001812	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGTGATTGTCATGTCCAAGATGAGGAACCTCAAGGTTGTCGGCGCCGCAGTGGCCACGCTGGGACTCGCCGCCACACTCGTCACCGGCGGAGCGGCGACCGCCAGTCCGTCGACGGAGAAGCCGGATGCCGGTTCGCACGTCGAGCTCCGCGCCGCGACCGCGGCGGTGCCCTGCTGGACCTCCGTCGAGCAGCCCAACGGCACGGGCACGACCATCTACGTGACCTACAACAACTGCGGCACGACGAACGCGAAGGTGACGCCGGCCTCGTCCGCCGTCAACAACAGCGGCACCTTCACCTATGTCGGCTGGTGCGCGACCATCACCCCCGGCACCGCCGGCGCCTGGGCGATCACTCCGGACTGGTTCCCGTCGACGCCGACGAACCGCTACACCGTGACGAACTGCCTCTAG	MVIVMSKMRNLKVVGAAVATLGLAATLVTGGAATASPSTEKPDAGSHVELRAATAAVPCWTSVEQPNGTGTTIYVTYNNCGTTNAKVTPASSAVNNSGTFTYVGWCATITPGTAGAWAITPDWFPSTPTNRYTVTNCL	MRVLALSAVLVVASIVGMPAMANEWQEKPSWNTHFSEHKAQGVIVLWNENKQQGFTNNLKRANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVVPVYQEFARQIGQARMSKMLHAFDYGNEDISGNLDSFWLDGGIRISATEQVAFLRKLYHNKLHVSERSQRIVKQAMLTEANSDYIIRAKTGYSTRIEPQIGWWVGWVELDDNVWFFAMNMDMPTADGLGLRQAITKEVLKQEKIIP	52.08	gnl|BL_ORD_ID|398|hsp_num:0	441			0	213	cloxacillin; oxacillin; cefalotin
BGC0000440.1|Teicoplanin_51 # 83287 # 84903 # 1 # ID=1_51;partial=00;start_type=GTG;rbs_motif=GAGG;rbs_spacer=9bp;gc_cont=0.772	BGC0000440.1|Teicoplanin_51 	83287	84903	+	Loose	1050	28.1054	srmB	34.43	3002828	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	GTGTTCGGTGAGCATGTGCGGACCCACCGGCAGCGACTCGGTCTCACCCAGGACGACCTGGCCGAGCGGGCCGGGCTGGGAGTGCGCAGCATTCGCAACATCGAGGCGGGCCGGGTTCGTGTGCCCCGGCCGTCCACGGTACGGCTGCTCGCCGACGCCTTCGCGCTGACCGGCCCTGCCCGGGACCTGTTCTGCTCGATCGCCGCTGCGCCCCGGGCCGTGCCGGTGGCCCCGAGCGACCCGCCGGTCGTGCCGCGGCAGCTGCCCGCCGCCAGCCCGGCGCATGTCGGGCGCCGAGCCGCGCTGGCCGCCCTCGACCAGCTGCTGGTCACCCCGTGTCGGCTCGCGGTCGTGCAGGGCCCCGCCGGGATCGGGAAGAGCACGCTGGCGCTGCACTGGGCGCACCGCGTCGCGTCCCGGTTCCCCGACGGCCAGCTCTATCTGGACCTCAAGGGCTACGGCCCGGCCCCGGCACCGCTCGGCGTGGCGGATGCGCTGTGCCGCCTGCTGGACGGGTTCGGTGTGCCGGCGGCGCGCATCCCCGCCGACACCGACGCCCGCGCCGCACTGTTGCGCAGCGTGACGGCCGACCGGAGCTTCCTGCTCGTGCTCGACAACGCGCGCGACGCCGACCAGGTCCGGCCGCTGTTGCCGGGCGCGCCGGGCGCCGTCACCGTCGTCACCAGCCGGGCCGACCACGCCGGCCTGGTCACGACAGCGGCCGCGCGCCTGGTGCCCCTCGGCCTGTTCCACGAGCGGGACGCCATCGACCTGCTCACCCACCACCTCGGCGCGGAGCGGGTGGCGGCCGAGCCGGCGGCCGTCTCCGCCATCATCGGGCGCTGCGCGCGGCTGCCGCTCGCCCTCGCGATCATCGCCGGCCGCGGCGCGGCCCGCGCCGACTTTCCGCTCAGCGAGCTGACCGGCGGCCCCTCGGTGCTCGACGAGCTCACCGGCGACGACGTCGGCGCCGACTTCCGGACCGTCATCTCCTGGTCGTACCGGCTGCTCAGCACGTCCGCCGCGCGGCTGTTCCGGCTGCTCGGCGCGGCTCCCGGCCGGGACATCGGCCCCGCCGCGGCGGCCAGCCTGGCCGGCACACCAGTGCGGGCGACCCGCCGCGACCTGCGCGAGCTCACCGCCGCGCATCTGGCGCACGAGCACCGGTCCGGGCGGTACCAGGTGCACGCGCTGCTCCGGTCCTACGCCGTCGAGCTGTGCTCCGGTCACGACCCGGCGTCCGAGCGGGACACCGCCCGGCGCCGGCTCGTCGACCACTACCTGCATGCGGCGTACGCCGCCGCGCCGCTGCTCGCGCCACGGCTGGCGCGGGGGCCGCTGCCGGCCCGGTGCGACGGCGTCACCGCCGAGCGGCCCGCCGACAGCCGAGCGGCGTTCGACTGGTTCACCGACGAGTACCCGAATCTGGTCGAGGTCCTGGCCCTGGCCCGCGACCTGGGCCTGCACGCCCATGCCTGGCAGCTGGCCGGCGCGGTGGGCGCGTTCCGGCACCGCCGCGGCCGATGGCACGACGTGATCGGACCGCACCGGGACGCGCCGGCCGTGGCCCCCGGCGACCCCATCGCCAGCGGCACTCCGGGCACGGGCTCGGCCTGA	MFGEHVRTHRQRLGLTQDDLAERAGLGVRSIRNIEAGRVRVPRPSTVRLLADAFALTGPARDLFCSIAAAPRAVPVAPSDPPVVPRQLPAASPAHVGRRAALAALDQLLVTPCRLAVVQGPAGIGKSTLALHWAHRVASRFPDGQLYLDLKGYGPAPAPLGVADALCRLLDGFGVPAARIPADTDARAALLRSVTADRSFLLVLDNARDADQVRPLLPGAPGAVTVVTSRADHAGLVTTAAARLVPLGLFHERDAIDLLTHHLGAERVAAEPAAVSAIIGRCARLPLALAIIAGRGAARADFPLSELTGGPSVLDELTGDDVGADFRTVISWSYRLLSTSAARLFRLLGAAPGRDIGPAAAASLAGTPVRATRRDLRELTAAHLAHEHRSGRYQVHALLRSYAVELCSGHDPASERDTARRRLVDHYLHAAYAAAPLLAPRLARGPLPARCDGVTAERPADSRAAFDWFTDEYPNLVEVLALARDLGLHAHAWQLAGAVGAFRHRRGRWHDVIGPHRDAPAVAPGDPIASGTPGTGSA	MSIAQYALHDITKRYHDCVVLDRVGFSIKPGEKVGVIGDNGSGKSTLLKILAGRVEPDNGALTVVAPGGVGYLAQTLELPLDATVQDAVDLALSDLRELEAAMREAEAELGESDENGSERELSAGLQRYAALVEQYQARGGYEADVRVEVALHGLGLPSLDRDRKLGTLSGGERSRLALAATLASSPELLLLDEPTNDLDDRAMEWLEDHLAGHRGTVIAVTHDRVFLDRLTTTILEVDSGSVTRYGNGYEGYLTAKAVERERRLREYEEWRAELDRNRGLITSNVARMDGIPRKMSLSVFGHGAYRRRGRDHGAMVRIRNAKQRVAQLTENPVHAPADPLSFAARIDTAGPEAEEAVAELTDVRVAGRLAVDSLTIRPGERLLVTGPNGAGKSTLLRVLSGELEPDGGSVRVGCRVGHLRQDETPWAPGLTVLRAFAQGREGYLEDHAEKLLSLGLFSPSDLRRRVKDLSYGQRRRIEIARLVSDPMDLLLLDEPTNHLTPVLVEELEQALADYRGAVVVVTHDRRMRSRFTGARLTMGDGRIAEFSAG	97.82	gnl|BL_ORD_ID|110|hsp_num:0	128			1005	1188	spiramycin
BGC0000440.1|Teicoplanin_54 # 86669 # 87100 # -1 # ID=1_54;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.708	BGC0000440.1|Teicoplanin_54 	86669	87100	-	Loose	1050	25.409	facT	38.71	3001313	protein homolog model	n/a	n/a	elfamycin antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGTGGGCGGACGTGCTTTCATCGGCGGCTCCGACACCGCGACCCCGGGAGCCGACGATCTTCTTCTTCGAGGGTGAGCGGGCCGGGCTGGCCAAGCGCCGGTCCCCGCTGGCCGGCTTCTGGGCGCTGCTGGTGGGCGGCGTCCTGGTCACCGTGCTGACGGTGGCGCTGCGGCCGGCGACCGACGTGCGCGACTGCCCGAACTACGGCGGCAACGGCAACGCCAGCGCCTTCCCCGACGAGATCTGGGACCTGTATTACCCGCTGATCCTGCTCGGCTGGCTGCTCGCGGTCGTGGTGGAGCAGTTGGTCCCGGTCACCTGGAACGGCCGTCGGGCCGGTCCGATCGTCGTCCGCGCCCTCCTCGCCGTCATGATCGCCTTGACCGCGTCCTGCTGCGCCGCCGTCAAGCTGCTGACCCTCTGCCACTAG	MWADVLSSAAPTPRPREPTIFFFEGERAGLAKRRSPLAGFWALLVGGVLVTVLTVALRPATDVRDCPNYGGNGNASAFPDEIWDLYYPLILLGWLLAVVVEQLVPVTWNGRRAGPIVVRALLAVMIALTASCCAAVKLLTLCH	MNKAGQAEKPAAAGPPATPETPEPDPKRWLALTVLLVATFMDLLDANIITVAIPSIQRDLGASTFAIQAMTAGYTLSFAVLLITGGRLGDIFGRKRMFLVGVGGFVLASAMCAAAPSTDLLVVARALQGLTAAVMVPQVLALIHVSFAPQEIGRVVSLYASMVGLAIVSGPLIGGALISWNPLDLGWRSIFVVNLPVGVLALVGAAKWMRESSSPHAKRLDIAGMLLIVLGLLLLMVPLTLGRELDWPVWSIVSLVAAAPVLVLFVVYERHKTAKDGSPLVTLSLFKVRAFGAGIGVQLLFSAIPAGFFLSWTLYLQAGLGWSALHTGLTAIPFSLCVPIVGGLAVRRLSPLYGRYCLLAGAVLMLAGILSYAWAADRFGTDITSWHAIPSMLLIGSGMGMLMPPLTALVLREVQPQEAGAASGIINATGQLGAALGVAVIGSLFFAALAGNAGPQAERVAPTVQSVSPRQASDLRDCATEALGQDDLAKVPDICSTLVQGADDGTRDTINGALGEIRAKTFVSTYSETLYWAAGGLVPVTALVLLLPHHRVRREEPAQ	25.58	gnl|BL_ORD_ID|1345|hsp_num:0	1469			1386	1479	factumycin
BGC0000440.1|Teicoplanin_55 # 87213 # 87347 # 1 # ID=1_55;partial=00;start_type=GTG;rbs_motif=GAGG;rbs_spacer=7bp;gc_cont=0.719	BGC0000440.1|Teicoplanin_55 	87213	87347	+	Loose	700	21.9422	OCH-6	37.5	3002519	protein homolog model	n/a	n/a	monobactam; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	OCH beta-lactamase	GTGGACGCCTCGGCATCGGTCAGCCCTGACGTGTCGGTCTTCGTCGACGACGTCCACGCGGCCCTCTCCCGGGTGGGGGCGGCGGGGTGGGAGATCGTGCATCCGCTCGGCGTCTGCCGCGTGCCGGTCGTATGA	MDASASVSPDVSVFVDDVHAALSRVGAAGWEIVHPLGVCRVPVV	MRKSTTLLIGFLTTAAIIPNNGALAASKANDGDLRRIVDETVRPLMAEQKIPGMAVAITIDGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAPELAGSSFDKITMRDLGTYTPGGLPLQFPDAVTDDSSMLAYFKKWKPDYPAGTQRRYSNPSIGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSGGALDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVGANNQGLGWEFYNYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVWLNKTGSTNGFGAYAAFIPAKKTGIVLLANRNYPIDERVKAAYRILQALDNKQ	11.28	gnl|BL_ORD_ID|1560|hsp_num:0	1698			798	894	
BGC0000440.1|Teicoplanin_56 # 87379 # 88320 # -1 # ID=1_56;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5bp;gc_cont=0.720	BGC0000440.1|Teicoplanin_56 	87379	88320	-	Loose	350	25.0238	vanB	42.11	3000013	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGATCACGTATCGGACCACCGGTCTCCCCGGTCCCGCGCCCACGGCGACCGTATCGGTCAAGCCGATCGTGCTGCCCGCGGCGCGGCGCGGCGGGGACCTGCAGGTGCGGGTCTCCGCACCGGTCACCGGCACCAACCTGCCGGTGGTGGTGTTCGCGCACGGATACGGATCGAACCTCGACGGCTACGGACCGCTGGTCGATCACTGGGCGGCCCACGGCTTCGTGGTGGTCCAGGCCACCCACCTGGACTCCCGGCGCCTCGACGTCGCAGCGGACCGGTCCCGCAGGCCGCACCTCTGGCTCTACCGGGTGCGGGACATGAAACGGATCCTCGACGGACTCGACGTTCTGGAGGCCTCGGTGCCCGGGCTGACCGGCCGGGCCGACCATCGTCGTATCGTCGCGGCCGGGCACTCCTTCGGCGGCCAGACCGCCGGCATCCTGGTGGGTCTGCGCGTCGCCGATCCGATGACCGGCATCGCGCGGGACCTGTCCGATTCCCGGGTCATCGCGAGCATTCAGCTGGCCACCGCCGGCCGCGGCGGCGACGATCTGACCCCGTTCGCCCTCCAGGTCGCACCCTGGCTGCGCGACCAGGACTTCTCGCACATCACCGCACCCGGGCTCGTCGTCGCCGGCGACCAGGACGAACTCCCGCTGTCCACCCGCGGAGCGTCCTGGATGACCGACCCGTACACCCTGGCCCGCGGCGCCAGGAGCCTGCTGACCGTTTTCGGCGGCCAGCACTCGCTCGGCGGCATCTCCGGTTACGACGCGGCGGAGACCACCGACGAGCACCCGGACCGGGTCGCGCTCATCCAGCAGGTCACCCTCGCCTACCTGCGCCACGTCACCGGCGTCGACCACACCGGCTGGCGAACCGCCCAGGCCCTCCTGGCCGGTGACTCCCACCGGCTCGGCCGGCTCGAATCCAAGTGA	MITYRTTGLPGPAPTATVSVKPIVLPAARRGGDLQVRVSAPVTGTNLPVVVFAHGYGSNLDGYGPLVDHWAAHGFVVVQATHLDSRRLDVAADRSRRPHLWLYRVRDMKRILDGLDVLEASVPGLTGRADHRRIVAAGHSFGGQTAGILVGLRVADPMTGIARDLSDSRVIASIQLATAGRGGDDLTPFALQVAPWLRDQDFSHITAPGLVVAGDQDELPLSTRGASWMTDPYTLARGARSLLTVFGGQHSLGGISGYDAAETTDEHPDRVALIQQVTLAYLRHVTGVDHTGWRTAQALLAGDSHRLGRLESK	MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWEADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVGCDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGVTKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIFRIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGIVLNEVNTLPGFTSYSRYPRMMAAAGITLPALIDSLITLALKR	91.52	gnl|BL_ORD_ID|1005|hsp_num:0	1098			222	279	vancomycin
BGC0000440.1|Teicoplanin_57 # 88431 # 88886 # 1 # ID=1_57;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=8bp;gc_cont=0.704	BGC0000440.1|Teicoplanin_57 	88431	88886	+	Loose	200	60.077	Pseudomonas aeruginosa soxR	32.76	3004107	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGTATCGGCGAGCTGGCCGCCCGCACCGGTGTCAGTGTCCGGGCACTGCGCTACTACGAGCAGCAGGATCTGCTCAGCGCCGAGCGCGGTTCGAGCAGCCATCGCCGGTACCCCGAGAGCGCGGTCGACCGGGTCCAGCTGATCCAGCGGTTGTACCAGGCCGGGCTGACCAGCAAGACCATCGTCGAGCTGCTGCCGTGCGTCGTCGGTGACCGCGCCACCCCGGCGATGCTCGAGCGGCTGGCAGCCGAACGCGAGCAGATCGATCAGCGCATCACCGATCTCGTCCGAACCCGGGACCGGCTCGACGCCGTGATCAGCAACGCGACCGACAGCATGCTTACCGGCGCCTCCTGCCGTGACGGTGACGTATCCGGCCGGCGGCCGGGCACGAAGCCGCGGCGATCGGCGGGAGGGACCGTGCGGGAGGAACACGGCGGGGGCGAGGTGTGA	MRIGELAARTGVSVRALRYYEQQDLLSAERGSSSHRRYPESAVDRVQLIQRLYQAGLTSKTIVELLPCVVGDRATPAMLERLAAEREQIDQRITDLVRTRDRLDAVISNATDSMLTGASCRDGDVSGRRPGTKPRRSAGGTVREEHGGGEV	MKNSCASRELSVGELARRAGVAVSALHFYETKGLISSQRNAGNQRRFSRETLRRVVVIKVAQRVGIPLAEIARALQTLPAGRSPSAADWARLSAQWKEDLTERIDKLLLLRDQLDGCIGCGCLSLQACPLRNPGDQLSAEGPGAHWLDAEGREHDG	96.79	gnl|BL_ORD_ID|2395|hsp_num:0	2775			27	375	tigecycline; ciprofloxacin; acriflavine; tetracycline; rifampin; chloramphenicol; ampicillin; norfloxacin; cefalotin; triclosan
BGC0000440.1|Teicoplanin_58 # 88969 # 89091 # 1 # ID=1_58;partial=01;start_type=ATG;rbs_motif=AGGA;rbs_spacer=12bp;gc_cont=0.797	BGC0000440.1|Teicoplanin_58 	88969	89091	+	Loose	900	21.1718	smeC	45.45	3003053	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGACAGGCAGCGCATCTTCCGGGCCGCGGCGACCGCGGCGGCCCTCACCGTGATCGCCGGGTGTGGTTCCGGCACGCCGGACGAGGGCGGGGCGGCCGCCGGCGGCGCCGCCCTCGCGGAT	MDRQRIFRAAATAAALTVIAGCGSGTPDEGGAAAGGAALAD	MKPMLLRALAAATMTTVLGGCVSMAPHYQRPEAPVPAQFGNAAIGAAEPALAMPAWRDVFLEPRLQQVIALALQNNRDLRVAVLQVEKERAQYRIQRAALLPSVDASGSVTRSRVSDANSETGVTQVTESDAVQVGISSWELDLFGRIRSLKNEALQNWLASAENQRAVRTSLVAEVATAWLALAADEQSLAFTQQTLDSQHQTLQRTEARHAQGLASGLDLSQVQTSVEAARGALAKLQAQQAQDRDALQLLVGAPLDPALLPTAQALDGSVALAPLPANLPSSVLLQRPDVLSAEHALQAANADIGAARAAFFPTLALTANYGHSSTALSTLFSAGTRGWSFAPSITAPIFHAGALKASLDASKIGKDIGIAQYEKAIQQAFSEVADALATRDHLTAQLDAQRALVADSQRSYTLADARYRTGLDGYLQSLDAQRSLYAAQQDLIALQQQEAGNRVTLFKVLGGGADAR	8.70	gnl|BL_ORD_ID|1160|hsp_num:0	1264			12	78	
